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Abstract		Premature	 ejaculation	 (PE)	 is	 characterized	 by	 a	 pattern	 of	 involuntary	ejaculation	prior	to,	upon,	or	shortly	after	penetration	leading	to	personal	or	interpersonal	 distress.	 Some	 definitions	 add	 a	 time	 limit	 of	 about	 1	minute	following	penetration.	Around	25%	of	the	male	population	report	ejaculating	before	 they	 wish	 to	 do	 so,	 while	 about	 4%	 are	 estimated	 to	 meet	 current	diagnostic	criteria.	PE	has	been	associated	with	anxiety,	depression,	low	self-esteem,	 sexual	distress,	 interpersonal	difficulties	 and	a	decreased	 quality	 of	life.	Little	is	known	of	what	causes	PE.	Many	possible	etiological	factors	have	been	explored,	however,	none	have	as	of	yet	been	replicated	and	confirmed	in	large	scale	studies.	The	 first-line	 treatment	 for	PE	 today	 is	pharmacological,	namely	 using	 selective	 serotonin-reuptake	 inhibitors,	 sometimes	 combined	with	sexological	therapy.			
Study	 I	 aimed	 at	 clarifying	 the	 temporal	 stability	 of	 PE	 symptoms.	 Two	longitudinal	samples	were	used:	a	population-based	sample	followed	six	years,	and	a	sample	of	patients	previously	diagnosed	with	PE,	who	were	untreated	at	the	time	of	the	study,	followed	three	years.	In	the	population-based	sample,	less	than	half	of	those	who	reported	ejaculation	latency	times	(ELT)	of	less	than	1	minute	at	the	first	data	collection	also	reported	it	six	years	later.	In	this	sample,	47%	 reported	 having	 experienced	 a	 change	 in	 ELT	 between	 the	 two	measurement	points.	In	the	clinical	sample,	only	5	out	of	16	men	reported	ELTs	of	less	than	1	minute	at	both	time	points.	In	the	clinical	sample,	63%	reported	having	experienced	a	change	in	ELT	between	the	two	measurement	points.		
Study	II	aimed	at	clarifying	the	direction	of	causality	between	PE	symptoms	on	the	one	hand,	and	anxiety,	depression,	and	sexual	distress	on	the	other.	In	a	longitudinal,	 population-based	 sample	 followed	 six	 years,	 bivariate	 analyses	revealed	that	PE	and	sexual	distress	were	mutually	positively	correlated	acorss	time.	Also	across	time,	PE	was	positively	correlated	with	future	anxiety,	and	depression	was	positively	 correlated	with	 future	PE.	 Correlation	coefficients	were	small	to	moderate.	However,	when	fitting	structural	equation	models	to	the	data,	 no	 associations	were	 found	across	 time	 between	PE	and	 the	other	variables.		
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Study	 III	 explored	 associations	between	PE	and	 the	 lifestyle	 factors	 alcohol	use,	physical	exercise,	and	body-mass	index.	Cross-sectional	population-based	and	 clinical	 samples	were	 used.	The	most	 consistent	 finding	was	 a	negative	association	between	PE	and	physical	exercise.	While	the	effect	size	was	small,	the	negative	association	was	robust,	since	it	was	observed	when	comparing	the	clinical	 sample	 to	 both	 the	 whole	 population-based	 sample	 and	 to	 an	 age-matched	subsample,	as	well	as	within	samples	and	in	multivariate	analyses	of	all	study	variables.		
Study	 IV	 aimed	 at	 developing	 more	 effective	 psychobehavioral	 treatment	protocols	 for	PE.	 Fifty	 PE	patients	were	 randomized	 into	 three	 groups:	 1)	 a	treatment	 regime	 consisting	 of	 vibrator-assisted	 start-stop	 exercises	 2)	vibrator-assisted	 start-stop	 exercises,	 and	 additional	 psychoeducation	 and	exercises	 aimed	 to	 improve	 the	 patient’s	 awareness	 and	 utilization	 of	physiological	cues	 related	 to	 sexual	arousal,	or	3)	waiting-list	control	group.	Both	 treatment	 groups	 improved	 with	 large	 effect	 sizes	 after	 treatment	compared	to	the	control	group.	The	treatment	groups	did	not	differ	on	the	PE	outcome	measure	at	any	time.	However,	the	second	group	also	improved	on	most	 secondary	 outcome	 measures,	 including	 anxiety	 and	 sexual	 distress,	indicating	a	favorable	outcome	for	the	group	receiving	additional	intervention.		In	 conclusion,	 PE	 symptoms	 might	 not	 be	 quite	 as	 stable	 over	 time	 as	previously	thought.	I	suggest	that	the	current	cutoff	for	ELT	for	PE	diagnosis	at	1	 minute	 is	 unnecessarily	 strict.	 Increasing	 the	 temporal	 criterion	 to	approximately	2–4	minutes	would	reduce	false	negatives,	while	the	criteria	for	distress	 and	 control	 reduce	 the	 risk	 of	 false	 positives.	 Furthermore,	 results	from	 the	 present	 studies	 showed	 no	 indication	 that	 anxiety	 and	 depression	would	be	major	etiological	factors	in	PE.	Hence,	these	should	probably	not	be	targeted	in	most	cases	in	attempts	to	improve	PE.	On	the	other	hand,	increased	physical	 exercise	may	be	 a	promising	 intervention	 for	 PE	 in	 some	men,	 and	should	 be	 further	 investigated	 in	 future	 studies.	 Vibrator-assisted	 start-stop	exercises	are	supported	by	replicated	evidence	suggesting	that	they	are	viable	treatment	options	for	PE.							 	
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Svensk	sammanfattning	Omkring	 en	 fjärdedel	 av	 alla	 män	 upplever	 att	 de	 vid	 samlag	 får	 utlösning	tidigare	än	de	önskar.	Ofrivillig	tidig	utlösning	(prematur	ejakulation,	PE)	har	samband	 med	 bl.a.	 lägre	 upplevd	 livskvalitet,	 ångest	 och	 interpersonella	problem.			I	 den	 första	 studien	 följdes	 för	 första	 gången	 symptomutvecklingen	 bland	obehandlade	män.	Det	fanns	betydande	variation	i	symptomnivå	över	några	års	tid,	och	ungefär	hälften	svarade	att	de	upplevt	en	förändring	i	latenstid.	Bland	en	grupp	som	tidigare	hade	diagnosticerats	med	PE	var	det	endast	en	tredjedel	som	uppfyllde	det	mest	strika	kriteriet	för	livslång	PE	vid	båda	mätningarna.		Lite	är	känt	gällande	vad	som	orsakar	PE.	 I	den	andra	studien	analyserades	möjliga	 kausala	 associationer	 mellan	 PE,	 ångest	 och	 depression.	 Även	 om	förväntade	bivariata	associationer	kunde	påvisas	över	tid	var	dessa	så	små	att	de	i	strukturekvationsmodeller	inte	var	statistiskt	signifikanta	över	en	period	på	 sex	 år.	 I	 den	 tredje	 studien	 analyserades	 associationer	 mellan	 PE	 och	livsstilsfaktorerna	fysisk	aktivitet,	alkoholbruk	och	kroppsmasseindex.	Fysisk	aktivitet	 var	 associerat	med	 lägre	 symptomnivå	 för	 PE.	 Effektstorleken	 var	liten,	men	kvarstod	även	när	övriga	faktorer	och	ålder	togs	i	beaktande.		Syftet	i	den	fjärde	studien	var	att	testa	och	vidareutveckla	en	psykobehavioral	behandlingsmetod	för	PE.	Femtio	deltagare	randomiserades	till	tre	grupper.	En	behandlingsgrupp	utförde	start-stop	övningar	med	en	handhållen	vibrator,	och	en	 annan	 behandlingsgrupp	 fick	 därutöver	 psykoedukation	 och	 utförde	övningar	för	att	öka	interoceptiv	medvetenhet.	Kontrollgruppen	fick	inte	någon	behandling.	 Båda	 behandlingsgrupperna	 uppvisade	 förbättringar	med	 stora	effektstorlekar	efter	behandlingen.	Den	andra	behandlingsgruppen	uppvisade	därtill	förbättringar	på	ett	flertal	sekundära	utfallsmått.			Föreliggande	 avhandling	 har	 visat	 att	 det	 finns	 betydande	 variation	 i	symptomnivå	över	tid,	vilket	kan	innebära	att	PE	ibland	inte	är	fullt	så	kronsikt	som	 hittills	 antagits.	 Detta	 öppnar	 dörren	 för	 kurativa,	 snarare	 än	symptomlindrande,	 behandlingar,	 av	 vilka	 vibratorassisterade	 start-stop	övningar	har	visats	vara	ett	gångbart	alternativ.	 	
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1.	INTRODUCTION	Premature	ejaculation	(PE)	is	considered	to	be	one	of	the	most	common	sexual	complaints	among	men,	as	approximately	20-30%	of	all	men	report	that	they	usually	 ejaculate	 before	 they	 wish	 to	 do	 so	 (Althof	 et	 al.,	 2014).	 However,	current	 diagnostic	 criteria	 (e.g.,	 in	 the	 DSM-5,	 American	 Psychiatric	Association,	2013,	p.443)	do	not	rely	solely	on	subjective	complaints,	but	also	on	 a	 time	 limit	 of	 approximately	 1	 minute.	 When	 these	 criteria	 are	 used,	prevalence	figures	have	been	estimated	to	around	4%	(Althof	et	al.,	2014),	as	most	men	who	subjectively	experience	rapid	ejaculation	engage	in	intercourse	for	longer	than	1	minute.		Studies	have	repeatedly	shown	that	PE	is	associated	with	a	range	of	negative	consequences	 for	 the	 individual,	 including	 lower	 confidence	and	self-esteem	(Rowland,	Patrick,	Rothman,	&	Gagnon,	2007;	Symonds,	Roblin,	Hart,	&	Althof,	2003),	personal	distress	(Giuliano	et	al.,	2008;	Patrick	et	al.,	2005;	Rowland	et	al.,	2007),	anxiety	(Dunn,	Croft,	&	Hackett,	1999;	Porst	et	al.,	2007;	Symonds	et	al.,	 2007)	 and	depression	 (Porst	 et	 al.,	 2007).	 Individuals	 suffering	 from	PE	report	 interpersonal	 difficulties	 (Giuliano	 et	 al.,	 2008;	 Patrick	 et	 al.,	 2005;	Rowland	et	al.,	2007),	 including	avoiding	discussing	sexual	issues	with	one’s	partner	 (McMahon	 et	 al.,	 2004),	 and	 refraining	 from	 establishing	 new	relationships	 (Symonds	 et	 al.,	 2003).	 For	 the	 partner,	 PE	 is	 negatively	associated	 with	 sexual	 satisfaction	 (Riley	 &	 Riley,	 2005)	 and	 orgasmic	frequency	(Hartmann,	Schedlowski,	&	Krüger,	2005).	Taken	together,	it	is	clear	that	PE	can	lead	to	a	severely	decreased	quality	of	life	(Rosen	&	Althof,	2008).			1.1	Definitions	1.1.1	According	to	the	International	Society	for	Sexual	Medicine	The	second	International	Society	for	Sexual	Medicine	(ISSM)	Ad	Hoc	Committee	for	 the	 Definition	 of	 Premature	 Ejaculation	 (Serefoglu	 et	 al.,	 2014,	 p.	 44)	defined	PE	as	follows:		 1.	Ejaculation	that	always	or	nearly	always	occurs	prior	to	or	within	about	1	minute	of	vaginal	penetration	(lifelong	PE)	or	a	clinically	significant	and	bothersome	reduction	in	latency	time,	often	to	about	3	minutes	or	less	(acquired	PE).		2.	The	inability	to	delay	ejaculation	on	all	or	nearly	all	vaginal	penetrations.		
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3.	 Negative	 personal	 consequences,	 such	 as	 distress,	 bother,	 frustration,	and/or	the	avoidance	of	sexual	intimacy.			1.1.2	 According	 to	 the	 Diagnostic	 and	 Statistical	 Manual	 of	 Mental	Disorders	5		The	5th	 edition	of	 the	Diagnostic	and	Statistical	Manual	of	Mental	Disorders	(American	Psychiatric	Association,	2013,	p.	443)	defines	PE	as	follows:			(A)		 A	 persistent	 or	 recurrent	 pattern	 of	 ejaculation	 occurring	 during	partnered	 sexual	 activity	 within	 approximately	 1	 minute	 following	vaginal	penetration	and	before	the	individual	wishes	it;		(B)		 The	 symptom	 in	 Criterion	 A	 must	 have	 been	 present	 for	 at	 least	 six	months	and	must	be	experienced	on	almost	all	or	all	(approximately	75–100%)	occasions	of	sexual	activity	(in	identified	situation	contexts	or,	if	generalized,	in	all	contexts);		(C)		 The	symptom	in	Criterion	A	causes	clinically	significant	distress	in	the	individual;		(D)		 The	 sexual	 dysfunction	 is	 not	 better	 explained	 by	 a	 nonsexual	 mental	disorder	 or	 as	 a	 consequence	 of	 severe	 relationship	 distress	 or	 other	significant	 stressors	 and	 is	 not	 attributable	 to	 the	 effects	 of	 a	substance/medication	or	another	medical	condition.			According	 to	 the	 manual,	 PE	 can	 be	 specified	 as	 lifelong	 or	 aquired	 (i.e.,	whether	or	not	the	disturbance	been	present	since	the	individual	first	became	sexually	active),	generalized	or	situational	(i.e.,	whether	or	not	it	occurs	only	with	 certain	 types	 of	 stimulations,	 situations	 or	 partners),	 and	 the	 current	severity	 can	 be	 specified	 as	 mild,	 moderate	 or	 severe	 (i.e.,	 intravaginal	ejaculation	latency	times	[IELT]	of	30-60	seconds,	15-30	seconds,	and	less	than	15	seconds,	respectively).		1.1.3.	According	to	the	International	Statistical	Classification	of	Diseases	and	Related	Health	Problems	-	Eleventh	Revision	(ICD11)		The	World	Health	Organization	(2018)	defines	male	early	ejaculation	(PE)	as	follows:	
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“Male	 early	 ejaculation	 is	 characterized	 by	 ejaculation	 that	
occurs	prior	to	or	within	a	very	short	duration	of	the	initiation	
of	 vaginal	 penetration	 or	 other	 relevant	 sexual	 stimulation,	
with	 no	 or	 little	 perceived	 control	 over	 ejaculation.	 The	
pattern	 of	 early	 ejaculation	 has	 occurred	 episodically	 or	
persistently	 over	 a	 period	 at	 least	 several	 months,	 and	 is	
associated	with	clinically	significant	distress.”			1.1.4	Classification	of	PE	subtypes	In	1943,	Shapiro	made	a	distinction	between	PE	of	type	A	and	B	based	on	his	clinical	observations,	with	one	difference	between	the	groups	being	that	group	A	had	gradually	developed	PE,	while	group	B	had	experienced	PE	from	the	very	first	 act	 of	 coitus	 (Shapiro,	 1943).	 Similarly,	 Godpodinoff	 (1989)	 made	 a	distinction	 into	 primary	 and	 secondary	 PE,	 where	 patients	 who	 reported	having	 had	 PE	 their	 entire	 lives	were	 classified	 as	 having	 primary	 PE.	 This	distinction	 is	still	 reflected	 in	 the	present	diagnostic	 criteria	by	 the	 ISSM,	 in	DSM-5,	and	in	the	ICD	as	lifelong	and	aquired	PE.	Additionally,	the	ICD	includes	an	“unspecified”	subtype,	for	patients	with	PE,	which	symptoms	do	not	fit	into	lifelong	or	acquired	PE.		1.2	Etiology	of	PE	The	 following	 sections	 review	 some	 of	 the	 many	 genetical,	 neurobiological,	psychological,	and	lifestyle	factors	that	have	been	proposed	to	be	part	of	the	etiology	of	PE.	While	the	mind	and	the	body	should	not	be	described	as	separate	entities	 (Rowland	&	Motofei,	 2007),	 since	 there	 is	 strong	 evidence	 that,	 for	example,	cognitive	processes	have	a	physiological	basis	in	the	brain	(Dehaene	&	Naccache,	2001),	the	term	“psychological	etiology”	is	used	here	in	the	sense	that	psychological	problems	may	contribute	to	PE.		1.2.1	Genetic	etiology	Evidence	from	twin	studies	indicate	a	heritable	component	of	around	30%	in	PE	etiology	(Jern,	Santtila,	Johansson,	Varjonen,	Witting,	von	der	Pahlen,	et	al.,	2009;	 Jern	 et	 al.,	 2007).	 This	 has	 spawned	 numerous	 attempts	 to	 identify	specific	 genetic	 loci,	mainly	 focusing	 on	 candidate	 genes	 in	 the	 serotonergic	system,	 however,	 no	 findings	 have	 thus	 far	 been	 reliably	 replicated	 (Jern	&	
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Ventus,	2017).	Regardless,	the	heritability	of	PE	is	lower	than	complex	traits	in	general	 (49%;	 Polderman	 et	 al.,	 2015),	 and	 the	 majority	 of	 variance	 in	 PE	appears	to	stem	from	non-shared	environmental	rather	than	familial	or	genetic	sources.		1.2.2	Neurobiological	etiology	The	monoamine	serotonin	is	believed	to	have	evolved	at	least	one	billion	years	ago,	 and	 is	 found	 in	 fungi,	 plants,	 and	animals	 (Azmitia,	 2006).	 Serotonin	 is	involved	in	a	wide	number	of	homeostatically	controlled	processes,	including	cell	 differentiation,	 temperature,	 blood	 clotting,	 digestion,	 attention,	aggression	and	mood,	with	most	of	the	body’s	serotonin	being	housed	 in	the	gut	 (Andrews,	 Thomson,	 Amstadter,	 &	 Neale,	 2012).	 Based	 primarily	 on	experimental	studies	on	animals,	the	serotonergic	system	has	been	proposed	to	 be	 involved	 in	 the	 regulation	 of	 the	 ejaculatory	 reflex.	 Specifically,	hyposensitivity	of	the	5-HT2C	and	hypersensitivity	of	the	5-HT1A	receptors	have	been	 hypothesized	 to	 be	 linked	 to	 early	 ejaculation	 (Waldinger,	 Berendsen,	Blok,	Olivier,	&	Holstege,	1998).	It	is,	however,	unclear	if	these	receptors	serve	the	same	function	in	different	species.	For	example,	orthologous	genes	rarely	contribute	to	the	same	genotype	in	rats	and	mice	(Vicens-Costa	et	al.,	2013).	If	mice	do	not	replicate	rats	on	a	genetic	level,	it	is	questionable	whether	results	from	research	on	mice	can	be	used	to	derive	hypotheses	for	human	contexts.	Regardless,	selective	serotonin	reuptake	 inhibitors	tend	to	delay	ejaculation,	which	 implies	 that	 men	 low	 in	 5-HT	 neurotransmission	 may	 have	 lower	ejaculatory	 thresholds	 (Althof	 et	 al.,	 2014).	 Dopamine	 and	 oxytocin	 both	appear	to	stimulate	ejaculation	in	animal	studies,	but	these	neurotransmitters	are	not	yet	well	studied	(Clément	et	al.,	2013,	2009).	There	is	some	evidence	indicating	 a	 neural	 organization	 in	 the	 spinal	 cord	 responsible	 for	 the	ejaculatory	reflex	in	both	rats	(Staudt	et	al.,	2012)	and	humans	(Chéhensse	et	al.,	2013).			
 1.2.3	Physiological	etiology	Experimental	studies	have	 found	associations	between	penile	sensitivity	and	ejaculatory	latency	(Guo	et	al.,	2017;	Xin	et	al.,	1996),	with	higher	sensitivity	being	 associated	 with	 shorter	 latency.	 Results	 are	 however	 not	 unanimous	(Perretti	et	al.,	2003;	Salonia,	Saccà,	et	al.,	2009).	Rowland,	Haensel,	Blom	and	Slob	(1993)	found	no	significant	difference	between	men	with	PE	(n	=	9)	and	
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sexually	 functional	 controls	 (n	 =	33),	 and	 significantly	 lower	 sensitivity	 in	 a	group	of	men	 suffering	 from	both	PE	and	 ED	 (n	 =	8),	which	 taken	 together	speaks	 against	 the	 hypersensitivity	 hypothesis.	 Nevertheless,	 the	 authors	found	a	strong	correlation	between	sensory	threshold	and	latency	within	the	PE	group	(r	=	.69,	p	.039).	That	penile	sensitivity	affects	ejaculatory	function	is	robustly	 supported	 by	 the	 evident	 ejaculation-dealying	 effect	 of	 topical	analgesics	(Wyllie	&	Hellstrom,	2011).	Note	that	this	does	not	necessitate	an	assumption	of	hypersensitivity	among	men	with	PE,	since	the	mechanism	is	the	same	 regardless	 of	 baseline	 sensitivity.	 Other	 proposed	 physiological	etiological	 components	 include	greater	 cortical	 representation	of	 the	genital	sensory	 stimuli	 (Fanciullacci,	 Colpi,	 Beretta,	 &	 Zanollo,	 1988),	 comorbid	erectile	difficulties	(Jannini,	Lombardo,	&	Lenzi,	2005),	prostatitis	(Screponi	et	al.,	 2001),	 and	 pelvic	 floor	 dysfunction	 (Myers	&	 Smith,	 2019).	 Zorba	 et	 al.	(2012)	measured	sympathetic	activity	by	means	of	heart	rate	variability,	and	found	increased	sympathetic	activity	in	patients	with	PE	compared	to	controls.	The	authors	hypothesize	that	the	increased	smooth	muscle	contractions	of	the	prostate	and	emission	of	seminal	fluids	following	sympathetic	activation	may	lead	 to	 PE	 in	 patients	 with	 an	 overactivation	 of	 the	 sympathetic	 nervous	system.		1.2.4	Psychological	etiology	Traditionally,	 psychological	 problems	 have	been	 seen	as	 contributing	 to	PE,	especially	 anxiety	 (Althof	 et	 al.,	 2014;	 McMahon	 et	 al.,	 2004).	 This	 is	 still	reflected	 in	 the	 DSM-5,	 as	 anxiety	 and	 depression	 are	 considered	 relevant	factors	supporting	diagnosis	(American	Psychiatric	Association,	2013,	p.	444).	In	a	meta-analysis	of	eight	observational	studies	involving	18,035	participants,	Xia	 et	al.	 (2016)	 found	a	statistically	 significant	association	between	PE	and	depression	(odds	ratio	=	1.63,	95%	CI	[1.42–1.87]).		Anxiety	and	PE	 in	 their	different	operationalizations	have	been	shown	to	be	associated	in	numerous	cross-sectional	studies.	Examples	include	associations	between	self-reported	anxiety	and	subjective	PE	symptom	severity	 (Porst	 et	al.,	 2007);	 associations	between	generalized	 anxiety	 and	 shorter	 ejaculation	latency	time	(Corona	et	al.,	2004;	Dunn	et	al.,	1999);	and	increased	incidence	of	 PE	 in	patient	 cohorts	diagnosed	with	 social	 phobia	 (Corretti,	 Pierucci,	 De	Scisciolo,	&	Nisita,	2006).	Liu	et	al.	(2019)	reported	significantly	higher	levels	of	anxiety	and	depression	in	patients	with	PE	compared	to	unaffected	controls,	
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and	 further,	 negative	 correlations	 between	 stopwatch-measured	 IELT	 and	anxiety	 in	both	patient	 and	 control	 groups,	 indicating	 that	 a	 shorter	 IELT	 is	associated	 with	 more	 symptoms	 of	 anxiety	 and	 depression.	 In	 a	 sample	 of	almost	800	men	complaining	of	PE,	Gao	et	al.	(2014)	found	increased	levels	of	anxiety	and	depression	in	men	with	PE	compared	to	controls,	and	especially	in	PE	subtypes	with	more	severe	symptoms.	 In	addition	to	the	aforementioned	studies,	where	general	and	trait-like	forms	of	anxiety	were	measured,	PE	has	also	been	found	to	be	associated	with	more	transient	forms	of	anxiety,	such	as	performance	anxiety	(Hartmann	et	al.,	2005;	McCabe	&	Cobain,	1998).	In	two	recent	 studies	 utilizing	 the	 Spielberg	 state–trait	 anxiety	 scale	 (Spielberger,	Gorusch,	&	Lushene,	1970),	the	researchers	found	associations	between	PE	and	state	anxiety,	but	not	trait	anxiety	(Kempeneers,	Andrianne,	Cuddy,	&	Blairy,	2018;	Mourikis	et	al.,	2015).	While	most	of	these	associations	have	been	of	a	small	to	moderate	effect	size,	there	does	seem	to	be	a	connection	between	PE	and	 mood	 disorders	 (anxiety	 and	 depression),	 however,	 the	 direction	 of	causality	between	them	is	unclear	(Althof	et	al.,	2014).	 	Several	mechanisms	of	action	between	anxiety	and	premature	ejaculation	have	been	 proposed.	 A	 physiological	 mechanism	 could	 be	 that	 anxiety	 increases	sexual	 arousal.	 This	was	demonstrated	 in	 rats	by	Barfield	 and	Sachs	 (1968)	who	 found	 that	 administering	 electric	 shocks	 to	 male	 rats	 led	 to	 quicker	mounting	 of	 receptive	 female	 rats.	 In	 humans,	 Barlow,	 Sakheim	 and	 Beck	(1983)	 found	 that	 the	 threath	 of	 an	 electric	 shock	 led	 to	 increased	 penile	circumference	while	viewing	an	erotic	film.	However,	these	findings	were	not	replicated	 in	 later	 studies	 by	 the	 same	 authors	 (Beck,	 Barlow,	 Sakheim,	 &	Abrahamson,	1987),	nor	by	Hale	and	Strassberg	 (1990),	who	 found	that	 the	threat	of	an	electric	shock,	as	well	as	(false)	feedback	that	the	participant’s	level	of	arousal	was	subnormal,	 inhibited	sexual	arousal.	 In	any	case,	anxiety	that	results	 in	sympathetic	activation	will,	according	 to	 the	 ejaculation	 threshold	theory,	 decrease	 the	 amount	 of	 genital	 stimulation	 needed	 to	 engage	 the	ejaculation	reflex	(McMahon,	Jannini,	Serefoglu,	&	Hellstrom,	2016;	Rowland,	2005). 
 Another	proposed	mechanism	is	that	anxiety	distracts	men	from	being	able	to	control	their	ejaculation	(Althof,	2006).	In	line	with	this,	Hartmann	et	al.	(2005)	found	 that	 PE	patients	were	more	preoccupied	with	 thoughts	 of	 controlling	their	 orgasm	 than	 functional	 controls.	 Distraction	 may	 also	 function	 as	 a	conscious	 avoidance	 strategy,	 or	 as	 a	way	 to	 try	 to	 control	 arousal	 (Kaplan,	
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Kohl,	Pomeroy,	Offit,	&	Hogan,	1974).	The	emotional	aspect	of	anxiety	may	in	the	 same	way	 be	 distracting,	 and	 it	 has	 been	 shown	 that	men	with	 PE	 fear	failure	during	intercourse	(Hartmann	et	al.,	2005)	and	report	emotions	of	guilt	and	 embarrassment	 (Rowland,	 Tai,	 &	 Slob,	 2003)	 during	 sexual	 stimulation	more	often	than	non-affected	controls.			From	a	behavioristic	viewpoint,	PE	is	seen	as	a	learned	behavior	(Althof,	2016),	conditioned	from	early	sexual	experiences,	for	example	a	lack	of	privacy	in	the	home	leading	a	young	person	to	hasty	lovemaking	or	masturbating	in	order	to	not	get	noticed	by	his	parents	(Masters	&	Johnson,	1970).	Performance	anxiety	has	been	especially	pointed	 out	 in	men	with	 comorbid	 erectile	dysfunction,	who	might	 have	 learned	 to	 ejaculate	 prematurely	 in	 order	 to	 evade	 loss	 of	erection	(Zorba	et	al.,	2012).			PE	has	also	been	characterized	as	a	lack	of	awareness	of	bodily	reactions	during	sex	(Kaplan,	1975).	 In	this	view,	the	lack	of	interoceptive	awareness	(IA,	the	sensory	awareness	that	originates	from	physiological	states,	processes,	actions	and	functions)	deprives	men	of	control	over	actions	that	lead	up	to	ejaculation.	According	to	Perelman	(2006),	men	with	PE	are	unable	to	indentify	and/or	act	upon	 	 premonitory	 sensations,	 such	 as	 testicular	 elevation,	 increased	 heart	rate,	and	contraction	of	muscles,	which	 foretell	 forthcoming	 ejaculation.	The	inability	 to	 control	 the	 level	 of	 arousal	 through	 cognitive	 and	 behavioral	responses	 to	 the	 premonitory	 signals	 leads	 men	 to	 cross	 the	 ejaculatory	threshold	 unwillingly.	 For	 some	 men,	 the	 window	 of	 opportunity	 between	emergence	of	premonitory	signals	and	emission	might	be	small.	Kaplan	et	al.	(1974)	hypothesized	that	the	inability	to	control	one’s	level	of	arousal	is	due	to	never	having	learned	the	necessary	skills,	and	that	the	phenomenon	is	caused	or	 exacerbated	 by	 anxiety	 in	 the	 sexual	 situation.	 In	 line	 with	 this,	 Barlow	(1986)	 noted	 that	 participants	 with	 sexual	 dysfunctions	 consistently	underestimated	their	arousal,	and	were	unable	to	perceive	any	means	by	which	they	 might	 be	 able	 to	 control	 their	 sexual	 arousal,	 even	 when	 they	 were	successfully	suppressing	their	arousal.			From	a	cognitive	perspective,	some	PE	patients	have	cognitive	distortions	such	as	 catastrophizing	 or	 overgeneralization	 (Althof,	 2016;	 Kempeneers	 et	 al.,	2018).	 As	 an	 example	 of	 an	 overgeneralization,	 a	man	who	 thinks	 “If	 I	 had	trouble	controlling	my	ejaculation	last	time,	I	won’t	be	able	to	control	it	now”	will	probably	not	even	try	to	do	something	to	improve	the	situation.	In	relation	
		 18	
to	IA,	catastrophizing	thoughts	may	lead	to	interpretations	of	bodily	signals	of	rising	sexual	arousal	as	a	sign	of	 impending	 failure.	Consequently,	 instead	of	treating	 bodily	 signals	 as	 useful	 information	 (i.e.,	 because	 such	 sensory	information	 can	 be	 used	 to	 regulate	 arousal	 by	 modifying	 behavior,	 e.g.,	switching	 position	 or	 thrusting	 more	 slowly)	 they	 are	 interpreted	 as	threatening,	 and	 thus	 induce	 anxiety.	Alternatively,	 individuals	may	actively	avoid	 paying	 attention	 to	 them.	 In	 a	 sample	 of	 49	 sexually	 functional	 men,	Winters,	 Christoff	 and	 Gorzalka	 (2009)	 asked	 participants	 to	 consciously	down-regulate	 their	 sexual	 arousal	 while	 viewing	 sexual	 videos.	 While	participants	 were	 able	 to	 reduce	 their	 arousal	 on	 average,	 some	 men	experienced	increased	physical	and	cognitive	arousal	while	trying	to	regulate.	The	authors	suggest	that	this	can	be	undestood	through	a	failure	in	emotion	regulation,	 where	 suppression	 of	 exciting	 thoughts	 in	 itself	 may	 increase	excitement	 in	 some	 men	 (Wegner,	 Shortt,	 Blake,	 &	 Page,	 1990)	 through	increased	sympathetic	arousal,	leading	to	a	cycle	where	attempted	supression	leads	to	increased	emotional	response.			
	
	
Figure	1.	Theoretical	associations	between	anxiety	and	premature	ejaculation.	Arrows	 depict	 possible	 causal	 associations	 between	 variables.	 Plus	 signs	
Anxiety
Distraction
Interoceptive 
awareness
Sympathetic 
activation
Premature 
ejaculation
+
+
+
+
--
+ Cognitive 
distortion
++ -
		 19	
indicate	a	positive	association	(i.e.,	an	increase	in	the	first	variable	leads	to	an	increase	in	the	second	variable)	and	minus	signs	indicate	negative	associations	(i.e.,	an	increase	in	the	first	variable	leads	to	a	decrease	in	the	second	variable.)	The	 dashed	 arrow	 between	 interoceptive	 awareness	 and	 anxiety	 depicts	 a	conditional	relationship,	where	interoceptive	awareness	may	lead	to	anxiety,	depending	on	how	the	physiological	signals	are	cognitively	interpreted.			The	relationship	between	anxiety,	PE	and	IA	is	complex	(Figure	1).	As	noted	earlier,	 higher	 IA	 ought	 to	 give	 a	 better	 basis	 for	 controlling	 ejaculation,	because	sensory	information	can	be	used	to	predict	when	the	ejaculatory	reflex	will	be	triggered.	At	the	same	time,	IA	is	suggested	to	play	an	etiological	role	in	anxiety,	 as	 anxiety	 patients	 report	 increased	 somatic	 sensitivity	 and	hypervigilance	(Domschke,	Stevens,	Pfleiderer,	&	Gerlach,	2010),	and	 IA	and	emotional	 states	 show	 similar	 brain	 activation	 in	 the	 right	 anterior	insular/opercular	cortex	(Critchley,	Wiens,	Rotshtein,	Ohman,	&	Dolan,	2004).	In	other	words,	IA	seems	putatively	to	play	a	double	role,	both	decreasing	PE	by	 providing	 necessary	 information	 about	 current	 sexual	 arousal,	 and	increasing	 PE	 via	 increased	 anxiety	 if	 the	 bodily	 signals	 are	 interpreted	 as	threatening.		1.2.5	Lifestyle	factors	Lifestyle	 factors	 such	 as	 alcohol	 consumption,	 physical	 exercise,	 and	 being	overweight	have	clear	associations	with	overall	health.	Lifestyle	has	also	been	linked	 to	 sexual	 dysfunctions,	 primarily	 erectile	 dysfunction,	 but	 also	premature	ejaculation.		Alcohol	has	an	acute	ejaculation-delaying	effect	(Malatesta,	Pollack,	Wilbanks,	&	Adams,	1979),	and	surveys	suggest	that	at	least	some	young	men	may	use	alcohol	with	the	intention	of	achieving	ejaculatory	delay	(Santtila,	Sandnabba,	&	Jern,	2009).	At	the	same	time,	alcohol	can	also	act	arousal-inducing	(George	&	 Stoner,	 2000),	 which	 perhaps	 could	 counteract	 some	 of	 the	 ejaculation-delaying	 effect.	 The	 association	 between	 alcohol	 consumption	 and	cardiovascular	 disease	 is	 thought	 to	 be	 U-shaped,	 with	 a	 moderate	consumption	 being	 protective	 of	 disease,	 while	 a	 large	 consumption	 is	associated	with	increased	risk	of	cardiovascular	disease	(Marmot	&	Brunner,	1991;	Ronksley,	Brien,	Turner,	Mukamal,	&	Ghali,	2011).	This	may	in	turn	have	
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a	 detrimental	 effect	 on	 sexual	 function,	 at	 least	 erectile	 function	 (Kumsar,	Kumsar,	&	Dilbaz,	2016).	It	is	perhaps	noteworthy	in	this	context,	that	erectile	dysfunction	 (ED)	displays	 considerable	 comorbidity	with	PE	 (McCabe	 et	 al.,	2016).	 Furthermore,	 the	 serotonergic	 system	 has	 been	 demonstrated	 to	 be	regulated	 by	 alcohol	 intake,	 in	 that	 the	 neurotransmitter	 is	 itself	 a	 likely	contributor	to	the	pharmacological	effects	of	alcohol,	and	different	serotonin	receptors	have	been	found	to	play	an	important	role	in	alcohol	use	disorders	(Agudelo,	Yoo,	&	Nair,	2015).	Thus,	in	combination	with	the	hypothesized	role	of	serotonin	in	ejaculatory	function,	alcohol	intake	is	an	interesting	candidate	to	 study	 in	 terms	 of	 identifying	 lifestyle	 factors	 that	 can	 affect	 ejaculatory	function.		The	role	of	physical	exercise	has	not	been	extensively	studied	in	the	context	of	PE.	Verze	et	al.	(2018)	found	no	statistically	significant	difference	in	physical	activity	 between	 men	 with	 and	 without	 PE	 (n	 =	 1104).	 In	 another	 study	involving	men	of	European	and	South	Asian	origin,	no	association	was	found	between	physical	inactivity	and	PE	(Malavige,	Wijesekara,	Ranasinghe,	&	Levy,	2015).	 Recently,	 however,	 physical	 exercise	 was	 tested	 as	 a	 treatment	intervention	 for	 PE	 (Kilinc,	 Aydogmus,	 Yildiz,	 &	 Doluoglu,	 2018).	 The	researchers	 reported	 3.5-fold	 increases	 in	 IELT	 in	 a	 group	 performing	moderate	exercise	30	minutes,	five	times	a	week	during	one	month.	The	effect	was	 of	 the	 same	magnitude	 as	 a	 control	 group	 using	 dapoxetine	 30mg	 on-demand.			Meta-analyses	 show	 that	 physical	 exercise	 is	 associated	 with	 decreased	depression	 and	 anxiety	 (Rebar	 et	 al.,	 2015),	 increased	 global	 self-esteem	(Spence,	McGannon,	&	Poon,	 2005),	 and	 improved	body-image	 (Campbell	&	Hausenblas,	2009).	A	reciprocal	relationship	between	anxiety	and	PE	has	been	suggested	(e.g.,	Althof	et	al.,	2014;	Jern,	2009),	where		previously	experienced	perceived	failures	lead	to	heightened	anxiety,	which	leads	PE,	thus	sustaining	the	dysfunction.	Improved	self-esteem	and	body-image,	along	with	decreases	in	depression	and	anxiety	could	plausibly	break	this	cycle.	According	to	Biddle	and	 Mutrie	 (2008),	 experiences	 of	 achievement	 and	 progression	 following	physical	exercise	can	lead	to	enhanced	self-efficacy	and	give	patients	insights	that	 there	 is	a	potential	 to	 control	 one’s	body,	which	 could	be	an	 important	insight	to	some	patient	suffering	from	PE.			
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Another	 supposed	 mechanism	 through	which	 physical	 exercise	 could	 affect	ejaculatory	 function	 is	 its	 effect	 on	 the	 serotonergic	 transmission.	 Chaouloff		(1997)	 showed	 that	 physical	 exercise	 is	 associated	with	 increased	 levels	 of	tryptophan	 as	 well	 as	 increased	 synthesis	 of	 5-HT.	 Likewise,	 Post,	 Kotin,	Goodwin,	and	Gordon	(1973)	showed	experimentally	that	physical	activity	was	associated	 with	 an	 increase	 of	 5-HIAA,	 a	 metabolite	 of	 serotonin,	 in	 the	cerebrospinal	 fluid.	 Given	 the	 ejaculation-delaying	 effect	 of	 serotonin,	 this	makes	 physical	 exercise	 an	 interesting	 target	 of	 study	 in	 the	 context	 of	 PE	research.			Physical	 exercise	 has	 also	 been	 found	 to	 be	 associated	 with	 lower	 stress	reactivity.	 In	 a	 meta-analysis	 of	 34	 experimental	 and	 correlational	 studies,	Crews	 and	 Landers	 (1987)	 found	 that	 fitter	 individuals	 displayed	 lower	reactivity	to	or	shorter	recovery	from	brief	psychosocial	stressors	(e.g.,	change	in	heart	rate	in	response	to	cognitive	performance	demands),	with	a	moderate	standardized	 mean	 effect	 size	 of	 0.48	 (p	 <	 .01).	 Lowered	 reactivity	 of	 the	sympathetic	nervous	system	could	possibly	explain	part	of	the	effect	physical	exercise	 has	 on	 PE,	 since	 men	 with	 PE	 have	 been	 observed	 to	 exhibit	 a	disruption	 of	 autonomic	processes,	with	decreased	parasympathetic	 activity	and	increased	sympathetic	activity	compared	to	functional	controls	(Ertekin,	Colakoglu,	&	Altay,	1995;	Rowland,	2010).		Given	the	possible	effects	of	physical	activity	on	PE,	it	is	also	interesting	to	look	at	connections	between	physical	inactivity	and	PE.	 It	 is	well	established	that	lack	 of	 exercise	 is	 a	 major	 contributor	 to	 many	 chronic	 diseases	 (Booth,	Roberts,	&	Laye,	2012),	and	several	studies	have	found	associations	between	chronic	 diseases	 and	 PE.	 Salama,	 Eid,	 Swedan	 and	 Hatem	 (2017)	 found	increased	prevalence	of	PE	among	patients	with	metabolic	syndrome	(MetS;	25.2%)	compared	to	controls	(7.6%,	p	<.001).	Likewise,	Serefoglu	et	al.	(2011)	reported	 that	 men	 with	 PE	 had	 significantly	 more	 diabetes	 mellitus,	hypertension,	 cardiovascular	 disease	 than	 men	 without	 PE.	 The	 same	associations	were	also	found	in	a	large	Chinese	sample	(Gao	et	al.,	2013).			Several	 reports	 note	 higher	 prevalence	 of	 chronic	 diseases	 in	 acquired	 PE	compared	to	other	subtypes	of	PE,	as	well	as	compared	to	nonaffected	controls.	Jeh	et	al.	(2018)	found	men	with	acquired	PE	having	more	metabolic	syndrome	than	men	without	PE.	Bolat	et	al.	(2017)	compared	100	men	diagnosed	with	acquired	 PE	 to	 100	 control	 cases,	 found	 higher	 prevalence	 of	 metabolic	
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syndrome	in	men	with	PE	(51%)	than	controls	(24%,	p	<	.001).	Further,	several	components	of	metabolic	syndrome	were	significantly	correlated	with	shorter	IELT	 and	 higher	 scores	 on	 the	 Premature	 Ejaculation	 Diagnostic	 Tool.	Compared	 to	other	subtypes	of	PE,	men	with	acquired	PE	more	often	suffer	from	diabetes,	 hypertension	and	ED	(Gao	 et	al.,	2013;	Serefoglu	 et	al.,	2011;	Zhang	et	al.,	2013).		ED	has	known	associations	with	coronary	artery	disease	(CAD),	MetS,	obesity	and	diabetes	mellitus	(Gorgel,	Gorgel,	&	Sefik,	2014;	Han	et	al.,	2011;	Salem	et	al.,	2009),	and	there	is	evidence	that	ED	symptoms	may	be	an	early	indicator	of	underlying	heart	disease,	that	sometimes	become	manifest	before	direct	CAD	symptoms	can	be	observed	(Inman	et	al.,	2009).	Majzoub	et	al.	(2016)	showed	that	PE	and	ED	were	more	prevalent	in	patients	with	diabetes	type	2,	and	that	diabetic	 patients	 with	 ED	 showed	 higher	 incidence	 of	 PE	 and	 shorter	 ELT.	Possible	mechanisms,	hypothesized	by	the	authors,	include	that	hypoglycemic	episodes	 and	 diabetic	 neuropathy	may	 inhibit	 serotonergic	 activity	 and	 are	associated	with	impaired	nitric	oxide	metabolism,	which	in	turn	might	increase	sympathetic	 nervous	 system	 activity	 (Francomano,	 Donini,	 Lenzi,	 &	 Aversa,	2013;	Saenz	de	Tejada	&	Goldstein,	1988).		Findings	 regarding	 associations	 between	 lifestyle	 factors	 and	 PE	 are	 not,	however,	 unanimous.	 Verze	 et	 al.	 (2018)	 found	 no	 statistically	 significant	difference	in	BMI,	alcohol	consumption,	or	physical	activity	between	men	with	and	without	PE	(n	=	1104).	Likewise,	in	a	study	focusing	on	couples,	Rosen	et	al.	(2016)	found	no	association	between	any	sexual	problem	(including	PE)	and	lifestyle	 factors	such	as	BMI,	alcohol	consumption,	and	frequency	of	physical	exercise.	There	are	possible	explanations	for	why	Rosen	et	al.	(2016)	found	no	link	between	 lifestyle	 factors	and	sexual	problems.	For	 example,	 their	 study	involved	 only	 couples,	 which	 may	 exclude	 individuals	 with	 the	 most	pronounced	PE	problems,	since	studies	have	suggested	that	some	PE	sufferers	avoid	forming	new	intimate	relationships	due	to	their	dysfunction	(Symonds	et	al.,	2003).	Moreover,	their	median	age	of	their	sample	was	relatively	high	at	55	years,	 with	 most	 individuals	 in	 long-term,	 stable	 relations	 (the	 average	relationship	duration	for	men	was	25	years).	This	could	have	excluded	many	individuals	 with	 sexual	 problems,	 as	 they	 are	 known	 to	 be	 associated	 with	relationship	problems.			
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Lifestyle	 factors	are	an	 important	 topic	 of	 research	 related	 to	PE,	 since	 they	could	 be	 very	 attractive	 targets	 for	 therapeutic	 intervention,	 not	 least	considering	their	secondary	health	benefits.			1.2.6	Summary		A	plethora	of	physiological	as	well	as	psychological	factors	in	PE	etiology	have	been	proposed	and	explored,	but	these	are	yet	to	be	confirmed	and	replicated	in	large	scale	studies	(Althof	et	al.,	2014).	Cross-sectional	studies	have	found	associations	 between	 PE	 and	 psychological	 problems,	 but	 research	 on	 the	direction	of	 causality	between	them	is	 limited	(Althof	 et	al.,	2014).	 It	 is	also	conceivable	 that	 PE	 and	 psychological	 problems	 reciprocally	 reinforce	 each	other	(Althof	et	al.,	2014;	Jern,	2009).		
 PE	 is	 associated	 with	 lifestyle	 factors	 such	 as	 physical	 exercise	 through	 a	network	of	lifestyle-related	non-communicable	diseases.	Possible	mechanisms	involve	 dysregulation	 of	 the	 serotonergic	 neurotransmission,	 increased	sympathetic	nervous	system	activity	and	erectile	dysfunction.		
Figure	2.	An	example	of	a	sexual	excitement	curve	during	a	sexual	encounter	(inspired	by	de	Carufel	&	Trudel,	2006).			Figure	2	presents	a	model	of	how	sexual	excitement	is	related	to	ejaculation.	When	a	man	becomes	sexually	aroused	he	first	achieves	erection,	and	when	the	arousal	 increases	 sufficiently,	 he	 finally	 crosses	 the	 ejaculation	 threshold.	There	 may	 be	 variation	 between	 individuals	 regarding	 the	 level	 of	 the	ejaculation	 threshold,	which	might	be	partly	 genetically	predisposed.	 Penile	
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sensitivity	could	also	be	understood	in	light	of	the	model,	where	the	ejaculation	threshold	would	be	lower	when	sensitivity	is	higher.	Interoceptive	awareness	is	 associated	 with	 men’s	 ability	 to	 determine	 their	 current	 level	 of	 sexual	excitement,	which	 allows	 them	 to	make	necessary	 adjustment	 to	 the	 sexual	activity,	 since	 the	 level	 of	sexual	excitement	 is	associated	with	 the	activities	taking	place	(e.g.,	vaginal	sex	is	associated	with	shorter	ELT	than	other	modes	of	ejaculation;	Jern,	Santtila,	Johansson,	Varjonen,	Witting,	Von	Der	Pahlen,	et	al.,	2009).		1.3	Treatment	of	PE	Following	 general	 trends	 in	 psychiatry,	 there	 has	 been	 a	 shift	 from	understanding	 PE	 as	 primarily	 a	 psychological	 problem	 to	 understanding	 it	mainly	 as	 a	 biological	 problem	 (Rowland	 &	 Motofei,	 2007).	 According	 to	guidelines	by	the	ISSM,	pharmacological	agents	are	currently	considered	first-line	treatment	for	lifelong	PE,	and	behavioral	psychotherapy	for	acquired	PE.	A	combination	of	different	approaches	can	sometimes	be	necessary	(Althof	et	al.,	2014).		1.3.1	Pharmacological	treatment	Serotonin	(5-HT)	exerts	an	inhibitory	effect	on	ejaculation	(Hull,	Muschamp,	&	Sato,	 2004;	Waldinger,	Berendsen,	 et	 al.,	 1998).	 Consequently,	 the	 currently	recommended	 first-line	 treatment	 for	 PE	 are	 selective	 serotonin	 reuptake	inhibitors	 (SSRIs;	 McMahon,	 2015).	 Studies	 on	 dapoxetine,	 the	 only	 SSRI	specifically	approved	for	treatment	of	PE,	have	demonstrated	2.5-	to	3.0-fold	increases	 in	 IELT,	 increased	 feelings	 of	 control,	 decreased	 distress	 and	increased	satisfaction	(McMahon	et	al.,	2011).			However,	 61%	 of	 participants	 reported	 adverse	 events,	 such	 as	 nausea,	dizziness,	 headache	 and	 diarrhoea	 following	 use	 of	 dapoxetine	 60	 mg	(Kaufman	 et	 al.,	 2009).	 Three	 independent	 studies	 on	 the	 acceptability	 of	Dapoxetine	 in	naturalistic	settings	have	 found	discontinuation	rates	ranging	from	70.6%	to	89.6%	after	one	year	of	use,	most	often	because	of	low	efficacy,	side	 effects,	 financial	 cost,	 and	 loss	 of	 interest	 in	 sex	 (Jern,	 Johansson,	Piha,	Westberg,	&	Santtila,	2014;	Mondaini	et	al.,	2013;	Park	et	al.,	2017).	Another	SSRI	 prescribed	 off-label	 for	 treatment	 of	 PE,	 Paroxetine,	 has	 been	 better	tolerated,	but	still	associated	with	considerable	discontinuation	rates	of	about	
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30%	 (Jern	 et	 al.,	 2014;	 Salonia,	 Rocchini,	 et	 al.,	 2009).	 Regardless	 of	acceptability,	a	recent	review	on	drug	safety	concluded	that	long-term	use	of	SSRIs	is	to	be	avoided	if	alternative	treatments	are	available	(Carvalho,	Sharma,	Brunoni,	Vieta,	&	Fava,	2016).	 In	 light	 of	 this,	 further	research	on	 treatment	options	are	warranted.		1.3.2	Topical	anastethics	Ejaculation	 consists	 of	 coordinated	 reflexes	 of	 emission	 and	 expulsion,	modulated	by	the	sensory	cortex	and	the	lumbosacral	spinal	cord.	The	onset	of	reflexes	are	facilitated	by	penile	sensory	input.	A	possible	means	to	delay	onset	of	 ejaculatory	 reflexes	 is	 thus	 to	 reduce	 neuronal	 transmission	 in	 sensory	afferents,	 which	 can	 be	 achieved	 using	 topical	 anastethics.	 Wyllie	 and	Hellstrom	 (2011)	 reported	 that	 that	 a	 mixture	 of	 lidocaine	 and	 prilocaine	applied	 five	minutes	 before	 intercourse	 led	 to	 increased	 feelings	 of	 control,	sexual	satisfaction,	and	up	to	six-fold	increases	in	IELT.	However,	there	is	a	risk	of	erectile	dysfunction	due	to	penile	numbness,	and	further,	a	risk	of	diffusion	of	the	topical	agent	leading	to	unwanted	reductions	in	sensitivity	in	the	partner	(Hatzimouratidis	et	al.,	2010).		1.3.3	Psychological	treatment	Starting	 with	 the	 “stop-and-start”	 technique	 first	 described	 by	 Semans	(Semans,	1956),	and	later	altered	to	the	“squeeze”	technique	of	Masters	and	Johnson	 (1970),	 behavioral	 treatment	 interventions	 were	 long	 considered	first-line	 treatments	 for	 PE	 (Althof	 et	 al.,	 2014).	 The	 techniques	 consist	 of	manual	stimulation	of	 the	penis	by	 the	man’s	partner	until	 the	man	 feels	an	urge	 to	 ejaculate.	 At	 this	 point,	 the	 partner	 either	 pauses	 stimulation,	 or	squeezes	 the	 penis	 with	 the	 thumb	 under	 the	 frenulum	 and	 two	 fingers	wrapped	 around	 the	 penis.	 When	 the	 man	 loses	 the	 urge	 to	 ejaculate	 the	partner	resumes	stimulation.	The	authors	reported	somewhat	unlikely	success	rates	 of	 100%	 (Semans,	 1956)	 and	 97.8%	 (Masters	 &	 Johnson,	 1970).	 The	purpose	is	to	improve	control	over	ejaculation	by	de-conditioning	of	learned	behavior,	altering	the	ejaculatory	reflex,	providing	an	opportunity	to	explore	new	sexual	techniques,	or	desensitizing	the	patient	to	anxiety	that	is	assumed	to	cause	PE	(Grenier	&	Byers,	1995).		In	 recent	 reviews	 (Althof,	 2016;	 Melnik	 et	 al.,	 2011)	 and	 a	 meta-analysis	(Cooper,	Martyn-St	James,	Kaltenthaler,	Dickinson,	&	Cantrell,	2015)	it	is	noted	
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that	 controlled	 studies	 of	 non-pharmacological	 treatments	 for	 PE	 are	 scarce	and	methodologically	 heterogeneous.	However,	 the	 existing	 studies	 indicate	that	behavioral	treatment	alleviate	PE,	and	importantly,	that	this	is	achieved	without	incurring	side	effects.		Current	psychotherapy	for	PE	takes	an	integrative	approach	with	elements	of	psychodynamic,	 systems,	 behavioral	 and	 cognitive	 influences,	 with	 a	 short-term	 setup	 addressing	 sexual	 skills/techniques,	 self-esteem,	 performance	anxiety	and	interpersonal	conflict	(Althof,	2016).	McCabe	(2001)	reported	50%	remediation	of	sexual	dysfunctions	following	a	10-week	CBT	program.	Pavone	et	 al.	 (2017)	 compared	 a	 homogenous	 group	 psychotherapy	 led	 by	 an	analytically	trained	psychoterapist	to	dapoxetine	and	combination	treatment,	and	found	group	therapy	and	combination	treatment	to	be	more	effective	than	dapoxetine	alone,	as	measured	by	IELT	and	PEDT.	Cormio	et	al.	(2015)	found	a	combination	of	dapoxetine	and	sexual	behavior	treatment	to	be	more	effective	than	dapoxetine	alone	in	men	with	lifelong	PE,	restoring	normal	functioning	in	the	majority	of	them.			Based	on	behavioral	techniques	and	the	penile	sensitivity	hypothesis,	Zamar	(2012)	developed	a	treatment	where	start-stop	exercises	are	performed	while	stimulating	 the	 penis	 with	 a	 handheld	 vibrator,	 since	 prolonged	 vibratory	stimulation	is	known	to	lead	to	feelings	of	numbness	and	decreased	sensory	perception	 (Herbenick	 et	 al.,	 2009;	 Malchaire,	 Rodriguez	 Diaz,	 Piette,	Gonçalves	Amaral,	&	de	Schaetzen,	1998).	Zamar	noted	11-fold	increase	of	IELT	in	61%	of	the	participants	(Zamar,	2012).	Jern	(2014)	replicated	a	somewhat	smaller	 but	 yet	 significant	 treatment	 effect,	 but	 the	 sample	 consisted	 of	patients	who	had	responded	poorly	to	pharmacological	treatment	with	SSRIs	and	 thus	 may	 have	 represented	 a	 subgroup	 whose	 PE	 symptoms	 were	particularly	difficult	 to	 treat.	 In	 a	 similar	 vein,	Rodríguez	 and	López	 (2016)	evaluated	a	device	designed	for	desensitization	by	adding	additional	 friction	and	 pressure,	 rather	 than	 vibrations,	 and	 found	 that	 participants	 reported	increased	 control	 over	 ejaculation	 after	 completing	 masturbatory	 exercises	using	the	device.		In	 describing	 a	 treatment	 approach	 combining	 pharmacological	 and	psychological	 interventions,	 Perelman	 (2006)	 hypothesizes	 that	 the	 IELT-increasing	effect	of	SSRIs	may	give	the	man	more	opportunities	to	notice	his	premonitory	 sensations.	 This	 could	 in	 turn	 enable	 him	 to	 make	 necessary	
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behavioral	or	cognitive	adjustments	in	order	to	keep	his	level	of	arousal	below	the	 ejaculatory	 threshold.	 If	 IELT	 can	 also	 be	 increased	 by	 penile	desensitization	through	prolonged	vibrational	stimulation,	this	could	arguably	in	the	same	manner	afford	the	man	time	and	opportunity	to	notice	premonitory	sensations	 and	 take	 necessary	 action	 to	 avoid	 ejaculation.	 de	 Carufel	 and	Trudel	 (2006)	 showed	 that	 a	 sexological	 psychoeducational	 intervention	aiming	 at	 teaching	 patients	 to	 notice	 and	 modulate	 their	 level	 of	 sexual	excitement	led	to	approximately	9-fold	increases	in	IELT.		In	order	to	be	able	to	modulate	sexual	excitement,	however,	the	patient	must	first	be	aware	of	the	his	level	of	sexual	excitement.	Interoceptive	awareness	has	been	shown	to	improve	following	practices	of	body	scan	and	breath	meditation	(Bornemann,	 Herbert,	 Mehling,	 &	 Singer,	 2015).	 Mindfulness-based	interventions	 (i.e.	 based	 on	 non-judgemental	 present	 moment	 awareness)	have	been	used	 to	 improve	 the	ability	 to	 register	bodily	responses	 to	sexual	stimuli	(Silverstein,	Brown,	Roth,	&	Britton,	2011).	The	methods	have	also	been	extensively	applied	to	a	range	of	sexual	dysfunctions,	including	low	desire	and	sexual	pain	(Brotto	&	Basson,	2014;	Brotto,	Basson,	&	Luria,	2008;	Brotto	&	Goldmeier,	 2015;	 Gunst	 et	 al.,	 2018;	 Rosenbaum,	 2013),	 however,	 using	samples	consisting	of	women	almost	exclusively	(Goldmeier	&	Mears,	2010).	Improving	 the	 ability	 to	 register	 bodily	 responses	 may	 plausibly	 lead	 to	positive	discoveries	and	experiences	of	control,	simultaneously	counteracting	resignation	and	tendencies	to	catastrophic	thinking.	Thus,	mindfulness-based	meditation	 training	 could	 be	 a	 novel	 and	 useful	 addition	 to	 interventions	targeting	 PE	 by	 increasing	 the	 patient’s	 awareness	 of	when	 the	 ejaculatory	reflex	 will	 be	 triggered,	 which	 could	 afford	 him	 time	 to	 alter	 his	 actions	accordingly.		Mindfulness-based	interventions	might	also	offer	patients	a	form	of	emotion	regulation.	 Whereas	 attempts	 to	 suppress	 sexually	 arousing	 thoughts	 and	feelings	 for	 some	 leads	 to	 the	 opposite,	 a	 reappraisal	 through	 emotional	distancing	may	be	associated	with	more	successful	down-regulation	of	arousal	(Winters	et	al.,	2009).	Learning	to	be	non-judgmentally	aware	of	sexual	stimuli	and	 one’s	 own	 reactions,	 and	 assume	 an	 objective	 and	 slightly	 distanced	attitude	(as	opposed	to	being	enmeshed	in	or	fused	with	the	experience),	might	provide	patients	with	an	opportunity	to	regulate	their	arousal	appropriately.				
		 28	
1.3.4	Pelvic	floor	rehabilitation	Pelvic	floor	rehabilitation	has	been	proposed	as	a	promising	treatment	option	for	 PE	 (Myers	 &	 Smith,	 2019).	 Using	 techniques	 originally	 designed	 to	rehabilitate	urinal	and	fecal	incontinence,	la	Pera	and	Nicastro	(1996)	applied	physiokinesitherapy	 (i.e.,	 personalized	 physical	 exercises	 to	 increase	awareness	and	strength	of	the	pelvic	floor	muscles)	and	electrostimulation	in	order	 to	 improve	 contractile	 strength,	 as	 well	 as	 biofeedback	 to	 learn	 to	recognize	and	control	pelvic	muscles.	After	20	sessions,	11	out	of	18	patients	reported	better	control	over	ejaculatory	reflex,	and	results	were	maintained	at	follow-up	 (6-14	 months).	 Using	 similar	 interventions,	 Pastore	 et	 al.	 (2012)	were	able	to	demonstrate	4-fold	increases	in	IELT	after	12	weeks	of	treatment.	In	another	study	by	Pastore	et	al.	(2014),	33	of	40	patients	gained	control	of	their	ejaculatory	reflex	after	treatment,	with	a	mean	3.5-fold	increase	in	IELT.			1.3.5	Surgical	interventions	Surgical	interventions,	including	dorsal	nerve	neurectomy,	hyaluronic	acid	gel	glans	 penis	 augmentation,	 and	 circumcision	 have	 also	 been	 proposed	 as	treatment	 options	 for	PE	aiming	 at	decreasing	 sensory	 input	 (Moon,	2016).	However,	due	to	a	dearth	of	data	and	conflicting	results,	in	addition	to	risks	of	complications	 following	 surgery,	 the	 ISSM	 excluded	 surgical	 interventions	from	 its	 recommendations	 regarding	 treatment	 for	 PE	 (Anaissie,	 Yafi,	 &	Hellstrom,	2016).				 	
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2.	HYPOTHESES	AND	RESEARCH	QUESTIONS	The	general	aims	of	the	present	dissertation	were	to:	1)	clarify	the	temporal	stability	 of	 PE	 symptoms;	 2)	 clarify	 the	 direction	 of	 causality	 between	 PE	symptoms	 and	 symptoms	 of	 mood	 disorders	 (anxiety	 and	 depression);	 3)	explore	the	associations	between	PE	and	lifestyle	factors	hypothesized	to	be	of	relevance	for	PE;	and	4)	investigate	whether	more	effective	psychobehavioral	treatment	 protocols	 for	 PE	 can	 be	 developed	 by	 incorporating	 attempts	 to	improve	the	patients’	ability	to	identify	and	monitor	physiological	signals.	The	main	 research	 questions	 (Q)	 are	 listed	 below,	 formulated	 as	 directied	hypotheses	(H)	when	previous	research	or	existing	theory	allowed	for	it:		H1:		 PE	symptoms	are	stable	over	time,	both	in	the	general	population	and	in	a	cohort	of	patients	diagnosed	with	PE.	(Study	I)	Q2:		 What	 is	 the	 direction	 of	 causality	 in	 the	 association	 between	 PE	 and	symptoms	of	mood	disorder	(anxiety	and	depression)?	(Study	II)	Q3:		 What	are	the	associations	between	PE	and	physical	exercise,	body-mass	index,	and	alcohol	consumption?	(Study	III)	H4:		 Vibrator-assisted	start-stop	exercises	alleviate	PE	symptoms.	(Study	IV)	H5:		 Additional	 interoceptive	 awareness	 training	 and	 psychoeducation	further	 improves	 the	 treatment	 effect	 of	 vibrator-assisted	 start-stop	exercises	on	PE.	(Study	IV)	 	
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3.	MATERIALS	AND	METHODS		3.1	Participants	Three	 independent	 samples	were	 used	 in	 the	present	 studies.	A	descriptive	overview	is	presented	in	Table	1.		Table	1		
Description	of	Samples			 		 		 Wave	(n)	Sample	name	 Study	 Origin	 1	 2	Population-based	sample	 I-III	 National	population	registry	 3923	 1024	Clinical	sample	 I,	III	 Patient	 databases	 from	 two	clinics	for	sexual	medicine	 175	 34	Treatment	sample	 IV	 Participants	 in	 treatment	study	 50	 -	
Note.	Wave	1	=	data	collection	in	year	2006	for	the	population-based	sample,	year	 2012	 for	 the	 clinical	 sample,	 and	 year	 2018	 for	 the	 treatment	 sample;	wave	2	=	data	collection	in	year	2012	for	the	population-based	sample	and	year	2015	for	the	clinical	sample.			3.1.1	Population-based	sample	(Studies	I-III)	A	 population-based,	 longitudinal	 sample	 was	 eligible	 for	 data	 analysis	 in	studies	 I,	 II	 and	 III.	 This	 sample	 (the	 Genetics	 of	 Sexuality	 and	 Aggression	sample,	see	 Johansson	et	al.,	2013)	was	collected	 in	2006,	and	consists	of	all	Finnish	twins	aged	18	to	33	who	have	Finnish	as	their	first	language,	as	well	as	their	 biological	 siblings.	 As	 the	 twins	 were	 not	 selected	 on	 any	 other	demographic	 or	 geographical	 grounds,	 the	 sample	 can	 be	 regarded	 as	representative	of	the	Finnish	population.			Participants	were	contacted	by	postal	mail	and	invited	to	complete	an	online	questionnaire.	Addresses	were	obtained	from	the	Central	Population	Registry	of	Finland.	An	eight-digit	code	was	generated	for	each	participant	to	be	used	as	logging	 in	 to	 the	 survey,	 and	 to	 enable	 anonymous	 handling	 of	 longitudinal	
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data.	 Those	 who	 did	 not	 respond	 to	 the	 initial	 invitation	 were	 sent	 two	reminder	letters,	one	week	apart.	Participants	were	informed	about	all	aspects	of	the	study,	including	that	participation	was	voluntary,	in	accordance	with	the	Helsinki	Declaration	of	1975,	as	revised	in	2008.	Written	informed	consent	was	obtained	 from	 all	 participants	 and	 the	 research	 plan	 was	 approved	 by	 the	Ethics	Committee	of	the	Åbo	Akademi	University	in	Turku,	Finland.		In	the	2006	data	collection,	2,559	men	responded	that	they	were	willing	to	be	contacted	again	for	follow-up	studies.	These	men	were	contacted	again	in	2012	and	invited	to	participate	in	a	follow-up	survey,	yielding	a	46%	response	rate	(n	=	1,173).	Of	these,	1,024	provided	informed	consent	to	participate.		3.1.2	Clinical	sample	(studies	I	&	III)		In	2012	and	2015,	we	contacted	all	patients	who	had	been	diagnosed	with	PE	by	a	medical	doctor	who	has	worked	with	male	sexual	problems	for	over	two	decades.	No	 exclusion	 criteria	were	applied	 in	 the	data-collection	stage.	The	patients	were	not	diagnosed	in	conjunction	with	participating	in	the	study,	but	had	been	diagnosed	at	an	earlier	time.	While	diagnoses	in	Finland	are	officially	based	on	ICD-10,	which	does	not	include	(I)ELT	as	a	diagnostic	criterion,	the	diagnosing	specialist	holds	a	fellowship	with	the	European	College	for	Sexual	Medicine,	and	has	considered	IELT	in	the	diagnoses.	Contact	information	was	obtained	 from	the	specialist’s	patient	register,	and	updated	postal	addresses	from	the	Central	Population	Registry	of	Finland.			In	2012,	419	individuals	identified	in	the	patient	registry	as	having	a	diagnosis	of	 PE	 were	 invited	 to	 take	 part	 in	 the	 studies.	 Of	 these,	 175	 respondents	completed	 the	 questionnaire.	 Seventy	 of	 these	 indicated	 willingness	 to	participate	in	follow-up	studies,	and	34	completed	the	second	survey	in	2015.			3.1.3	Treatment	sample	(Study	IV)	Study	 IV	was	 conducted	 at	 the	 Karolinska	University	Hospital	 in	 Stockholm,	Sweden.	Participants	 for	 the	study	were	 recruited	 through	advertisement	 in	local	newspapers	and	online	using	Google	AdWords.	Prospective	participants	were	screened	by	telephone.	In	order	to	be	included	participants	had	to	be	at	least	18	years	old,	understand	spoken	and	written	Swedish,	have	an	ELT	under	3	minutes,	not	experience	erectile	difficulties	that	interferes	with	penetration	
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or	masturbation,	not	suffer	from	multiple	sclerosis	or	other	chronic	illness	that	may	affect	ejaculatory	function	and	not	use	pharmacological	agents	that	may	affect	IELT,	such	as	SSRIs	or	opioid	analgesics.	Additionally,	participants	had	to	engage	in	intercourse	during	participation	in	the	study	in	order	to	be	included.		Eighty-six	individuals	declared	interest	in	participating	in	the	study.	Of	these,	50	 were	 deemed	 eligible	 based	 on	 inclusion	 criteria.	 At	 post-treatment,	 30	provided	data,	while	21	and	12	provided	data	at	3-month	and	6-month	follow-ups,	 respectively.	 Drop-out	was	 handled	 by	 utilizing	 both	 per-protocol	 (i.e.,	including	 only	 respondents	 with	 complete	 data	 sets)	 and	 intention-to-treat	analysis	 (i.e.,	 including	 all	 participants,	 with	 the	 last	 observation	 carried	forward	for	participants	with	missing	data).		3.2	Measures	The	 self-report	 questionnaire	 Multiple	 Indicators	 of	 Premature	 Ejaculation	(MIPE;	Jern,	Santtila,	Johansson,	Varjonen,	Witting,	von	der	Pahlen,	et	al.,	2009;	Jern	 et	 al.,	 2007)	was	 used	 to	measure	 symptoms	 of	 premature	 ejaculation	during	the	last	two	years.	The	questionnaire	consists	of	seven	items,	of	which	five	responded	to	on	a	5-point	or	and	two	on	a	3-point	Likert-type	scale,	with	a	range	of	7–31.	A	score	of	21	has	been	proposed	as	a	cut-off,	identifying	90%	of	patients,	while	keeping	false	positives	at	6	%	(Jern,	Piha,	&	Santtila,	2013).	In	this	questionnaire,	respondents	are	asked	to	report	their	ejaculatory	function	during	the	past	two	years.	Items	include	questions	about	ejaculation	latency,	feelings	of	control	over	ejaculation,	and	number	of	thrusts	before	ejaculation.	The	measure	has	been	validated	against	both	other	measures	of	PE	symptoms	and	stopwatch	data,	and	has	been	 shown	to	differentiate	 very	well	 between	patients	and	controls	(AUC	=	.98,	see	Jern	et	al.,	2013)	and	confirmatory	factor	analyses	 have	 indicated	 a	 good	 model	 fit	 (Jern,	 Santtila,	 Johansson,	 &	Sandnabba,	 2010).	 Items	 were	 back-translated	 into	 Finnish.	 Reliability	coefficients	are	interpreted	as	excellent	if	α	≥	.9,	good	if	α	=	.8–.9,	acceptable	if	α	=	.5–.6,	and	questionable	if	α	=	.6–.7	(George	&	Mallery,	2003)	In	the	present	studies,	 internal	 reliabilities	 were	 acceptable	 (ωs	 =	 .81–.82	 in	 study	 II;	Cronbach’s	αs	=.75–.76	in	study	III).			The	CHecklist	 for	Early	Ejaculation	Symptoms	(CHEES;	 Jern	et	al.,	2013)	was	also	 used	 to	 measure	 symptoms	 of	 PE.	 CHEES	 is	 an	 empirically	 derived	composite	 self-report	 questionnaire	 consisting	 one	 item	 from	 the	 MIPE	
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questionnaire,	two	items	from	the	Premature	Ejaculation	Profile	(PEP;	Patrick	et	al.,	2009),	and	two	 items	 from	the	Premature	Ejaculation	Diagnostic	Tool	(PEDT;	 Symonds	 et	 al.,	 2007).	 The	 items	 cover	 subjectively	 estimated	ejaculation	 latency	 time	 (ELT),	 feeling	 of	 control,	 feelings	of	 frustration	 and	relationship	difficulties	as	a	consequence	of	rapid	ejaculation,	and	propensity	to	 ejaculate	 with	 very	 little	 stimulation.	 CHEES	 has	 been	 validated	 against	stopwatch-measured	ELT	and	other	commonly	used	self-report	questionnaires	for	measuring	PE,	 in	both	 clinical	and	population-based	 samples	(Jern	 et	al.,	2013).	 CHEES	 was	 shown	 to	 differentiate	 between	 diagnosed	 patients	 and	population-based	controls	very	well	(AUC	=	.98,	95%	CI	[.97,	.98]),	better	than	MIPE,	PEP,	and	PEDT.	Empirically	derived	cutoffs	for	CHEES	are	as	follows:	21-25	 is	 strongly	 indicative	 of	 fulfilling	 diagnostic	 criteria	 for	 PE	 (correctly	identifies	 44%	 of	 diagnosed	 PE	 patients	 as	 PE	 sufferers	 and	 incorrectly	identifies	1%	of	controls	as	PE	sufferers),	17-20	is	indicative	of	PE	(correctly	identifies	90%	of	diagnosed	patients	as	PE	sufferers	and	incorrectly	identifies	5%	of	controls	as	PE	sufferers),	5-16	points	indicate	a	low	probability	of	PE.	A	Swedish	(Dhejne,	Jern,	&	Arver,	2017)	and	a	back-translated	Finnish	version	of	the	scale	was	used.	In	study	IV,	CHEES	had	a	somewhat	low	internal	reliability	(α	=	.61),	which	is	likely	due	to	the	items	covering	relevant	diagnostic	criteria,	which	do	not	necessarily	correlate	highly.	CHEES	was	developed	in	2013,	and	since	it	outperformed	MIPE	it	was	chosen	for	the	subsequent	data	collections.		Both	MIPE	 and	 CHEES	 rely	 on	 subjectively	 estimated	 ELT.	 A	meta-analysis	regarding	the	relevance	of	methodological	design	of	studies	of	PE	revealed	no	significant	 mean	 difference	 between	 subjectively	 estimated	 and	 stopwatch-measured	IELT	(Waldinger,	Zwinderman,	Schweitzer,	&	Olivier,	2004)		The	Sexual	Distress	Scale	(SDS;	Jern	et	al.,	2008)	was	used	to	measure	distress	related	to	sexuality	and	sexual	behavior	and	performance.	The	SDS	is	gender-neutral,	and	adapted	from	the	Female	Sexual	Distress	Scale	(Derogatis,	Rosen,	Leiblum,	Burnett,	&	Heiman,	2002).	Seven	questions	are	answered	on	a	5-point	Likert	 scale	 covering	 topics	 of	 distress	 and	 embarrassment	 about	 sexual	problems,	and	feelings	of	inadequacy.	The	SDS	items	were	back-translated	into	Finnish.	 Jern	 et	 al.	 reported	 the	 items	 loading	 on	 a	 single	 factor,	with	 item	loadings	ranging	from	.65	to	.79,	and	Cronbach’s	α	=	.89.	In	the	present	studies,	internal	reliabilities	were	good	to	excellent	(study	I	α	=.86;	study	II	ωs	=	.89–.91).	The	SDS	was	used	in	Study	II	to	elucidate	causal	associations	between	PE	and	distress,	and	in	Study	IV	as	a	secondary	outcome	measure.	
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	The	 Brief	 Symptom	 Inventory-18	 (BSI)	 was	 used	 to	 measure	 general	psychological	distress.	The	BSI	was	developed	 from	the	Symptoms	Checklist	(SCL-90;	 Derogatis	 &	Melisaratos,	 1983).	 The	 subscales	 of	 the	 SCL-90	 have	previously	been	shown	to	possess	good	discriminant	validity	in	Finnish	(Holi,	Sammallahti,	 &	 Aalberg,	 1998)	 and	 Swedish	 samples	 (Fridell,	 Cesarec,	Johansson,	&	 Thorsen,	 2002).	 Participants	 rate	how	much	 bother	 they	have	experienced	during	the	last	week	on	a	5-point	Likert	scale.	We	used	two	of	the	subscales	 measuring	 anxiety	 and	 depression.	 The	 anxiety	 subscale	 covers	symptoms	 of	 nervousness,	 tension,	 restlessness	 and	 panic	 states,	 and	 the	depression	subscale	covers	anhedonia,	hopelessness	and	suicidal	ideation.	In	the	 present	 studies,	 internal	 reliabilities	 were	 good	 to	 excellent	 (study	II	ωsanxiety	=	.80–.81,	ωsdepression	=	.86–.89;	study	IV	αanxiety	=	.93,	αdepression	=	.90).	The	BSI	was	used	in	Study	II	to	elucidate	causal	associations	between	PE	and	symptoms	of	mood	disorders,	and	in	Study	IV	as	a	secondary	outcome	measure.		The	State-Trait	Anxiety	Inventory	(STAI;	Spielberger	et	al.,	1970)	was	used	in	Study	IV	to	measure	anxiety	as	a	stable	trait	and	in	a	specific	sexual	situation.	Unlike	the	original	version,	where	respondents	are	asked	to	rate	how	anxious	they	feel	in	the	moment	they	are	filling	out	the	questionnaire,	respondents	in	the	present	study	were	asked	to	rate	how	anxious	they	felt	during	the	last	few	times	they	had	sex	with	a	partner.	Each	subscale	contains	20	questions	that	are	answered	on	a	4-point	Likert	scale.	 In	study	 IV,	 the	 reliability	was	 excellent	(αtrait	=	.95,	αstate	=	.93).		The	 five-item	version	of	 the	 International	 Index	of	Erectile	Function	(Rosen,	Cappelleri,	Smith,	Lipsky,	&	Peña,	1999)	was	used	to	measure	erectile	function.	Items	 cover	 the	 ability	 to	 achieve	 and	 maintain	 an	 erection	 sufficient	 for	penetrative	sex	and	satisfaction	with	intercourse.	Items	are	answered	on	a	five-point	 Likert	 scale.	 In	 the	 present	 studies,	 internal	 consistencies	were	 good,	ranging	from	.80	to	 .89.	The	index	was	used	to	analyze	associations	between	ED	and	physical	exercise	in	Study	III,	and	was	used	as	a	screening	instrument	in	study	IV.		The	Alcohol	Use	Disorders	Identification	Test	(Saunders,	Aasland,	Babor,	de	la	Fuente,	&	Grant,	1993)	was	used	to	measure	alcohol	consumption	in	Study	III.	The	 ten	 items	 relate	 to	 frequency	 and	 amount	 of	 drinking	 and	 negative	outcomes	of	drinking,	and	are	answered	on	a	scale	from	0	to	4.	In	study	III,	the	
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internal	 reliability	 was	 good	 in	 the	 population-based	 sample	 (α	 =	 .82)	 and	acceptable	the	clinical	sample	(α	=	.73).		The	 Godin	 Leisure-Time	 Exercise	 Questionnaire	 (Godin,	 1997)	 was	 used	 in	Study	III	to	measure	how	much	participants	engage	in	physical	exercise.	The	questions	ask	how	many	times	per	week	the	participant	engaged	in	strenuous	(e.g.,	 hockey),	 moderate	 (e.g.,	 fast	 walking),	 or	 mild	 exercise	 (e.g.,	 golf)	 for	longer	than	15	minutes	during	their	free	time.	The	variables	are	weighted	and	added	into	a	composite	score.	In	study	III,	the	internal	reliability	was	low	both	in	the	population-based	sample	(α	=	.24)	and	the	clinical	sample	(α	=	.23).	This	is	 due	 to	 some	 respondents	 reporting	 engaging	 in	 only	 one	 or	 two	 of	 the	categories,	 leading	 to	 there	 being	 many	 zeros,	 which	 drastically	 reduces	internal	consistency.	In	a	validation	study	by	Eisenmann	et	al.	(2002),	the	test-retest	 reliability	 over	 1	 week	 was	 r	 =	 .62,	 and	 convergent	 validity	 was	supported	by	use	of	an	accelerometer.		Body	mass	index	(BMI)	was	used	in	Study	III	to	measure	respondents’	weights	in	relation	 to	 their	height.	BMI	was	calculated	 from	self-reported	height	and	weight,	according	to	the	standard	formula	of	kilograms	per	meter	squared.		The	Multidimensional	Assessment	of	Interoceptive	Awareness	(MAIA;	Mehling	et	 al.,	 2012)	was	used	 in	 Study	 IV	 to	measure	 interoceptive	 awareness.	The	measure	 consists	 of	 eight	 subscales:	 noticing,	 not-distracting,	 not-worrying,	attention	regulation,	emotional	awareness,	self	regulation,	body	listening,	and	trusting.	Thirty-two	items	are	answered	on	a	six-pont	Likert	scale.	Two	of	the	subscales,	body	listening	and	noticing,	have	in	women	been	linked	to	greater	awareness	of	genital	arousal	and	greater	levels	of	concordance	between	genital	and	 subjective	 arsoual	 (Handy	 &	 Meston,	 2016).	 No	 similar	 studies	 of	concordance	have	been	conducted	using	MAIA	 in	male	samples.	 In	study	 IV,	internal	reliabilities	for	the	eight	subscales	ranged	from	.59	to	.91.		3.3	Study	designs	and	statistical	analyses	In	the	following	sections	I	present	how	each	study	was	designed	to	answer	or	test	 its	 respective	 research	 question	 or	 hypothesis,	 and	 how	 results	 were	analyzed.			
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3.3.1	Study	I	
Study I investigated hypothesis 1 (H1:	PE	symptoms	are	stable	over	time	in	the	general	population	and	in	a	cohort	of	patients	diagnosed	with	lifelong	PE).	We	utilized	two	longitudinal	samples	measured	twice	over	six	years	(population-based	sample)	and	three	years	(clinical	sample).			In	order	to	assess	the	stability	of	PE	symptoms	over	time,	we	first	looked	at	how	many	participants	reported	an	IELT	under	1	minute	at	both,	none,	or	one	of	 the	 time	points.	As	 this	 time	 cutoff	 is	 considered	 relevant	 for	diagnosing	lifelong	PE,	it	would	be	expected	that	participants	who	reported	IELTs	under	1	minute	at	the	first	measurement	would	also	report	IELTs	under	1	minute	at	the	second	measurement	if	lifelong	PE	is,	as	the	name	implies,	a	chronic	condition.	All	respondents	in	the	clinical	sample	were	expected	to	report	IELTs	under	1	minute,	as	they	had	been	diagnosed	with	PE	previously.	Secondly,	we	analyzed	how	much	of	the	variability	in	PE	symptoms	at	the	later	time	point	could	be	explained	by	PE	symptoms	at	the	first	time	point	by	using	linear	regression.	A	high	 degree	 of	 explained	 variance	 at	 the	 subsequent	 time	 point	 would	 be	expected	 if	 PE	 was	 a	 lifelong,	 stable	 condition.	 Thirdly,	 at	 the	 second	measurement,	 participants	 were	 asked	 to	 provide	 a	 self-assessment	 of	 any	change	in	PE	symptoms	since	the	first	measurement	three	or	six	years	ago,	if	there	was	any.		In	the	population-based	sample,	3923	completed	the	first	survey,	and	1024	the	second.	 In	 the	 clinical	 sample,	 175	 participants	 completed	 the	 first	 data	collection	 and	 34	 completed	 the	 second	 data	 collection.	 After	 excluding	participants	 who	 used	 SSRIs	 at	 either	 time	 point,	 and	 participants	 who	answered	less	than	40%	of	PE-related	items,	the	final	sample	sizes	were	843	for	the	population-based	sample	and	16	for	the	clinical	sample.	Missing	data	were	 imputed	 using	 the	 expectation	 maximization	 procedure	 in	 SPSS	 21.0	using	 intra-scale	 information.	 Statistically,	 analyses	 were	 conducted	 using	descriptive	statistics	and	linear	regression.		3.3.2	Study	II	Study	II	investigated	the	direction	of	causality	between	PE	on	the	one	hand,	and	anxiety	and	depression	on	the	other	(Q2).	Using	the	population-based	sample,	we	 tested	 two	 competing	 models	 regarding	 the	 relationships	 between	 PE,	anxiety,	 sexual	 distress	 and	 depression.	 According	 to	 the	 first	 model,	 we	
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expected	 that	 anxiety	 and	 sexual	 distress	 at	 time	 1	 would	 be	 positively	associated	with	PE	at	time	2.	On	the	contrary,	according	to	the	second	model,	PE	 at	 time	 1	 was	 expected	 to	 be	 positively	 associated	 with	 anxiety,	 sexual	distress	 and	 depression	 at	 time	 2.	 Post-hoc,	 I	 ran	 a	model	 constraining	 all	parameters	between	PE	and	the	other	variables	in	the	structural	model	to	zero	(i.e.,	essentially	combining	both	models),	in	a	more	stringent	test	of	there	being	any	longitudinal	association	between	the	factors. 	Structural	equation	models	were	fitted	to	the	data	to	test	the	aforementioned	models.	To	test	models,	 relevant	structural	regression	parameters	were	 first	omitted	(Figure	3).	The	constrained	model	was	then	compared	to	the	saturated	model.	If	the	constrained	model	had	a	significantly	worse	fit	to	data,	this	was	interpreted	 as	 indicating	 that	 the	 omitted	 parameters	 differed	 significantly	from	zero.	Because	the	sample	was	clustered	(twins	and	siblings	in	families),	maximum	likelihood	estimation	with	robust	standard	errors	was	used	(Muthen	&	Satorra,	1995).	This	also	allowed	handling	of	missing	data.						
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Figure	 3.	 The	 structural	 part	 of	 first	 model	 in	 study	 II.	 Note	 the	 omitted	parameters	between	PE2	and	SDS1	and	ANX1.	PE	=	premature	ejaculation,	SDS	=	 sexual	 distress,	 ANX	 =	 anxiety,	 DEP	 =	 depression,	 1	 =	 time	 1,	 2	 =	 time	 2.	Measurement	model	not	depicted.		3.3.3	Study	III	Study	III	investigated	associations	between	PE	and	physical	exercise,	BMI,	and	alcohol	 consumption	 (Q3).	 This	 was	 done	 cross-sectionally	 and	 in	 a	 case-control	 manner,	 using	 both	 population-based	 and	 clinical	 samples.	 For	 the	population-based	 sample,	 data	 were	 used	 from	 the	 second	 wave	 of	 data	collection,	and	 for	the	clinical	sample,	data	were	used	from	the	first	wave	of	data	collection,	as	the	relevant	variables	were	gathered	only	in	these	waves.	Participants	 were	 excluded	 from	 analysis	 if	 they	 used	 SSRIs	 or	 other	medication	than	may	affect	PE	symptoms,	and	if	they	had	any	missing	data.	To	control	for	familial	dependence	(as	the	population-based	sample	consisted	of	genetically	related	individuals),	one	person	per	family	was	randomly	included	
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in	 the	 population-based	 sample.	 The	 total	 sample	 sizes	 were	 863	 for	 the	population-based	and	69	for	the	clinical	sample.		Independent	sample	t-tests	were	used	to	compare	mean	differences	between	the	groups.	The	clinical	sample	was	compared	to	the	population-based	sample,	as	well	as	 to	an	age-matched	subset	 of	 the	population-based	(as	 the	 clinical	sample	[M	=	43.8]	was	significantly	older	than	the	population-based	sample	(M	=	33.1]).	Bivariate	correlations	were	used	to	analyze	associations	between	the	variables	within	the	groups.	Finally,	a	multiple	linear	regression	was	conducted	where	 PE	 was	 the	 dependent	 variable	 and	 physical	 exercise,	 age,	 erectile	function,	 alcohol	 consumption,	 and	 BMI	 were	 entered	 as	 independent	variables.	
 3.3.4	Study	IV	Study	 IV	 investigated	 if	 vibrator-assisted	 start-stop	 exercises	 alleviate	 PE	symptoms	 (H4),	 and	whether	 the	 treatment	 effects	 are	 further	 enhanced	by	additional	interoceptive	awareness	training	and	psychoeducation	(H5).	It	also	provided	 further	 data	 regarding	 the	 associations	 between	 PE	 symptom	severity,	anxiety,	depression,	sexual	distress,	and	interoceptive	awareness.		Participants	were	randomized	into	one	of	two	different	treatment	groups	or	a	waiting	 list	 control	 condition.	 No	 statistically	 significant	 differences	 were	found	between	the	three	groups	at	the	first	measurement,	with	the	exception	of	one	MAIA	subscale,	indicating	a	successful	randomization.	Participants	in	the	waiting	 list	 control	 group	were	 randomly	 allocated	 to	 the	 treatment	 groups	following	a	6-week	waiting	period.		The	6-week	intervention	involved	two	visits	to	the	clinic,	at	the	beginning	and	end	of	treatment.	Participants	answered	online	questionnaires	at	home	before	and	immediately	after	treatment,	as	well	as	3	and	6	months	after	treatment.	The	waiting	 list	 control	 group	 additionally	 completed	 questionnaires	 at	 the	beginning	of	 the	waiting	period	(i.e.,	 six	weeks	before	 treatment).	The	study	was	approved	by	the	Regional	Ethical	Review	Board	in	Stockholm,	Sweden,	in	accordance	with	the	Declaration	of	Helsinki.	All	participants	provided	written,	informed	consent.		
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The	 first	 treatment	 group	 (VSS;	 short	 for	 Vibrator-assisted	 Start-Stop)	performed	 vibrator-assisted	 start-stop	 exercises	 three	 times	 a	 week	 for	 6	weeks.	 Participants	 were	 instructed	 to	 masturbate	 while	 stimulating	 the	underside	 of	 glans	 penis	 with	 a	 handheld	 vibrator,	 until	 ejaculation	 felt	imminent,	and	then	take	a	break	and	remove	the	vibrator.	When	ejaculation	was	no	longer	imminent,	participants	were	to	resume	masturbation	using	the	device.	This	was	to	be	repeated	three	times,	and	on	the	third	time	participants	could	 ejaculate	 if	 they	 so	 wished,	 in	 accordance	 with	 the	 manufacturer’s	instructions.	Participants	were	not	restricted	from	engaging	in	any	other	sexual	activities	during	treatment.		In	 the	 second	 treatment	 group	 (VSS+)	 participants	 additionally	 received	further	psychoeducation	and	performed	interoceptive	awareness	exercises	in	the	form	of	15-minute	guided	body	scan	meditations	to	be	completed	prior	to	the	vibrator-assisted	start-stop	exercises.	The	psychoeducation	involved	topics	such	 as	 the	 connection	 between	 interoceptive	 awareness	 and	 PE,	 and	techinques	to	monitor	and	control	sexual	excitement.	
	Both	intention-to-treat	(ITT)	and	per-protocol	(PP)	analyses	were	conducted.	In	 ITT	analyses,	 the	 last	 observation	was	carried	 forward	 in	case	of	missing	data.	 This	 can	 be	 considered	 to	 be	 a	 conservative	 approach	 in	 pre-post	analyses,	as	participants	who	do	not	provide	data	are	assumed	to	have	had	no	change.	On	the	other	hand,	ITT	analyses	may	overestimate	long-term	effects	as	any	potential	treatment	effect	is	assumed	to	be	sustained.	Pre-post	treatment	effects	were	analyzed	using	analysis	of	covariance	with	post-treatment	scores	being	 the	 dependent	 variable,	 treatment	 group	 being	 the	 between-groups	factor	 (waiting	 list,	 VSS,	 VSS+),	 and	 pre-treatment	 measurement	 used	 as	 a	covariate	in	order	to	reduce	error	variance	(Dimitrov	&	Rumrill,	2003).	Within-group	differences	were	calculated	using	dependent	sample	t-tests.	Differences	between	the	two	treatment	groups	at	follow-up	were	tested	using	independent	sample	t-tests.	 	
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4.	RESULTS	4.1	Study	I	The	clinical	sample	had	been	diagnosed	with	PE	by	a	physician	specializing	in	sexual	 medicine	 prior	 to	 study	 participation,	 and	 the	 participants	 were	untreated	during	participation	in	the	study.	As	such,	it	would	be	expected	that	all	participants	in	the	clinical	sample	met	the	diagnostic	criterion	of	ELT	less	than	1	minute.	However,	only	50%	(n	=	8)	reported	ELT	less	than	1	minute	in	2012	(Table	2).	Of	these,	five	men	reported	equally	short	ELT	in	2015,	while	an	additional	 two	that	did	not	report	ELT	 less	 than	1	minute	 in	2012	did	so	 in	2015.	The	autoregressive	coefficient	was	high	(b	=	0.83,	p	<	.001).	In	terms	of	subjective	 perception	 of	 change,	 63%	 (n	 =	 10)	 reported	 that	 their	 ELT	 had	changed	 (i.e.,	 that	 their	 ELT	 used	 to	 be	 somewhat	 shorter/longer;	 or	 a	 lot	shorter/longer)	between	the	two	measurement	points.		In	the	population-based	sample,	16	individuals	reported	an	ELT	of	less	than	1	minute	in	2012.	Of	these,	seven	reported	equally	short	ELT	in	2015,	while	an	additional	13	that	did	not	report	ELT	less	than	1	minute	in	2012	did	so	in	2015.	The	autoregressive	coefficient	in	this	sample	was	moderate	(b	=	0.58,	p	<	.001),	suggesting	 that	 ELT	 was	 more	 stable	 in	 the	 clinical	 sample.	 In	 terms	 of	subjective	perception	of	 change,	47%	(n	=	397)	reported	 that	 their	ELT	had	changed	(i.e.,	used	to	be	somewhat	or	a	lot	shorter	or	longer).	
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Table	2	
Subjectively	Estimated	Ejaculation	Latency	Times	in	the	Population-Based	and	
Clinical	Samples			 Sample		 Population-based	(n)	   Clinical	(n)	Item	response	option	 Time	1	 Time	2	   Time	1	 Time	2	I	usually	do	not	ejaculate	 11	 6	 	 0	 0	More	than	10	min	 316	 282	 	 0	 0	Between	5	and	10	min	 330	 348	 	 1	 0	Between	1	and	5	min	 170	 187	 	 7	 9	Less	than	1	min	 16	 20	   8	 7	
Note.	Time	1	=	data	collection	in	year	2006	for	the	population-based	sample,	year	2012	for	the	clinical	sample;	Time	2	=	data	collection	in	year	2012	for	the	population-based	sample	and	year	2015	for	the	clinical	sample.		4.2	Study	II	Bivariate	 correlations	 between	 latent	 factors	 are	 presented	 in	 Table	 3.	 All	variables	 had	 statistically	 significant	 positive	 correlations	 within	 both	 time	points.	 PE	 and	 sexual	 distress	 were	mutually	 positively	 correlations	 across	time.	 PE	 at	 Time	 1	was	 positively	 correlated	with	 anxiety	 at	 Time	 2,	while	depression	at	Time	1	was	positively	correlated	with	PE	at	Time	2.	These	cross-time	cross-domain	coefficients	were	small	to	moderate.		Table	3	
Estimated	 Correlations	 between	 Latent	 Variables	 Measuring	 Premature	
Ejaculation,	Sexual	Distress,	Anxiety,	and	Depression			 PE1 PE2	 SDS1 SDS2	 ANX1 ANX2	 DEP1 
PE1 -	 	 	 	 	 	 	PE2	 .659***	 -	 	 	 	 	 	
SDS1 .563***	 .347***	 -	 	 	 	 	SDS2	 .228***	 .414***	 .467***	 -	 	 	 	
ANX1 .121**	 .087	 .384***	 .279***	 -	 	 	ANX2	 .091*	 .209***	 .307***	 .478***	 .544***	 -	 	
DEP1 .156***	 .127**	 .445***	 .349***	 .854***	 .445***	 -	DEP2	 .074	 .135**	 .315***	 .533***	 .493***	 .828***	 .529***	
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Note.	PE	=	premature	ejaculation,	SDS	=	sexual	distress,	ANX	=	anxiety,	DEP	=	depression,	1	=	time	1,	2	=	time	2	*	p	<	.05,	**	p	<	.01,	***	p	<	.001		Two	models	were	fitted	to	the	data;	the	first	to	test	whether	anxiety	predicted	future	PE,	and	the	second	whether	PE	predicted	future	anxiety	and	depression.	Neither	of	the	models	had	significantly	worse	fit	than	the	saturated	model.	A	post-hoc	 model	 excluding	 all	 paths	 over	 time	 between	 PE	 and	 the	 other	variables	also	did	not	fit	significantly	worse	than	the	saturated	model	(Δχ2(6)	=	5.45,	p	=	.49).	Thus,	no	associations	across	time	were	found	in	these	models.	All	models	explained	approximately	the	same	amount	of	variance	in	PE	at	Time	2	(R2s	=	.431-.440).		4.3	Study	III	Respondents	 in	 the	 clinical	 sample	were	 less	 inclined	 to	 engage	 in	 physical	exercise	(M	=	27.53,	SD	=	21.01)	than	the	population-based	sample	(M	=	34.68,	
SD	=	22.82,	t(930)	=	2.52,	p	=	.012,	d	=	0.85).	The	clinical	sample	also	used	less	alcohol	(M	=	6.94,	SD	=	4.46)	than	the	population-based	sample	(M	=	8.10,	SD	=	5.27,	 t(85.86)	 =	 2.03,	 p	 =	 .045,	 d	 =	 0.23).	 No	 difference	 in	 BMI	 was	 found	between	 the	 groups.	 When	 comparing	 the	 clinical	 sample	 to	 age	 matched	controls,	 no	 statistically	 significant	 differences	 between	 groups	 remained,	although	group	means	were	in	the	same	direction	as	when	the	full	population-based	sample	was	compared	to	the	clinical	sample.		Within	the	population-based	sample,	PE	was	weakly	negatively	correlated	with	physical	exercise	(r	=	-.09,	p	<	.05).	This	correlation	was	more	pronounced	in	the	oldest	group,	which	was	age	matched	to	the	clinical	sample	(r	=	 -.29,	p	<	.05).	PE	was	not	statistically	significantly	correlated	with	alcohol	consumption	or	BMI.			In	a	multiple	regression	analysis,	PE	was	statistically	significantly	predicted	by	physical	exercise	(β	=	-.09,	p	=	 .007;	Table	4),	even	while	controlling	for	age,	erectile	 function,	 alcohol	 consumption	 and	 BMI,	 suggesting	 that	 individuals	who	exercised	less	experienced	more	PE	symptoms.				
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Table	4	
Multiple	 regression	 of	 variables	 predicting	 premature	 ejaculation	 in	 the	
population-based	and	clinical	sample		 b	 SE	 𝛽	 t	 p	Constant	 18.49	 1.69	 	 10.92	 <.001	Physical	exercise	 -0.02	 0.01	 -.09	 2.72	 .007	Age	 0.15	 0.02	 .21	 6.76	 <.001	Erectile	function	 0.31	 0.04	 .23	 7.41	 <.001	Alcohol	consumption	 -0.01	 0.03	 -.01	 0.28	 .776	BMI	 -0.00	 0.04	 -.00	 0.11	 .911	
Note.	BMI	=	body	mass	index,	SE	=	Standard	error		4.4	Study	IV	In	 study	 IV,	 there	was	 a	 statistically	 significant	 correlation	between	 PE	and	sexual	 distress	 at	 the	 first	 measurement	 (r	 =	 .486,	 p	 <	 .001).	 PE	 was	 not,	however,	 correlated	with	 trait	or	state	anxiety	during	sex	as	measured	with	STAI,	nor	anxiety	or	depression	as	measured	with	BSI.	In	addition,	PE	was	not	associated	with	erectile	function.			4.4.1	Pre-post	analyses	The	waiting	 list	 control	group	had	no	statistically	significant	changes	 in	any	variable	over	the	waiting	period.	The	VSS	group	had	a	statistically	significant	improvement	of	PE	symptoms	during	the	treatment	period	(t	=	3.22,	p	=	.005),	but	no	statistically	significant	changes	in	any	other	outcome	variable.	The	VSS+	group	showed	improvements	on	PE	(t	=	3.78,	p	=	.001)	after	treatment,	and	in	addition,	improvements	on	the	following	secondary	outcome	variables:	sexual	distress	(t	=	2.48,	p	=	.023),	STAI	trait	anxiety	(t	=	2.77,	p	=	.013),	STAI	state	anxiety	during	sex	(t	=	2.18,	p	=	.043),	and	BSI	anxiety	(t	=	2.17,	p	=	.044).		An	 analysis	 of	 covariance	 (ANCOVA)	 revealed	 that	 there	 were	 statistically	significant	differences	in	PE	between	the	groups	at	post	treatment	(F	=	5.65,	p	=	.006,	ITT	analysis),	and	the	effect	size	was	large	(partial	η2	=	 .20).	Pairwise	comparisons	showed	large	treatment	effects	in	both	the	VSS	group	(d	=	1.05,	95%	CI	=	 [0.27,	1.82])	and	 the	VSS+	group	(d	=	1.07,	95%	CI	=	 [0.32,	1.82])	compared	 to	 the	 control	 group.	The	 treatment	 effect	was	pronounced	when	analyzing	only	items	related	to	dysfunction	(ELT,	feeling	of	control,	ejaculation	
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with	 very	 little	 stimulation).	 The	 treatment	 groups	 did	 not	 differ	 from	 one	another	in	terms	of	statistical	significance	or	effect	size	at	post	treatment.			
	
Figure	4.	Change	in	CHEES	category	from	pre-	to	post-treatment.	A	decrease	in	category	 indicates	 decreased	 symptoms	 of	 PE.	 The	 three	 categories	 are	“strongly	indicative	of	fulfilling	diagnostic	criteria	for	PE”,	“indicative	of	PE”,	and	 “low	 probability	 of	 PE”	 (Jern	 et	 al.,	 2013).	 No	 patients	 had	 a	 higher	categorization	at	post-treatment	 than	pre-treatment.	VSS	=	vibrator-assisted	start-stop	 group,	 VSS+	 =	 vibrator-assisted	 start-stop	 and	 psychobehavioral	intervention	group.		Comparing	the	two	treatment	groups	regarding	change	of	categorization	on	the	main	 outcome	measure	 revealed	 that	more	 than	 half	 of	 the	 VSS	 group	 had	scores	within	the	same	category	before	and	after	treatment	(Figure	4).	On	the	contrary,	a	majority	of	the	VSS+	had	improved	one	or	two	categories	during	treatment.	This	possibly	 implies	a	better	treatment	effect	in	the	VSS+	group.	Prior	to	treatment,	the	mean	of	both	treatment	groups	fall	within	the	category	“strongly	indicative	of	fulfilling	diagnostic	criteria	for	PE”.	In	ITT	analyses,	the	means	of	both	groups	after	treatment	are	in	the	lower	bound	of	the	“indicative	of	PE”	category	in	ITT	analyses,	while	the	means	in	PP	analyses	are	in	the	upper	bound	of	the	category	“low	probability	of	PE”.		
0
2
4
6
8
10
12
No change -1 category -2 categories
Nu
m
be
r o
f p
at
ie
nt
s
Change in CHEES category 
from pre- to post-treatment
VSS VSS+
		 46	
	ANCOVA	 analyses	 revealed	 no	 statistically	 significant	 between-group	differences	on	any	secondary	outcome	measure.	However,	despite	not	being	statistically	 significant,	 pairwise	 comparisons	 revealed	 that	 the	 VSS+	 group	displayed	 larger	 improvements	 in	 sexual	 distress,	 and	 all	 STAI	 and	 BSI	measures	 compared	 to	 the	VSS	 group,	with	medium	effect	 sizes	 (ds	=	0.38–0.66).	 Surprisingly,	 interoceptive	 awareness	 did	 not	 differ	 significantly	between	groups,	which	 indicates	 that	 the	 interoceptive	 awareness	 exercises	performed	by	the	VSS+	did	not	have	had	the	intended	IA-improving	effect.	All	results	were	similar	in	ITT	and	PP	analyses.		4.4.2	Follow-up	analyses	Participants	from	the	waiting	list	were	included	 in	one	of	the	two	treatment	groups	in	the	follow-up	analyses.	No	statistically	significant	differences	in	PE	symptoms	were	found	between	the	two	treatment	groups	at	either	follow-up	time.	ITT	analyses	revealed	that	improvements	in	PE	symptoms	were	sustained	after	 3	 and	 6	 months	 in	 both	 treatment	 groups	 when	 compared	 to	 pre-treatment	(Figure	5).	However,	follow-up	analyses	were	based	on	a	very	small	number	of	respondents,	and	is	therefore	unreliable.	At	6-month	follow-up	in	PP	analyses,	the	mean	of	the	VSS	group	rises	back	to	baseline	(Figure	6).	This	is	 however	 not	 because	 of	 a	 waning	 treatment	 effect,	 but	 it	 can	 rather	 be	explained	by	dropout,	as	the	mean	of	the	subgroup	of	eight	participants	who	provided	data	at	this	time	point	was	consistently	around	20	at	all	time	points.	Consequently,	conclusions	regarding	long-term	efficacy	should	be	drawn	only	with	great	caution.			
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Figure	5.	Premature	ejaculation	scores	from	intention-to-treat	analyses.	NVSS	=	23,	NVSS+	 =	 27.	 Range	 5–25,	 higher	 scores	 indicate	 more	 severe	 symptoms.	Empirically	 derived	 cutoff	 scores:	 21-25:	 strongly	 indicative	 of	 fulfilling	diagnostic	criteria	for	PE,	17-20:	indicative	of	PE,	5-16:	low	probability	of	PE.	VSS	=	 vibrator-assisted	 start-stop	group,	VSS+	=	 vibrator-assisted	 start-stop	and	psychobehavioral	intervention	group.		
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Figure	6.	Premature	ejaculation	scores	from	per-protocol	analyses.	Range	5–25,	higher	scores	 indicate	more	severe	symptoms.	Empirically	derived	cutoff	scores:	21-25:	strongly	indicative	of	fulfilling	diagnostic	criteria	for	PE,	17-20:	indicative	of	PE,	5-16:	low	probability	of	PE.	VSS	=	vibrator-assisted	start-stop	group,	VSS+	=	vibrator-assisted	start-stop	and	psychobehavioral	intervention	group.			 	
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5.	DISCUSSION	The	 discussion	 section	 is	 structured	 as	 follows.	 In	 the	 context	 of	 previous	relevant	research,	I	first	discuss	results	pertaining	to	the	diagnostic	criteria	of	PE,	followed	by	issues	of	etiology,	and	finally	treatment	of	PE.	Following	this,	limitations	 of	 the	 present	 studies	 are	 considered.	 Finally,	 some	 interesting	future	avenues	of	research	are	presented.		5.1	Diagnostic	considerations	Throughout	its	history,	the	definition	of	PE	has	been	the	object	of	considerable	debate	 (Waldinger	 &	 Schweitzer,	 2019).	 With	 each	 new	 edition	 of	 the	diagnostic	 manuals	 presenting	 somewhat	 varied	 definitions,	 consensus	regarding	diagnostic	criteria	has	not	yet	been	reached.	For	example,	the	latest	version	of	the	DSM	includes	cutoffs	for	IELT	where	previous	versions	did	not	(American	Psychiatric	Association,	2013),	whereas	the	new	ICD-11	no	longer	includes	 any	 cutoff	 for	 IELT	 while	 the	 previous	 version	 did	 (World	 Health	Organization,	2018).	The	present	study	adds	relevant	empirical	results	for	the	discussions	on	ELT	cutoff	and	subtypes	of	PE.		5.1.1	Ejaculation	latency	time	cutoff	According	 to	 the	 International	 Society	 for	 Sexual	Medicine,	 PE	 is	defined	by	nearly	always	having	had	an	IELT	of	approximately	1	minute	(lifelong	PE)	or	a	bothersome	reduction	of	IELT	to	about	3	minutes	(acquired	PE);	inability	to	delay	 ejaculation;	 and	 negative	 personal	 consequences	 such	 as	 distress	(Serefoglu	et	al.,	2014,	pp.	44).	According	to	this	definition,	neither	a	short	IELT	nor	 distress	 about	 a	 subjectively	 experienced	 short	 IELT,	 are	 in	 themselves	sufficient	for	diagnosis	–	a	combination	of	IELT,	lack	of	control,	and	distress	is	necessary.	These	criteria	are	not	always	present	simultaneously.	Rowland	et	al.	(2004)	found	that	some	men	who	ejaculate	before	they	wish	do	not	see	it	as	a	problem.	Similarly,	 Patrick	et	al.	 (2005)	observed	 that	some	men	with	 short	IELTs	were	not	distressed	about	their	IELTs,	while	on	the	contrary,	some	men	with	comparably	long	IELTs	were	nevertheless	distressed.	While	every	patient	can	express	their	experienced	distress,	any	objective	cutoff	for	what	is	to	be	considered	 short	 in	 terms	 of	 IELT	 is	 determined	 by	 the	 scientific	 and	professional	field.	But	how	is	this	cutoff-point	for	IELT	determined?		
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The	 empirical	 underpinning	 for	 ISSM’s	 definition	 is	 partly	 based	 on	epidemiological	stopwatch-measured	data.	In	two	studies,	unimodal	positively	skewed	 distributions	 of	 IELT	were	 found	with	medians	 of	 5.4	minutes	 in	 a	convenience	 sample	 (Waldinger	 et	 al.,	 2005)	 and	 6.0	 minutes	 in	 a	 random	sample	(Waldinger,	Mcintosh,	&	Schweitzer,	2009).	This	is	to	say	that	there	is	not	 a	 clearly	 distinguishable	 group	 with	 shorter	 IELTs	 than	 the	 general	population,	but	rather	a	cutoff	point	is	chosen	along	the	unimodal	continuum	of	the	distribution	of	IELT.	The	cutoff	of	approximately	1	minute	was	chosen	based	on	statistical	 infrequency	(about	2.5%	of	 the	population	report	 IELTs	less	than	1	minute),	and	on	a	study	which	found	that	99	of	110	men	who	saught	treatment	 for	 lifelong	 PE	 reported	 IELTs	≤	1	minute	 (Serefoglu	 et	 al.,	 2014;	Waldinger,	Hengeveld,	Zwinderman,	&	Olivier,	1998).		The	 reasons	 for	 choosing	 a	 cutoff	 of	 approximately	 1	minute	 has,	 however,	been	questioned.	Söderfeldt	et	al.	(2017,	p.	865)	note	that	“[…]	the	fact	that	a	phenomenon	 is	 statistically	 rare	 does	 not	 automatically	 equal	 pathology	 as	anyone	with	 red	hair	will	 confirm”.	Rowland	and	Kolba	 (2015)	 criticize	 the	validity	of	relying	on	stopwatch	studies	where	participants’	 level	of	distress	was	not	 also	 assessed,	 and	 further,	 that	 the	 self-selected	 sample	of	patients	used	 in	 the	 study	 by	Waldinger	 et	 al.	 (1998)	 was	 not	 representative	 of	 PE	patients	in	general.	The	authors	argue	that	the	1-minute	cutoff	excludes	many	men	who	 otherwise	 fulfill	 criteria	 for	 PE,	 and	 that	 this	 creates	 an	 artificial	dichotomization	between	men	who	are	in	fact	very	similar.	In	support	of	their	view,	Rowland	and	Kolba	present	empirical	data	by	analyzing	a	total	of	1183	men	(374	of	whom	reported	ejaculation	before	they	desired).	They	found	very	small	differences	in	levels	of	distress	between	participants	who	reported	IELTs	of	 <	 1	 minute	 compared	 to	 1–2	 minutes,	 while	 the	 level	 of	 distress	 was	comparably	 lower	 in	 participants	 reporting	 IELTs	 of	 2–5	 minutes.	Furthermore,	 the	 authors	 refer	 to	 previous	 unpublished	 data	 comparing	distress	 and	 bother,	 demographic	 variables,	 general	 medical	 history,	relationship	 and	 sexual	 parameters	 (including	 erectile	 functioning),	 and	perceived	 attributions	 for	 the	 problem,	 and	 found	 that	men	with	 IELTs	 <	 1	minute	were	similar	to	those	reporting	IELTs	of	1–2	minutes.	These	two	groups	were	 more	 similar	 to	 each	 other	 than	 to	 a	 comparison	 group	 of	 sexually	functional	men.	Based	on	 these	 findings,	Rowland	and	Kolba	argue	 that	a	2-minute	cutoff	would	reduce	false	negatives.		
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The	cutoff	has	been	further	criticized	by	Perelman	(2017),	who	reviewed	the	empirical	stopwatch-measured	IELT	data,	and	noted	that	the	majority	of	men	(>	∼65%)	reported	an	IELT	within	the	range	of	approximately	4	to	10	minutes.	This	range,	he	suggests,	could	be	used	as	the	point	of	reference,	with	men	who	involuntarily	 ejaculate	 within	 4	 minutes,	 and	 are	 distressed	 by	 it,	 could	 be	diagnosed	 with	 PE.	 While	 suggesting	 somewhat	 different	 cutoffs,	 perhaps	partly	due	to	Rowland	and	Kolba	(2015)	using	the	intervals	0–1,	1–2,	and	2–5	for	IELT	while	Perelman	(2017)	analyzed	continuous	data,	the	authors	of	both	reports	agree	that	the	current	temporal	criterion	is	too	strict.		The	 arguments	 presented	 thus	 far	 have	 been	 based	 on	 prevalence	 and	statistics,	but	what	if	the	issue	of	a	cutoff	is	not	an	empirical	question?	From	an	evolutionary	 perspective,	 Hong	 (1984)	 argued	 that	 PE	 could	 have	 been	selected	for,	since	protohumanoids	with	shorter	IELTs	could	have	had	greater	opportunity	 to	mate	with	several	partners	and	were	 less	 likely	 to	sustain	or	afflict	physical	damage	during	mating.	Further,	Hong	argues,	short	IELTs	may	forestall	aggressive	 competition	over	 chances	 to	mate	with	a	partner,	which	facilitated	group	harmony.	Taken	together,	this	could	mean	having	a	short	IELT	was	associated	with	increased	longevity	and	chance	of	passing	on	genes.			If	 the	distribution	of	 IELT	has	been	shaped	by	such	biological	 factors,	and	a	short	 IELT	 even	 might	 have	 been	 advantageous	 at	 some	 point,	 the	 current	experiences	of	short	IELTs	being	problematic	and	the	need	for	there	to	be	a	diagnosis	can	only	be	explained	by	the	meaning	that	is	placed	on	IELT	in	today’s	society.	Comparing	PE	to	ED,	another	common	male	sexual	dysfunction,	shows	that	the	dysfunctions	are	dissimilar	on	this	point.	In	ED,	the	penis	is	not	usable	for	 its	 biological	 function	 of	 penetration,	 while	 in	 PE,	 the	 penis	 arguably	performs	 its	biological	 function	with	 excellence	(bar	anteportal	 ejaculation),	while	not	performing	according	to	cultural	standards.	On	an	ultimate	level	of	explanation,	only	anteportal	ejaculation	can	be	deemed	dysfunctional,	since	the	ultimate	function	of	ejaculation	is	to	fertilize	an	egg,	and	there	is	no	evidence	to	say	 that	 the	probability	 of	 fertilization	 is	higher	 if	 intercourse	duration	 is	longer.	However,	on	a	proximate	level	of	explanation,	that	is,	in	the	context	of	sex	 taking	 place	 for	 recreational	 purposes,	 the	 function	 can	 become	dysfunctional	 if	 it	 impedes	pleasure	and	 causes	 interpersonal	distress	 (most	men	 probably	 seek	 treatment	 for	 their	 PE	 in	 order	 to	 improve	 their	recreational	sex,	rather	than	their	fertility.)	According	to	this	reasoning,	(I)ELT	is	an	inexpedient	measure,	since	the	focal	point	is	the	subjective	experience.		
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	Söderfeldt	 et	 al.	 (2017)	 argue	 that	 PE	 as	 a	 diagnosis	 reflects	 strict	 cultural	standards	centered	around	heterosexual	 coitus,	and	 that	 the	diagnosis	 itself	and	 the	 focus	 on	 IELT	 in	 turn	 reinforce	 these	 narrow	 male	 sexual	 scripts.		According	to	this	perspective,	the	problem	emerged	when	the	old	biology	was	situated	within	a	new	set	 of	 cultural	norms.	A	discrepancy	between	a	man’s	ejaculatory	 latency	 and	 his	 conception	 of	 how	 long	 it	 should	 be	 can	 lead	 to	suffering.	 While	 it	 is	 generally	 not	 possible	 for	 a	 clinician	 to	 alter	 cultural	norms,	 it	 is	 sometimes	possible	 to	 reduce	 suffering	by	 altering	 the	man,	 for	example	by	prolonging	the	man’s	ELT.	However,	with	about	a	third	of	the	male	population	subjectively	experiencing	their	ELTs	being	too	short	(Althof	et	al.,	2014),	some	form	of	objective	cutoff	is	useful	to	guide	us	in	deciding	when	to	accept	a	man’s	ELT	as	too	short,	and	here	empirical	data	are	useful.		The	present	study	adds	relevant	empirical	findings	to	this	discussion.	Results	from	Study	I	indicate	that	some	individuals	diagnosed	with	PE	fluctuate	in	their	ELT	across	both	sides	of	the	1-minute	mark.	This	means	that,	if	a	one-minute	ELT	cutoff	were	 to	be	abided	by,	 they	sometimes	 fulfilled	diagnostic	criteria	and	sometimes	did	not,	even	if	this	does	not	necessarily	reflect	their	subjective	experience.	 In	 Study	 IV,	 it	was	 interesting	 to	note	 that	 a	minority	 (20%)	of	participants	who	sought	help	reported	always	having	had	an	ELT	≤	1	minute,	in	contrast	 to	 the	previously	 cited	study	(90%;	Waldinger,	Hengeveld,	 et	al.,	1998).	 This	 difference	 might	 perhaps	 be	 explained	 by	 differences	 in	recruitment	strategy	and	wording	of	recruitment	material,	cultural	differences	or	decreasing	stigma,	or	that	the	population	of	men	with	PE	seeking	treatment	is	indeed	more	diverse	in	terms	of	ELT	than	what	was	observed	in	the	study	by	Waldinger.			In	any	case,	our	investigation	suggests	that	that	ELT	is	not	always	stable	over	time.	Furthermore,	not	only	men	reporting	ELT	<	1	minute	seek	help	for	PE.	In	conjunction	 with	 data	 from	 a	 study	 by	 Rowland	 and	 Kolba	 (2015),	 who	reported	similarities	in	distress	on	either	side	of	the	1	minute	mark	for	ELT,	I	suggest	 that	 the	 current	 cutoff	 for	 ELT	 for	 PE	 diagnosis	 at	 1	 minute	 is	unnecessarily	 strict.	 Increasing	 the	 temporal	 criterion	 to	 approximately	2–4	minutes	 would	 reduce	 false	 negatives,	 while	 the	 criteria	 for	 distress	 and	control	reduce	the	risk	of	false	positives.			
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5.1.2	Subtypes	of	PE	Results	from	Study	I	indicate	that	a	substantial	proportion	of	men	had	stable	symptoms	of	PE,	 including	 individuals	with	 severe	 symptoms.	However,	 the	results	of	Study	I	clearly	suggest	that	PE	symptoms	are	less	stable	over	time	than	 previously	 thought.	 This	 is	 most	 clearly	 demonstrated	 by	 the	 fact	 that	around	 half	 of	 the	 men	who	 reported	 ELTs	 less	 than	 1	 minute	 at	 the	 first	measurement	did	not	do	so	a	few	years	later.	This	finding	is	corroborated	by	subjectively	experienced	changes	in	ELT	between	the	two	measurement	points	in	 both	 the	 clinical	 sample	 (63%	 experienced	 a	 change	 in	 ELT)	 and	 the	population-based	sample	(47%	reported	change).	Furthermore,	only	a	third	of	the	 previously	 diagnosed,	 but	 at	 the	 time	 of	 the	 study	 untreated,	 patients	reported	 ELTs	 less	 than	 1	 minute	 at	 both	 time	 points.	 Taken	 together,	hypothesis	 1	 (i.e.,	 that	 PE	 symptoms	 are	 stable	 over	 time	 in	 the	 general	population	and	in	a	cohort	of	patients	diagnosed	with	PE)	was	not	supported.		At	present,	the	chronicity	of	lifelong	PE	is	accepted	as	fact,	as	demonstrated	in	the	ISSM’s	definition:	“Ejaculation	that	always	or	nearly	always	occurs	prior	to	or	within	about	1	minute	of	vaginal	penetration	(lifelong	PE)[…]”	(Serefoglu	et	al.,	2014,	p.	44).	The	definition	is	logically	sound	in	itself	–	if	ejaculation	always	occurs	within	the	same	problematic	time	frame,	then	it	is	a	chronic	condition.	However,	 the	 evidence	 presented	 in	 the	 aforementioned	 article	 regarding	chronicity	 is	 based	 solely	 on	 retrospective	 reports	 –	 not	 longitudinal	investigations.	Overall,	the	literature	on	long-term	follow-up	of	chronicity	of	PE	is	 nearly	 nonexistent.	 Akre,	 Berchtold,	 Gmel	 and	 Suris	 (2014)	 followed	 the	development	of	PE	over	16	months	among	3700	Swiss	conscripts.	Of	the	403	respondents	who	fulfilled	the	study’s	criteria	for	PE	at	the	first	time	point,	a	majority	 (56%)	 no	 longer	 did	 so	 at	 the	 second	 timepoint.	 However,	 the	measure	used	was	not	 validated	and	 lacked	 important	PE	 indicators	such	as	ELT,	and	there	were	no	exclusion	criteria,	such	as	receiving	treatment	for	PE	or	using	SSRIs,	meaning	that	no	strong	conclusions	should	be	drawn	from	the	study.	However,	the	results	from	Study	I	corroborate	results	from	Akre	et	al.	(2014),	in	that	both	studies	suggest	considerable	variability	in	PE.		Other	purely	observational	studies	of	the	stability	of	PE	symptoms	have	only	been	 conducted	 in	 the	 short	 term	 (up	 to	 4	 weeks),	 in	 conjunction	 with	development	of	patient-reported	outcome	(PRO)	questionnaires	(Althof	et	al.,	2006;	Patrick	 et	al.,	2005;	Symonds	 et	al.,	2007).	Within	drug	 trials,	placebo	control	 groups	 are	usually	 followed	a	maximum	 of	12	weeks	 (Cooper	 et	 al.,	
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2015).	There	are,	however,	a	few	exceptions.	Buvat	et	al.	(2009)	reported	small	but	 not	 statistically	 significant	mean	 improvements	 on	 IELT	 and	 PROs	 in	 a	placebo	group	followed	24	weeks.	Likewise,	no	statistically	significant	group-level	changes	were	found	within	placebo	control	groups	at	6	month	follow-up	in	two	studies	by	Safarinejad	(2007;	Safarinejad	&	Hosseini,	2006).	Participants	in	these	control	groups	may	however	be	affected	by	the	placebo	effect,	meaning	that	their	experienced	level	of	PE	may	be	affected	by	their	taking	part	in	a	drug	trial	 and	 receiving	 an	 intervention.	 In	 conclusion,	 much	 of	 the	 evidence	 on	which	 current	 diagnostic	 subgroups	 rely	 can	 be	 described	 as	 anecdotal	 or	expert	opinion,	which	is	the	weakest	level	of	evidence	according	to	the	Oxford	Center	 for	 Evidence	 Based	 Medicine’s	 Levels	 of	 Evidence	 working	 group	(2009).			Study	 I	 presents	 the	 best	 available	 long-term	 observational	 data	 on	 PE	symptoms.	Yet,	the	data	are	not	optimal	for	the	research	question.	After	making	necessary	exclusions	of	participants	receiving	treatment	that	could	affect	PE	symptoms,	 the	 clinical	 sample	 was	 very	 small.	 This	 reduces	 the	 external	validity	of	the	findings,	as	the	resulting	sample	may	not	be	representative	of	a	general	population	of	men	with	PE.	Further,	participants	were	not	explicitly	asked	about	chronicity,	so	the	validity	of	discussing	the	lifelong	subtype	based	on	 these	 data	 can	 be	 questioned.	 In	 the	 study,	 we	 analyzed	 the	 number	 of	respondents	who	reported	average	ELTs	of	less	than	1	minute	during	the	last	two	years	(in	the	population-based	sample)	or	during	the	last	six	months	(in	the	clinical	sample).	According	to	the	ISSM,	acquired	PE	is	characterized	by	“…	[a]	reduction	in	latency	time,	often	to	about	3	minutes	or	less”	(Serefoglu	et	al.,	2014,	p.	44).	Thus,	we	applied	a	criterion	for	ELT	that	was	stricter	than	what	is	usually	found	in	patients	who	suffer	from	acquired	PE.	Additionally,	the	time	frame	(two	years	and	six	months)	excludes	patients	suffering	from	transient	conditions,	which	Waldinger	(2007)	would	characterize	as	natural	variable	PE.	While	these	operationalizations	lead	to	a	sample	resembling	patients	suffering	from	lifelong	PE,	 it	 is	clear	that	the	results	from	Study	I	do	not	disprove	the	existence	of	lifelong	complaints.	Study	I	does,	however,	in	conjunction	with	the	lack	of	empirical	evidence	of	stability,	raise	very	important	questions	regarding	the	 evidence-base	 that	 make	 up	 the	 foundation	 of	 current	 diagnoses,	 the	appropriateness	 of	 the	 epithet	 ‘lifelong’,	 and	 risks	 of	 over-diagnosing	chronicity.			
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Researchers’	and	clinicians’	perceptions	of	a	disorder	affect	how	they	deal	with	the	 problem	 and	 the	 patient.	 A	 PE	 subtype	 definition	 including	 the	 word	“lifelong”	may	suggest	that	it	 is	 incurable	and	stable,	and	that	any	treatment	offered	will	 only	be	able	 to	 temporarily	alleviate	 symptoms	(a	point	of	 view	explicated	by,	e.g.,	Waldinger,	2007).	Overdiagnosing	chronicity	reduces	hope,	and	has	implications	for	what	treatments	are	offered	by	clinicians	and	accepted	by	patients:	for	example,	why	perform	time-consuming	exercises,	change	your	lifestyle,	or	receive	somewhat	invasive	physiotherapeutic	interventions	if	any	effects	of	such	endeavors	in	the	end	are	temporary?	All	of	these	interventions,	as	reviewed	in	the	present	thesis,	have	promising	results	regarding	long-term	effects.	While	pharmacotherapy	is	helpful	and	effective	for	many	patients,	its	status	as	 first-line	 treatment	 is	partly	 contingent	on	 the	view	of	PE	as	being	unchangeable,	which	empirical	findings	suggest	is	questionable.			The	relevance	of	diagnostic	subtypes	themselves	are	also	questionable,	at	least	from	 a	 clinical	 perspective.	 The	 second	 International	 Society	 for	 Sexual	Medicine	ad	hoc	committee	for	the	definition	of	premature	ejaculation	agreed	on	a	 joint	definition	for	lifelong	and	acquired	PE,	where	the	difference	being	the	cutoff	for	IELT	(approximately	1	minute	vs.	often	less	than	3	minutes),	and	whether	 the	 complaint	 had	 always	 been	 present	 or	 emerged	 during	 the	patient’s	life	(Serefoglu	et	al.,	2014).	The	definition	was	based	on	a	review	of	the	literature,	where	the	committee	found	that	men	with	lifelong	and	acquired	PE	have	similar	IELTs,	similar	experiences	of	ejaculatory	control	and	similar	levels	 of	 distress.	 Regarding	 treatment,	 the	 ISSM	 has	 proposed	 the	 same	treatment	(pharmacotherapy	and	behavioral/psychotherapy)	for	both	lifelong	and	acquired	PE,	assuming	that	the	acquired	PE	is	not	secondary	to	some	other	dysfunction	such	as	ED,	which	should	be	treated	first	(Althof	et	al.,	2014).	In	light	 of	 the	 similarities	 in	 clinical	 presentation,	 lack	of	 evidence	 of	different	etiologies,	and	 the	practically	 identical	 treatment	 recommendations,	 there	 is	little	apparent	utility	of	diagnostic	subtypes,	at	least	in	clinical	settings.		5.2	Etiology	of	premature	ejaculation	5.2.1	The	etiological	role	of	anxiety	In	Study	II,	the	direction	of	causality	between	symptoms	of	anxiety	and	PE	was	analyzed.	 While	 statistically	 significant	 bivariate	 correlations	 were	 found	across	 time	 between	 variables,	 both	 across-	 and	 within-time	 associations	between	anxiety	and	PE	symptoms	were	small.	In	the	longitudinal	analyses,	no	
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clear-cut	causal	effects	of	either	anxiety	on	PE,	or	PE	on	anxiety,	were	detected.	At	first	glance,	the	results	of	the	present	study	can	be	interpreted	as	suggesting	that	the	role	of	anxiety	as	an	etiological	component	of	PE	is	limited.	However,	lack	of	support	for	the	role	of	anxiety	is	not	the	same	as	proof	against	it,	and	it	should	be	borne	in	mind	that	the	present	Study	II	only	included	measures	from	two	time	points	several	years	apart,	on	which	I	will	elaborate	in	the	following.		Two	recent	cross-sectional	studies	found	elevated	levels	of	state	anxiety,	but	not	 trait	 anxiety,	 in	 PE	 patients	 as	 compared	 to	 the	 general	 population	(Kempeneers	et	al.,	2018;	Mourikis	et	al.,	2015).	The	BSI,	which	was	used	to	measure	anxiety	in	Study	II,	has	been	shown	to	correlate	with	both	Spielberg	state	anxiety	(ρ	=	.69,	Abu	Ruz	et	al.,	2010)	and	trait	anxiety	(r	=	.47–.60,	Lang,	Norman,	Means-Christensen,	&	Stein,	2009).	While	the	items	of	the	BSI	can	be	argued	 to	 resemble	 state	 anxiety	 (e.g.,	 “Feeling	 so	 restless	 you	 could	not	 sit	still”),	the	time	of	reference	captures	the	past	seven	days	rather	than	a	specific	moment.	Furthermore,	the	time	lag	in	the	present	study	was	six	years	between	measurements,	 and	 the	 autoregressive	 coefficient	 for	 BSI	 anxiety	was	 high.	This	 would	 imply	 that	 what	 was	 measured	 was	 quite	 stable	 and	 trait-like,	rather	 than	 transient	 states.	 As	 such,	 the	 present	 study	 is	 in	 line	 with	Kempeneers	et	al.	(2018)		and	Mourikis	et	al.	(2015),	in	that	no	association	was	found	between	PE	and	trait	anxiety.	It	is	quite	possible	that	we	were	unable	to	capture	a	 true	covariation	between	anxiety	and	PE	 in	Study	 II	 if	 the	 type	of	anxiety	that	covaries	with	PE	symptom	severity	is	more	state-like.			This	was	indeed	partly	corroborated	by	the	findings	in	Study	IV.	At	baseline,	PE	was	more	strongly	correlated	to	STAI	state	anxiety	during	sex	(r	=	 .17)	than	STAI	trait	anxiety	(r	=	.05)	and	BSI	anxiety	(r	=	.06).	The	effect	sizes	might	be	diminished	 due	 to	 restriction	 of	 range,	 since	 the	 study	 design	 excluded	participants	without	PE	and	individuals	using	SSRIs	(e.g.,	to	treat	some	anxiety-related	disorder).	 In	summary,	our	results	 in	combination	with	other	recent	investigations	concerning	the	association	between	anxiety	and	PE	suggest	that	the	 possible	 role	 of	 anxiety	 in	 PE	 etiology	 should	 be	 investigated	 using	measures	of	anxiety	in	the	actual	sexual	situation	(i.e.,	model	state	rather	than	trait	anxiety).			In	case	anxiety	was	a	large	etiological	factor	in	PE,	it	could	be	expected	that	improvements	in	anxiety	would	be	followed	by	improvements	in	PE.	This	was,	however,	not	observed	in	Study	IV.	The	VSS	and	VSS+	groups	had	very	similar	
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mean	 scores	 of	 PE	 throughout	 the	 study.	 However,	 the	 VSS+	 group	 had	substantially	 lower	 levels	 of	 anxiety	 on	 all	 measures	 than	 the	 VSS	 group	following	treatment,	even	if	the	difference	was	not	statistically	significant.	The	change	 in	 anxiety	 being	 independent	 from	 change	 in	 PE	 speaks	 against	 the	etiological	role	of	anxiety	in	PE.		5.2.2	The	etiological	role	of	depression	In	 Study	 II,	we	 found	 small	 but	 statistically	 significant	 correlations	 between	depression	and	PE	within	both	time	points	(rT1	=	.156;	rT2	=	.135).	These	results	are	in	line	with	a	meta-analysis	by	Xia	et	al.	(2016),	who	found	a	statistically	significant	 association	 between	 PE	 and	 depression	 over	 eight	 included	studies	 (r	 =	 .13;	 the	 effect	 size	was	 converted	 to	 r	 according	 to	Borenstein,	Hedges,	Higgins,	&	Rothstein,	2009).	While	the	study	selection	criteria	were	not	fully	transparent	in	the	meta-analysis,	and	there	were	also	some	indications	of	publication	bias,	the	effect	size	is	of	the	same	magnitude	as	we	found	in	Study	II,	providing	further	evidence	that	there	is	link	between	PE	and	depression.	A	plausible	 explanation	 for	 this	 association	 is	 that	 PE	 and	 depression	 share	 a	common	 etiological	 background,	 with	 a	 disregulation	 of	 the	 serotonergic	system,	as	SSRIs	are	known	to	both	increase	ELT	(Buvat	et	al.,	2009;	Kaufman	et	al.,	2009;	Pryor	et	al.,	2006)	and	decrease	symptoms	of	depression	(Barth	et	al.,	2016).	Another	reasonable	explanation	is	that	PE	could	lead	to	lower	self-confidence	and	interpersonal	difficulties,	including	refraining	from	engaging	in	new	 romantic	 relationship	 (Symonds	 et	 al.,	 2003),	 which	 could	 lead	 to	loneliness	 and	 self-criticism,	 which	 are	 associated	 with	 depression	 (Besser,	Flett,	&	Davis,	2003).	A	third	explanation	is	that	depression	is	associated	with	lower	 self-efficacy	 (Muris,	 2002),	 which	 could	 decrease	 feelings	 of	 control.	Depression	is	also	highly	associated	with	anxiety,	with	a	comorbidity	of	50%	(Hirschfeld,	 2001),	 meaning	 that	 that	 depressive	 symptoms	 such	 as	 self-criticism	may	trigger	anxiety-related	mechanisms	of	PE.	Regardless	of	possible	mechanisms	between	PE	and	anxiety,	Study	II	showed	that	associations	were	even	smaller	across	a	period	of	six	years,	and	model	fitting	results	indicated	that	the	associations	were	of	little	significance.	These	results	suggest	that	while	there	may	be	a	small	but	statistically	robust	association	between	depression	and	PE,		depression	is	probably	not	a	major	etiological	factor	in	PE.		5.2.3	The	etiological	role	of	lifestyle	factors	In	Study	III,	no	associations	were	found	between	PE	and	the	lifestyle	factors	alcohol	 consumption	 and	 BMI.	 This	 is	 in	 line	 with	 two	 recent	 independent	
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observational	studies	on	a	clinical	sample	of	 Italian	men	(Verze	 et	al.,	2018)	and	American	men	with	sexual	problems	and	their	partners	(Rosen,	Heiman,	Long,	Fisher,	&	Sand,	2016).		The	 strongest	 finding	 in	 Study	 III	 was	 a	 small	 but	 statistically	 significant	association	 suggesting	 that	 PE	 symptoms	 tended	 to	 decrease	 as	 physical	activity	increased	(r	=	-.09,	p	<	.01).	When	comparing	the	mean	level	of	physical	exercise	 between	 the	 clinical	 and	 population-based	 samples,	 this	 effect	was	large	(t[930]	=	2.52,	p	=	.012,	d	=	0.85).	This	association	maintained	statistical	significance	even	controlling	for	confounding	effects	of	other	lifestyle	factors	and	age,	albeit	with	a	smaller	 effect	size.	Furthermore,	 the	same	association	was	also	found	within	the	population-based	sample,	with	a	small,	but	expected,	negative	correlation	between	PE	symptoms	and	physical	activity.		These	 results	 are	 in	 line	 with	 a	 recently	 published	 observational	 study	 by	Yildiz,	Kilinc,	 and	Doluoglu	 (2018),	who	 compared	men	who	participated	 in	regular	 calisthenic	 and/or	 fitness	 exercise	 programs	 to	 men	 who	 led	 a	sedentary	 lifestyle.	 Men	 who	 exercised	 reported	 statistically	 significantly	longer	IELTs	(316	seconds	vs.	189	seconds,	p	<	.001)	and	lower	scores	on	the	Premature	 Ejaculation	 Diagnostic	 Tool	 (PEDT;	 6.18	 vs.	 10.02,	 p	 <	 .001).	According	 to	 a	 validation	 study	 of	 the	 PEDT	 (Symonds	 et	 al.,	 2007),	 the	suggested	cutoff	for	having	no	PE	is	less	than	or	equal	to	8,	indicating	that	men	who	 exercised	 probably	 did	 not	 have	 PE,	 while	 men	 who	 led	 a	 sedentary	lifestyle	 were	 more	 likely	 to	 have	 PE.	 There	 were	 statistically	 significant	correlations	between	the	measure	of	physical	activity	and	IELT	(r	=	 .368,	p	<	.001,	suggesting	longer	IELTs	as	a	function	of	more	exercise)	and	PEDT	(r	=	-.383,	 p	 <	 .001,	 suggesting	 decrements	 in	 PE	 symptoms	 in	 individuals	 who	exercised	more).			However,	 in	 the	 studies	 by	 Rosen	 et	 al.	 (2016)	 and	 Verze	 et	 al.	 (2018),	 no	association	between	PE	and	exercise	was	found.	Since	the	publication	of	these	conflicting	 cross-sectional	 results,	 Kilinc,	 Aydogmus,	 Yildiz	 and	 Doluoglu	(2018)	conducted	a	promising	intervention	study,	where	they	randomized	105	men	who	met	ISSM	criteria	for	lifelong	PE	into	one	of	three	groups:	one	group	using	 30	 mg	 dapoxetine	 on	 demand;	 a	 second	 group	 performing	moderate	exercise	 for	 30	 minutes	 five	 times	 a	 week;	 and	 a	 third	 group	 performing	minimal	physical	activity.	Results	indicated	that	on-demand	use	of	dapoxetine	and	moderate	physical	exercise	both	resulted	in	3.5-fold	increases	in	IELT	after	
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30	 days,	 while	 no	 change	 was	 observed	 in	 the	 group	 performing	 minimal	physical	 exercise.	The	authors	hypothesized	 that	 the	mechanism	of	action	 is	through	 the	 increased	 availability	 of	 serotonin	 following	 physical	 activity,	which	has	been	demonstrated	in	previous	studies	(Chaouloff,	1997;	Post	et	al.,	1973).	 This	 is	 supported	 by	 research	 demonstrating	 ejaculation-delaying	effects	of	SSRI	medication,	which	makes	physical	exercise	an	interesting	target	of	study	in	the	context	of	PE	research.		This	new	avenue	of	research	on	the	relationship	between	physical	exercise	and	PE	still	need	robust	replications	and	experimental	designs	to	confirm	that	the	direction	of	causality	is	such	that	physical	activity	alleviates	PE	symptoms.			It	 has	 been	 suggested	 that	 different	 subtypes	 of	 PE	 could	 have	 different	etiologies,	with	 lifelong	being	more	strongly	 influenced	by	biological	 factors	and	 acquired	 having	 more	 psychological	 risk	 factors,	 which	 could	 indicate	different	 treatment	 (McMahon	 et	 al.,	 2016;	 Waldinger,	 2007).	 However,	 as	McMahon	et	al.	(2016)	notes,	most	of	these	proposed	etiologies	are	speculative	at	 best.	 In	 case	 the	 proposed	 mechanism	 of	 alteration	 of	 serotoniergic	transmission	 following	 physical	 exercise	 is	 correct,	 interventions	 aimed	 at	increasing	physical	activity	could	be	offered	to	both	patient	groups,	as	it	has	also	been	reported	that	dapoxetine	is	equally	effective	for	lifelong	and	acquired	PE	(Porst	et	al.,	2010)		5.3	Treatment	of	premature	ejaculation	5.3.1	Vibrator-assisted	start-stop	exercises	In	Study	IV,	we	found	that	six	weeks	of	vibrator-assisted	start-stop	exercises	alleviated	PE	symptoms	at	group	level,	both	in	terms	of	ejaculatory	function	(e.g.	ELT,	feeling	of	control)	and	consequences	(e.g.	relationship	difficulties	and	distress),	 thus	 supporting	 hypothesis	 H4.	 These	 results	 are	 in	 line	 with	previous	 studies	 demonstrating	 the	 potential	 effectiveness	 of	 the	 present	intervention.	 In	a	pilot	study	where	11	participants	received	an	intervention	equivalent	to	the	VSS	group,	Jern	(2014)	found	a	medium-sized	standardized	mean	difference	on	CHEES	between	pre-	and	post-treatment	(d	=	.71),	which	is	comparable	to	the	corresponding	within-group	effect	size	for	the	VSS	group	in	the	present	study	(d	=	0.54).	In	the	first	report	on	the	effect	of	vibrator-assisted	start-stop	exercises,	Zamar	(2012)	reported	an	11-fold	improvement	in	ELT	in	61%	of	the	sample.	This	effect	is	larger	than	what	was	reportedby	Jern	(2014),	
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where	 the	 outcome	was	 also	measured	 by	 stopwatch,	 possibly	 due	 to	 Jern	recruiting	participants	who	had	previously	been	unsuccessfully	 treated	with	pharmaceuticals	 (i.e.,	 these	 individuals	 could	 have	 represented	 a	 treatment-resistent	subgroup	of	the	PE	patient	population).	Another	possible	explanation	is	that	Zamar,	as	the	manufacturer	of	the	device	used	in	all	three	studies,	could	have	arrived	at	inflated	treatment	effect	sizes,	as	industry	sponsorship	and	self-evaluation	 of	 commercial	 products	 generally	 associated	 with	 arriving	 at	slightly	 larger	 effect	 sizes	 compared	 to	 research	 performed	 by	 independent	researchers	with	no	conflicts	of	interest	(Lundh,	Lexchin,	Mintzes,	Schroll,	&	Bero,	2017).		In	 summary,	 the	 concordant	 results	 from	 Study	 IV,	 Jern	 (2014),	 and	 Zamar	(2012)	provide	replicated	evidence	showing	that	vibrator-assisted	start-stop	exercises	can	be	used	to	treat	PE.		In	the	study	by	Zamar	(2012),	a	larger	treatment	effect	was	found	for	a	group	performing	 vibrator-assisted	 start-stop	 exercises,	 as	 compared	 to	 a	 group	performing	conventional,	vibrator-less	start-stop	exercises.	This	indicates	that	the	addition	of	the	vibrating	device	increases	the	treatment	effect.	A	possible	mechanism	 of	 action	 is	 reduced	 penile	 sensitivity	 following	 exposure	 to	vibration,	 since	 numbness	 and	 decreased	 sensory	 perception	 has	 been	reported	following	vibrational	exposure	to	genitals	(Herbenick	et	al.,	2009)	and	hands	and	arms	(Malchaire	et	al.,	1998).	This	suggested	mechanism	of	reduced	penile	 sensitivity	 is	 supported	 by	 the	 evident	 ejaculation-delaying	 effect	 of	topical	analgesics	(Wyllie	&	Hellstrom,	2011).			In	 case	 the	 intervention	 would	 lead	 to	 a	 long-term	 reduction	 of	 penile	sensitivity,	this	could	perhaps	in	itself	explain	the	treatment	effect.	 If,	on	the	other	hand,	a	possible	reduction	of	sensitivity	was	of	a	more	temporary	nature,	the	reduced	sensitivity	might	in	some	way	affect	the	effectiveness	of	the	start-stop	 exercises.	 For	 example,	 longer	 ejaculation	 latency	might	 contribute	 to	extinction	 of	 a	 conditioned	 response.	 Another	 possible	 mechanism	 is	 that	decreased	penile	sensitivity	 leads	 to	 longer	 IELT,	which	Perelman	(2006)	 in	turn	hypothesized	affords	the	individual	time	to	learn	the	necessary	skills	to	control	 ejaculation.	 However,	 since	 penile	 sensitivity	 was	 not	 measured	 in	Study	IV,	it	was	not	possible	to	test	this	hypothesized	mechanism.	It	would	also	be	 interesting	 to	 compare	 the	VSS	 intervention	 to	start-stop	 exercises	while	
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using	 a	 placebo	 device	 that	 does	 not	 vibrate,	 to	 elucidate	 whether	 the	vibrations	are	an	essential	part	of	the	intervention.		5.3.2	Psychoeducation	and	exercises	related	to	interoceptive	awareness		In	 Study	 IV,	 there	 were	 no	 statstically	 significant	 differences	 in	 outcome	measures	 between	 treatment	 groups.	 This	 means	 that,	 contrary	 to	 our	hypothesis,	 there	 was	 no	 additional	 treatment	 benefit	 when	 receiving	psychoeducation	and	performing	exercises	meant	to	improve	IA	in	addition	to	vibrator-assisted	start-stop	exercises.	There	were,	however,	some	indications	of	larger	improvements	in	the	VSS+	than	the	VSS	group.	With	regard	to	change	in	categorization	on	the	primary	outcome	measure	(i.e.,	strongly	indicative	of	PE,	indicative	of	PE,	or	low	probability	of	PE)	between	pre-	and	post-treatment,	79%	of	the	VSS+	group	improved	by	one	or	two	diagnostic	categories	(Jern	et	al.,	2013),	while	 the	 corresponding	numbers	 for	 the	VSS	 group	was	41%.	 In	terms	 of	 secondary	 outcome	measures,	 the	 VSS+	 group	 showed	 statistically	significant	within-group	 improvements	on	sexual	distress,	 STAI	 trait	anxiety	and	state	anxiety	during	sex,	as	well	as	BSI	anxiety.	No	statistically	significant	changes	 on	 any	 secondary	 outcome	 was	 observed	 in	 the	 VSS	 group.	 No	statistically	significant	between-group	differences	were	found,	probably	due	to	low	 statistical	 power,	 since	 pairwise	 comparisons	 of	 effect	 sizes	 did	 reveal	some	differences	between	the	treatment	groups	(ds	ranging	from	0.38	to	0.66	on	 secondary	 outcome	 measures).	 Taken	 together,	 the	 added	 elements	 of	psychoeducation	and	IA	exercises	seem	to	lead	to	improved	outcomes	overall.	Whether	 or	 not	 to	 offer	 any	 or	 all	 of	 these	 additional	 interventions	 to	 the	patient,	considering	possible	additional	benefit	in	relation	to	the	increased	cost	in	 terms	 of	 time	 and	 effort,	 must	 be	 decided	 using	 clinical	 judgement	 in	collaboration	with	the	patient.		In	Study	IV,	we	found	no	clear	 indication	that	IA	and	PE	were	related.	There	was	a	negative	correlation	between	the	total	MAIA	score	at	baseline	and	change	in	PE	from	pre-	to	post-treatment,	indicating	that	higher	IA	was	associated	with	a	larger	treatment	effect,	however,	it	was	not	statistically	significant	(r	=	-.13,	
p	 =	 .379,	 n	 =	 50).	 As	 a	 manipulation	 check	 of	 the	 effect	 of	 performing	 IA	exercises,	we	 compared	 scores	 on	 IA	 scales	post	 treatment.	 Contrary	 to	 our	expectation,	 there	were	no	differences	between	the	 treatment	groups.	Thus,	the	 exercises	 did	 not	 have	 the	 intended	 effect,	 and	 we	were	 unable	 to	 test	whether	improved	IA	would	reduce	PE	symptoms.		
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	A	 recent	 laboratory	 study	demonstrated	 that	 a	 higher	 level	 of	 interoceptive	awareness	 was	 associated	 with	 better	 ability	 to	 recognize	 genital	 changes	following	 sexual	 stimuli	 in	 a	 sample	 consisting	 of	women	who	 experienced	difficulties	 with	 genital	 sexual	 arousal	 (Handy	 &	 Meston,	 2018).	 The	researchers	went	on	to	recommend	that	“if	a	woman	reports	being	unable	to	detect	 changes	 in	 her	 genitals	 during	 states	 of	 sexual	 arousal,	 techniques	focused	on	 increasing	 interoception	 could	 improve	awareness	of	 her	 genital	arousal”	(p.	406).	In	an	intervention	study,	Bornemann,	Herbert,	Mehling	and	Singer	(2015)	had	participants	attend	13	weekly	group	sessions	and	perform	daily	practices	including	body	scan	exercises	and	breath	meditation.	Following	this,	 the	 researchers	 were	 able	 to	 demonstrate	 small	 to	 moderate	improvements	on	five	out	of	eight	subscales	of	MAIA		(d	ranging	from	0.2	to	0.7),	suggesting	that	it	is	possible	to	improve	IA	by	training.			The	hypothesized	association	between	PE	and	a	 lack	of	awareness	of	 bodily	reactions	 during	 sex	 (Kaplan,	 1975)	 is	 theoretically	 sound,	 but	 so	 far	 not	thoroughly	 tested.	 The	 hypothesis	 is	 indirectly	 supported	 by	 the	 succesful	physiotherapeutical	 interventions	 where	 participants	 learn	 to	 control	 their	pelvic	floor	musculature	(La	Pera	&	Nicastro,	1996;	Pastore	et	al.,	2014,	2012).	Since	Mehling	et	al.	(2015)	found	improvements	in	IA	following	an	intervention	more	 extensive	 than	 the	 one	 employed	 in	 Study	 IV,	 where	 no	 effects	 were	found,	it	follows	that	a	more	intensive	IA	traning	regimen	may	be	necessary	in	order	to	elucidate	any	potential	effects	of	IA	training	on	PE.		5.3.3	The	role	of	anxiety	in	treatment	of	PE	As	anxiety,	performance	anxiety	in	particaular,	has	traditionally	been	seen	as	an	etiological	component	of	PE,	some	treatment	interventions	aim	at	reducing	anxiety	as	a	means	of	reducing	PE	(Althof,	2016).	As	observed	in	Study	IV,	levels	of	anxiety	and	PE	changed	independently	following	treatment,	since	the	effect	on	 PE	was	 practically	 indentical	 in	 both	 groups,	 while	 the	 VSS+	 group	 also	displayed	treatment	effects	on	several	measures	of	anxiety.	This	speaks	against	the	idea	that	an	improvement	in	anxiety	 in	general	would	be	followed	by	an	improvement	 in	PE.	This	 is	not	 to	 say	 that	anxiety	should	not	be	a	 target	 of	intervention	in	and	of	itself,	however,	it	is	perhaps	not	the	most	fruitful	way	to	reduce	PE	symptoms.	Distress	directly	related	to	PE	could,	on	the	other	hand,	be	an	interesting	avenue	of	intervention	(e.g.,	by	normalisation	of	the	problem,	
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improving	 communication	 between	 partners,	 or	 a	 broadening	 of	 the	 sexual	script),	since	a	reduction	of	distress	by	definition	could	reduce	PE.		5.3.4	Conclusions	regarding	treatment	An	increasing	body	of	evidence	suggests	that	psychological	interventions	are	viable	options	in	the	treatment	of	PE.	Study	IV	shows	that	behavioral	methods	can	 lead	 to	 significant	 decrements	 in	 PE	 symptoms,	 since	 a	majority	 of	 the	participants	improved	in	terms	of	their	categorization	on	a	validated	scale	of	PE.	 In	 the	 present	 study,	 the	 treatment	 incurred	 no	 side	 effects	 and	 the	available	data	implied	a	lasting	treatment	response.	This	is	the	third	study	to	demonstrate	 the	 treatment	 effect,	meaning	 that	 replicated	 results	show	that	the	vibrator-assisted	start-stop	technique	improves	PE	symptoms.		Comparing	 psychological	 treatment	 to	 first-line	 pharmacological	 treatment	reveals	pros	and	cons	with	both	modes	of	treatment.	Pharmacotherapy	of	PE	is	associated	with	side	effects,	contributing	to	making	treatment	with	dapoxetine	unacceptable	to	most	patients	(Jern	et	al.,	2014;	Mondaini	et	al.,	2013;	Park	et	al.,	 2017).	 On	 the	 contrary,	 no	 side	 effects	 have	 been	 reported	 for	 the	 VSS	intervention	 in	 the	 present	 or	 previous	 studies	 (Jern,	 2014;	 Zamar,	 2012).	Regarding	ease	of	use,	taking	a	pill	is	quick	and	can	give	results	in	a	few	hours,	while	start-stop	 exercises	 require	an	 investment	of	 time	and	effort,	and	any	payoff	is	not	necessarily	immediate.	This	aspect	may	however	be	weighed	up	if	the	 psychological	 intervention	 would	 lead	 to	 long-term	 effects,	 whereas	pharmacological	 agents	 are	 known	 to	 have	 a	 time-limited	 effect.	 As	 for	convenience,	dapoxetine	must	be	 taken	1	 to	3	hours	previous	 to	anticipated	intercourse,	which	hampers	spontaneity.			Topical	 analgesics	 need	 also	 be	 administrated	 before	 intercourse	 can	 be	initiated,	which	can	be	experienced	as	inconvenient.	And	while	they	effectively	prolong	ELT,	 optimal	dosage	might	be	difficult	 to	 attain,	with	 risk	of	 penile	hypo-anesthesia,	 as	 well	 as	 contamination	 of	 the	 partner,	 with	 following	vaginal	or	anal	numbness	(McMahon,	2015).	Among	other	treatment	options,	pelvic	 floor	rehabilitation	has	shown	promising	treatment	effects	(La	Pera	&	Nicastro,	1996;	Pastore	et	al.,	2014,	2012),	but	is	also	time	consuming,	and	the	procedure	 can	 be	 somewhat	 invasive	 if	 anal	 electrode	 probes	 are	 used	 for	biofeedback.	Physical	exercise	has	recently	been	tested	as	an	intervention	for	PE,	 with	 results	 showing	 similar	 effectiveness	 for	 moderate	 exercise	 and	
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dapoxetine	(Kilinc	et	al.,	2018).	However,	lifestyle	changes,	such	as	increasing	physical	 exercise,	 can	be	 very	difficult	 to	 attain	 and	 sustain,	 as	 known	 from	decades	of	 research	on	 treatment	of	cardiovascular	diseases	(Teixeira	 et	al.,	2015).			Choosing	between	treatment	options	depends	on	how	the	goal	of	treatment	is	formulated.	For	example,	Kilinc	et	al.	(2018,	p.	4)	state	that	“The	ultimate	aim	of	PE	treatment	is	to	increase	IELT.”	Indeed,	prolonging	the	time	of	intercourse	can	be	an	important	goal,	giving	better	opportunities	to	both	everyone	involved	to	 enjoy	 the	 sexual	 activity.	 But	 it	 is	 not	 in	 itself	 necessarily	 sufficient,	 as	individuals	 can	 be	 distressed	 regardless	 of	 their	 objectively	measured	 IELT	(Patrick	et	al.,	2005).	An	opposing	view	was	offered	by	Söderfeldt	et	al.	(2017,	p.	866):		
”Doubtlessly,	 and	regardless	 of	 their	actual	 IELT,	many	men	
experience	 distress	 over	 ejaculatory	 latency,	 but	 methods	
seeking	 to	 prolong	 the	 duration	 of	 vaginal	 penetration	 only	
confirm	the	underlying	idea	that	sustained	coitus	is	required	
in	 fulfilling	 (hetero-)sexual	 interactions.	 Extension	 of	 the	
sexual	 repertoire	 and	 liberation	 from	 the	 coital	 imperative	
have	 the	potential	 to	 improve	 the	sexual	 lives	 of	many	more	
than	those	who	experience	relief	from	SSRI-enhanced	IELTs.”			Broadening	of	the	sexual	script	is	a	common	theme	in	sexological	therapy.	For	example,	 a	 goal	 of	 treatment	 in	 de	 Carufel	 and	 Trudels	 (2006)	 functional-sexological	treatment	of	PE	is	to	develop	an	appreciation	for	visual,	emotional,	tactile,	 corporal,	verbal,	and	auditory	stimuli,	 in	order	to	increase	enjoyment	derived	 from	 sex,	 and	 decrease	 reliance	 on	 a	 set	 pattern	 or	 predetermined	order	of	engagement	of	a	sexual	encounter.			Choosing	the	best	treatment	for	PE	is	not	only	a	question	of	looking	at	what	treatment	 shows	 largest	 effects.	 The	 choice	 should	 also	 be	 tailored	 to	 the	specific	 patient’s	 wants	 and	 needs,	 and	 the	 resources	 available.	 For	 some	patients,	 the	 best	 alternative	 is	 a	 quick	 and	 convenient	 pill.	 For	 others,	 an	investment	 of	 time	 and	 effort	 into	 learning	 to	 control	 one’s	 own	 body	 is	necessary	 or	more	 suitable.	 The	 results	 from	 the	 present	 study	 shows	 that	psychological	and	behavioral	interventions	can	be	offered	as	adequate	options	for	treatment.		
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	5.4	Limitations	The	prevalence	of	PE	in	the	general	population	is	estimated	to	be	less	than	4%	(Althof	 et	 al.,	 2014).	 Consequently,	 despite	 the	 large	 size	 of	 the	population-based	sample,	the	number	of	men	who	plausibly	could	fulfill	diagnostic	criteria	for	the	most	severe	subtype	of	PE	 is	small.	This	may	decrease	power	to	 find	meaningful	associations.	However,	the	sample	is	still	larger	than	many	samples	used	by	other	authors	in	previous	studies.		Furthermore,	 the	 measures	 used	 in	 the	 population-based	 sample	 does	 not	allow	for	differentiating	between	diagnostic	subtypes.	In	Study	I,	we	therefore	had	to	rely	on	a	single	diagnostic	criterion	as	a	proxy	for	lifelong	PE,	albeit	the	criterion	 that	 has	 often	been	argued	 to	be	 the	most	 important	PE	 indicator,	namely	 an	 ELT	 of	 less	 than	 1	minute.	 It	 is	 possible	 that	 participants	 in	 the	population-based	 sample	 who	 reported	 ELTs	 of	 less	 than	 1	 minute	 have	experienced	a	significant	reduction	in	latency	time,	and	thus	would	fit	better	in	the	 acquired	 rather	 than	 lifelong	 subtype.	 If	 this	 was	 the	 case,	 some	 of	 the	variability	could	be	readily	explained	by	participants	acquiring	PE.	However,	the	 most	 interesting	 findings	 concern	 the	 opposite	 scenario,	 where	participants	who	previously	fulfilled	the	strictest	diagnostic	criterion	(ELT	<	1	minute)	cease	to	do	so,	despite	not	receiving	treatment.	The	first	data	collection	was	conducted	before	the	current	diagnostic	criteria	were	published,	and	the	nosology	has	varied	considerably	over	time	(it	could	well	be	argued	that	the	debate	regarding	how	PE	should	be	defined	and	measured	is	far	from	resolved).	But	while	 the	methods	 used	might	 not	 be	 ideal	 for	 resolving	 the	 questions	about	stability	over	time,	and	while	there	were	significant	dropout	which	may	skew	and	decrease	generalizability	of	the	results,	Study	I	–	to	my	knowledge	–	still	represents	the	best	available	published	data	on	the	temporal	stability	of	PE,	and	it	points	to	the	need	to	further	examine	the	definition	and	diagnostic	criteria	for	PE.			In	Study	II,	the	time	lag	between	measurements	was	six	years.	If	the	possible	causal	associations	between	anxiety	and	PE	function	on	a	shorter	time	frame,	they	would	perhaps	not	be	noticed	with	the	current	setup.	As	such,	the	current	null	findings	should	not	be	interpreted	as	proof	of	there	being	no	association	over	 time.	 Further,	 with	 only	 two	 measurement	 points,	 cross-lagged	 panel	models	may	not	be	able	to	take	stable	between-person	differences	into	account,	
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which	may	bias	cross-lagged	estimates	(Hamaker,	Kuiper,	&	Grasman,	2015).	And	 again,	 we	 were	 not	 able	 to	 differentiate	 between	 proposed	 diagnostic	subgroups	 that	 may	 be	 relevant,	 since	 they	 might	 have	 different	 etiologies	(Althof	et	al.,	2014).		In	Study	III,	the	number	of	patients	diagnosed	with	PE	was	quite	small	at	n	=	69.	This	was	in	no	small	part	due	to	the	fact	that	the	majority	of	the	sample	was	using	 some	 kind	 of	 pharmacological	 treatment	 that	 affected	 ejaculatory	function,	and	 therefore	needed	to	be	 excluded	 from	statistical	analyses.	The	sample	 size	 is	 nonetheless	 sufficient	 to	 detect	 medium	 effect	 sizes,	 which	means	 that	 the	 study	 had	 enough	 statistical	 power	 to	 find	 associations	 that	would	be	meaningful	in	terms	of	etiology.	It	is,	however,	possible	that	there	is	some	systematic	difference	between	participants	who	do	and	do	not	receive	treatment,	 which	 would	 reduce	 generalizability	 of	 the	 results.	 Regarding	measures,	the	Godin	Leisure-Time	Exercise	Questionnaire	explicitly	focuses	on	free	time	only.	Therefore,	some	individuals	who	do	physically	straining	work	may	 have	 come	 across	 as	 leading	 a	 sedentary	 lifestyle	 in	 our	 data	when	 in	reality,	the	opposite	was	true.	BMI	is	arguably	also	a	flawed	measure	of	physical	fitness,	since	it	does	not	differentiate	between	different	kinds	of	mass.	That	is,	a	 fit	 person	who	 is	 heavy	 due	 to	muscle	mass	 may	 be	 interpeted	 as	 being	overweight.	 These	 problems	 increase	 measurement	 error,	 which	 could	possibly	diminish	observable	effect	sizes	between	PE	and	lifestyle	factors.		In	 Study	 IV,	 there	 was	 considerable	 dropout	 in	 follow-up	 measurements,	making	interpretations	of	long-term	effects	difficult.	The	two	treatment	groups	did	not	receive	an	equal	amount	of	attention	from	the	clinician,	with	the	VSS	group	 receiving	 about	 20	 minutes	 and	 the	 VSS+	 group	 receiving	 about	 45	minutes	 during	 the	 first	 meeting.	 Clinician	 attention	 is	 known	 to	 affect	treatment	response	(Freedland,	Mohr,	Davidson,	&	Schwartz,	2011),	and	might	thus	explain	some	of	the	differences	between	the	groups.	Moreover,	the	groups	were	made	more	similar	to	each	other	than	would	perhaps	have	been	optimal,	as	 both	 groups	 responded	 to	 32	 items	 measuring	 interoceptive	 awareness	several	 times.	 This	 might	 in	 itself	 mimic	 the	 effects	 of	 an	 interoceptive	awareness	improvement	intervention,	since	all	participants	would	likely	know	that	interoceptive	awareness	is	of	interest,	in	turn	deceasing	internal	validity.	Taken	together,	these	aspects	of	the	study	design	reduce	our	ability	to	conclude	that	 observed	 differences	 and	 similarities	 between	 groups	 are	 due	 to	 the	intervention	they	received.	Finally,	treatment	was	delivered	by	the	first	author	
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only;	having	multiple	clinicians	providing	treatment	would	have	reduced	the	risk	of	any	potential	bias	(such	as	 the	 clinician’s	preconceived	hypothesis	 of	which	 treatment	 will	 be	 more	 effective)	 and	 shown	 generalizability	 of	treatment	effect	across	clinicians.			5.5	Future	directions	If	the	field	of	sexual	medicine,	and	research	focusing	on	PE	in	particular,	is	to	continue	its	move	towards	evidence-based	practice,	the	most	important	step	would	be	to	collect	more	data	of	better	quality.	Much	effort	has	been	directed	at	ELT	cutoffs,	and	the	debate	regarding	optimal	cutoff	for	diagnosis	is	ongoing.	However,	 questions	 concerning	 the	 quality	 of	 evidence	 on	which	 diagnostic	subdivision	 have	 been	 proposed,	 and	 the	 usefulness	 of	 these	 subtypes,	 has	been	 overlooked.	 Diagnostic	 subdivisions	 have	 been	 proposed	 based	 on	retrospective	 self-reports	 from	 patients	 and	 clinical	 experience,	 which	 is	unsatisfactory	 from	an	evidence-base	point	 of	 view.	An	 important	 first	 step	would	be	to	conduct	prospective	long-term	studies	of	how	PE	symptoms	vary	over	time,	and	also	as	a	function	of	external	factors	that	could	be	relevant.	For	example,	how	do	PE	symptoms	vary	as	a	function	of	different	partners?		Regarding	 vibrator-assisted	 start-stop	 exercises,	 it	 would	 be	 interesting	 to	include	 measures	 of	 penile	 sensitivity.	 This	 could	 test	 the	 hypothesized	mechanism	 (i.e.,	 that	 changes	 in	 sensitivity	 correspond	 to	 changes	 in	 PE	symptoms).	To	test	the	effect	of	the	vibrations,	the	intervention	could	be	tested	against	an	intervention	using	a	placebo	device	that	does	vibrate.			In	the	present	study,	the	exercises	intended	to	produce	improvement	in	IA	did	not	 have	 the	 expected	 effect:	we	 assumed	 that	 IA	would	 be	 associated	with	ejaculatory	function,	but	 found	no	robust	evidence	to	suggest	this	is	actually	the	case.	However,	this	could	be	tested,	for	example,	in	a	laboratory	with	a	case-control	design	and	objective	measures	of	IA	(e.g.,	heartbeat	detection	tasks).	If	the	 hypothesized	 association	 was	 indeed	 found,	 future	 intevention	 studies	could	employ	a	more	intensive	and	comprehensive	IA	training,	in	an	attempt	to	accomplish	changes	in	control	over	ejaculation.	It	would	also	be	interesting	to	see	 if	 there	 is	any	 treatment	 effect	 of	an	 IA	 intervention	alone,	 compared	to	vibrator	assisted	start-stop	exercises.		
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To	further	elucidate	the	hypothesis	regarding	the	etiological	role	of	anxiety	in	PE,	 future	 studies	 could	 utilize	 experimental	 or	more	 fine-grained	 temporal	observational	 approaches.	 Are	 there	 any	 patterns	 in	 day-to-day	 levels	 of	anxiety	and	severity	of	PE?	How	do	the	physiological,	cognitive	and	emotional	aspects	 of	 anxiety	 before	 and	 during	 sex	 correspond	 to	 PE?	 Ecological	momentary	assessments	as	well	as	experimental	methods	could	provide	new	insights	into	the	complex	phenomenon	of	PE,	such	as	the	possible	mediating	roles	 of	 sympathetic	 activation,	 cognitive	 distortion	 and	 interoceptive	awareness.		In	recent	 years,	 the	 importance	of	 replication	 in	science	 in	general	 has	been	highlighted,	after	reviews	suggesting	a	substantial	number	of	research	findings	fail	 to	 replicate.	 This	 has	 been	 shown	 both	 for	 behavioral	 sciences	 (Gilbert,	King,	Pettigrew,	&	Wilson,	2016;	Open	Science	Collaboration,	2015)	as	well	as	many	areas	of	biomedical	research	(Begley	&	Ioannidis,	2015;	Macleod	et	al.,	2014;	Prinz,	Schlange,	&	Asadullah,	2011).	Regarding	the	etiology	of	PE,	myriad	possible	 explanations	 have	 been	 proposed	 and	 tested,	 but	 few	 have	 been	robustly	 replicated	 (Althof	 et	 al.,	 2014).	 For	 example,	 numerous	 molecular	genetic	studies	aiming	to	elucidate	PE	etiology	have	been	published	in	the	past	decade,	with	unconvincing	records	of	replication	 (e.g.,	 Jern	&	Ventus,	2017).	Other	parts	of	the	field	of	PE	reasearch,	such	as	treatment	research	(especially	psychological	 treatment),	 is	 lacking	 in	 quantity	 and	 comparability	 of	 data	(Cooper	et	al.,	2015).	An	important	step	towards	better	quality	of	evidence	in	the	literature	concerning	PE	would	be	to	conduct	more	replication	studies.	
 		
		 69	
	References	Abu	 Ruz,	 M.	 E.,	 Lennie,	 T.	 A.,	 Riegel,	 B.,	McKinley,	S.,	Doering,	L.	V,	&	Moser,	D.	K.	(2010).	Evidence	that	the	brief	symptom	 inventory	 can	 be	 used	 to	measure	anxiety	quickly	and	reliably	in	 patients	 hospitalized	 for	 acute	myocardial	infarction.	The	Journal	of	
Cardiovascular	 Nursing,	 25(2),	 117–123.	https://doi.org/10.1097/JCN.0b013e3181b56626	Agudelo,	M.,	Yoo,	C.,	 &	Nair,	M.	P.	 (2015).	Alcohol-induced	 serotonergic	modulation:	 The	 role	 of	 histone	deacetylases.	 Alcohol,	 85(7),	 635–642.	https://doi.org/10.1016/j.neuroimage.2013.08.045.The	Akre,	C.,	Berchtold,	A.,	Gmel,	G.,	&	Suris,	J.-C.	(2014).	 The	 evolution	 of	 sexual	dysfunction	 in	 young	men	 aged	 18-25	 years.	 The	 Journal	 of	 Adolescent	
Health,	 55(6),	 736–743.	https://doi.org/10.1016/j.jadohealth.2014.05.014	Althof,	 S.	 E.	 (2006).	 Treatment	 of	 Rapid	Ejaculation	 -	 Psychotherapy,	Pharmacotherapy,	 and	 Combined	Therapy.	 In	 S.	 R.	 Leiblum	 (Ed.),	
Principles	 &	 Practice	 of	 Sex	 Therapy	(4th	ed.,	pp.	221–223).	New	York,	NY:	Guilford	Press.	Althof,	 S.	E.	 (2016).	Psychosexual	 therapy	for	 premature	 ejaculation.	
Translational	Andrology	and	Urology,	
5(4),	 475–481.	https://doi.org/10.21037/tau.2016.
05.15	Althof,	S.	E.,	Mcmahon,	C.	G.,	Waldinger,	M.	D.,	 Serefoglu,	 E.	 C.,	 Shindel,	 A.	 W.,	Adaikan,	P.	G.,	…	Torres,	L.	O.	(2014).	An	 Update	 of	 the	 International	Society	 of	 Sexual	 Medicine’s	Guidelines	 for	 the	 Diagnosis	 and	Treatment	of	Premature	Ejaculation	(PE).	 Sexual	 Medicine,	 11,	 1392–1422.	https://doi.org/10.1111/jsm.12504	Althof,	 S.	 E.,	 Rosen,	 R.	 C.,	 Symonds,	 T.,	Mundayat,	R.,	May,	K.,	&	Abraham,	L.	(2006).	Development	and	validation	of	 a	 new	 questionnaire	 to	 assess	sexual	 satisfaction,	 control,	 and	distress	 associated	 with	 premature	ejaculation.	 Journal	 of	 Sexual	
Medicine,	 3(3),	 465–475.	https://doi.org/10.1111/j.1743-6109.2006.00239.x	American	 Psychiatric	 Association.	 (2013).	
Diagnostic	 and	 Statistical	Manual	 of	
Mental	 Disorders	 (5th	 ed.).	Washington,	 DC:	 American	Psychiatric	Publishing.	Anaissie,	J.,	Yafi,	F.	A.,	&	Hellstrom,	W.	J.	G.	(2016).	 Surgery	 is	 not	 indicated	 for	the	 treatment	 of	 premature	ejaculation.	 Translational	 Andrology	
and	 Urology,	 5(4),	 607–612.	https://doi.org/10.21037/tau.2016.03.10	Andrews,	P.	W.,	Thomson,	J.	A.,	Amstadter,	A.,	&	Neale,	M.	C.	(2012).	Primum	non	nocere:	 An	 evolutionary	 analysis	 of	
		 70	
whether	 antidepressants	 do	 more	harm	 than	 good.	 Frontiers	 in	
Psychology,	 3(APR),	 1–19.	https://doi.org/10.3389/fpsyg.2012.00117	Azmitia,	E.	C.	(2006).	Serotonin	and	Brain:	Evolution,	 Neuroplasticity,	 and	Homeostasis.	International	Review	of	
Neurobiology,	 77(06),	 31–56.	https://doi.org/10.1016/S0074-7742(06)77002-7	Barfield,	R.	J.,	&	Sachs,	B.	D.	(1968).	Sexual	behavior:	 Stimulation	 by	 painful	electrical	shock	 to	 skin	 in	male	rats.	
Science,	 161(3839),	 392–395.	https://doi.org/10.1126/science.161.3839.392	Barlow,	 D.	 H.	 (1986).	 Causes	 of	 Sexual	Dysfunction :	The	Role	of	Anxiety	and	Cognitive	 Interference.	 Journal	 of	
Consulting	 and	 Clinical	 Psychology,	
54(2),	140–148.	Barlow,	D.	H.,	Sakheim,	D.	K.,	&	Beck,	 J.	G.	(1983).	 Anxiety	 increases	 sexual	arousal.	 Journal	 of	 Abnormal	
Psychology,	 92(1),	 49–54.	https://doi.org/10.1037/0021-843X.92.1.49	Barth,	 M.,	 Kriston,	 L.,	 Klostermann,	 S.,	Barbui,	 C.,	 Cipriani,	 A.,	 &	 Linde,	 K.	(2016).	 Efficacy	 of	 selective	serotonin	 reuptake	 inhibitors	 and	adverse	events:	Meta-regression	and	mediation	 analysis	 of	 placebo-controlled	 trials.	The	British	 Journal	
of	 Psychiatry,	 208,	 114–119.	https://doi.org/10.1192/bjp.bp.114.150136	Beck,	J.	G.,	Barlow,	D.	H.,	Sakheim,	D.	K.,	&	
Abrahamson,	 D.	 J.	 (1987).	 Shock	Threat	and	Sexual	Arousal:	The	Role	of	 Selective	 Attention,	 Thought	Content,	 and	 Affective	 States.	
Psychophysiology,	 24(2),	 165–172.	https://doi.org/10.1111/j.1469-8986.1987.tb00273.x	Begley,	 C.	 G.,	 &	 Ioannidis,	 J.	 P.	 A.	 (2015).	Reproducibility	 in	 science:	Improving	the	standard	for	basic	and	preclinical	 research.	 Circulation	
Research,	 116(1),	 116–126.	https://doi.org/10.1161/CIRCRESAHA.114.303819	Besser,	A.,	Flett,	G.	L.,	&	Davis,	R.	A.	(2003).	Self-criticism	,	dependency,	silencing	the	 self	 ,	 and	 loneliness :	A	 test	 of	 a	mediational	 model.	 Personality	 and	
Individual	 Differences,	 34(8),	 1735–1752.	https://doi.org/10.1016/S0191-8869(02)00403-8	Biddle,	 S.	 J.	 H.,	 &	 Mutrie,	 N.	 (2008).	
Psychology	 of	 Physical	 Activity:	
Determinants,	 well-being	 &	
Interventions	 (2nd	 ed.).	 New	 York,	NY:	Routledge.	Bolat,	 D.,	 Kocabas,	 G.	 U.,	 Gunlusoy,	 B.,	Aydogdu,	 O.,	 &	 Aydin,	M.	 E.	 (2017).	The	 relationship	 between	 acquired	premature	ejaculation	and	metabolic	syndrome:	 A	 prospective,	comparative	 study.	 International	
Journal	of	Impotence	Research,	29(3),	105–109.	https://doi.org/10.1038/ijir.2017.3	Booth,	 F.	W.,	 Roberts,	 C.	 K.,	 &	 Laye,	 M.	 J.	(2012).	 Lack	 of	 exercise	 is	 a	 major	cause	 of	 chronic	 diseases.	
Comprehensive	 Physiology,	 2(2),	
		 71	
1143–1211.	https://doi.org/10.1002/cphy.c110025	Borenstein,	 M.,	 Hedges,	 L.,	 Higgins,	 J.,	 &	Rothstein,	H.	(2009).	Introduction	to	
Meta-Analysis.	 Chichester,	 West	Sussex,	UK:	Wiley.	Bornemann,	B.,	Herbert,	B.	M.,	Mehling,	W.	E.,	 &	 Singer,	 T.	 (2015).	 Differential	changes	 in	 self-reported	 aspects	 of	interoceptive	 awareness	 through	 3	months	 of	 contemplative	 training.	
Frontiers	in	Psychology,	6(JAN),	1–13.	https://doi.org/10.3389/fpsyg.2015.00504	Brotto,	 L.	 A.,	 &	 Basson,	 R.	 (2014).	 Group	mindfulness-based	 therapy	significantly	 improves	 sexual	 desire	in	 women.	 Behaviour	 Research	 and	
Therapy,	 57(1),	 43–54.	https://doi.org/10.1016/j.brat.2014.04.001	Brotto,	L.	A.,	Basson,	R.,	&	Luria,	M.	(2008).	A	 mindfulness-based	 group	psychoeducational	 intervention	targeting	 sexual	 arousal	 disorder	 in	women.	 Journal	 of	 Sexual	 Medicine,	
5(7),	 1646–1659.	https://doi.org/10.1111/j.1743-6109.2008.00850.x	Brotto,	 L.	 A.,	 &	 Goldmeier,	 D.	 (2015).	Mindfulness	 interventions	 for	treating	 sexual	 dysfunctions:	 The	gentle	 science	 of	 finding	 focus	 in	 a	multitask	 world.	 Journal	 of	 Sexual	
Medicine,	 12(8),	 1687–1689.	https://doi.org/10.1111/jsm.12941	Buvat,	J.,	Tesfaye,	F.,	Rothman,	M.,	Rivas,	D.	A.,	&	Giuliano,	F.	(2009).	Dapoxetine	
for	 the	 Treatment	 of	 Premature	Ejaculation :	 Results	 from	 a	Randomized	,	Double	-	Blind	,	Placebo	-	 Controlled	 Phase	 3	 Trial	 in	 22	Countries.	 European	 Urology,	 55(4),	957–968.	https://doi.org/10.1016/j.eururo.2009.01.025	Campbell,	 A.,	 &	 Hausenblas,	 H.	 A.	 (2009).	Effects	 of	 exercise	 interventions	 on	body	image:	A	meta-analysis.	Journal	
of	Health	Psychology,	14(6),	780–793.	https://doi.org/10.1177/1359105309338977	Carvalho,	A.	F.,	Sharma,	M.	S.,	Brunoni,	A.	R.,	Vieta,	 E.,	 &	 Fava,	 G.	 A.	 (2016).	 The	safety,	 tolerability	 and	 risks	associated	 with	 the	 use	 of	 newer	generation	 antidepressant	 drugs:	 A	critical	 review	 of	 the	 literature.	
Psychotherapy	 and	 Psychosomatics,	
85(5),	 270–288.	https://doi.org/10.1159/000447034	Chaouloff,	 F.	 (1997).	 Effects	 of	 acute	physical	 exercise	 on	 central	serotonergic	 systems.	 Medicine	 &	
Science	 in	 Sports	 &	 Exercise,	 29(1),	58–62.	https://doi.org/10.1097/00005768-199701000-00009	Chéhensse,	 C.,	 Bahrami,	 S.,	 Denys,	 P.,	Clément,	P.,	Bernabé,	J.,	&	Giuliano,	F.	(2013).	 The	 spinal	 control	 of	ejaculation	 revisited:	 A	 systematic	review	 and	 meta-analysis	 of	anejaculation	 in	 spinal	 cord	 injured	patients.	 Human	 Reproduction	
Update,	 19(5),	 507–526.	https://doi.org/10.1093/humupd/d
		 72	
mt029	Clément,	 P.,	 Bernabé,	 J.,	 Compagnie,	 S.,	Alexandre,	 L.,	 McCallum,	 S.,	 &	Giuliano,	 F.	 (2013).	 Inhibition	 of	ejaculation	 by	 the	 non-peptide	oxytocin	 receptor	 antagonist	GSK557296:	 a	 multi-level	 site	 of	action.	 British	 Journal	 of	
Pharmacology,	 169(7),	 1477–1485.	https://doi.org/10.1111/bph.12198	Clément,	 P.,	 Pozzato,	 C.,	 Heidbreder,	 C.,	Alexandre,	L.,	Giuliano,	F.,	&	Melotto,	S.	 (2009).	 Delay	 of	 Ejaculation	Induced	 by	 SB-277011,	 a	 Selective	Dopamine	 D3	 Receptor	 Antagonist,	in	 the	 Rat.	 The	 Journal	 of	 Sexual	
Medicine,	 6(4),	 980–988.	https://doi.org/10.1111/j.1743-6109.2008.01173.x	Cooper,	 K.,	 Martyn-St	 James,	 M.,	Kaltenthaler,	 E.,	 Dickinson,	 K.,	 &	Cantrell,	A.	 (2015).	 Interventions	 to	treat	 premature	 ejaculation:	 A	systematic	 review	 short	 report.	
Health	 Technology	 Assessment,	
19(21),	 1–180.	https://doi.org/10.3310/hta19210	Cormio,	L.,	Massenio,	P.,	La	Rocca,	R.,	Verze,	P.,	Mirone,	 V.,	 &	 Carrieri,	 G.	 (2015).	The	Combination	of	Dapoxetine	and	Behavioral	 Treatment	 Provides	Better	Results	than	Dapoxetine	Alone	in	 the	Management	of	Patients	with	Lifelong	 Premature	 Ejaculation.	
Journal	 of	 Sexual	 Medicine,	 12(7),	1609–1615.	https://doi.org/10.1111/jsm.12925	Corona,	 G.,	 Petrone,	 L.,	 Mannucci,	 E.,	Jannini,	E.,	Mansani,	R.,	Magini,	A.,	…	Maggi,	 M.	 (2004).	 Psycho-biological	
correlates	 of	 rapid	 ejaculation	 in	patients	attending	an	andrologic	unit	for	 sexual	 dysfunctions.	 European	
Urology,	 46,	 615–622.	https://doi.org/10.1016/j.eururo.2004.07.001	Corretti,	G.,	Pierucci,	S.,	De	Scisciolo,	M.,	&	Nisita,	 C.	 (2006).	 Comorbidity	between	 social	 phobia	 and	premature	ejaculation:	study	on	242	males	 affected	 by	 sexual	 disorders.	
Journal	 of	 Sex	 &	 Marital	 Therapy,	
32(2),	 183–187.	https://doi.org/10.1080/00926230500442342	Crews,	 D.,	 &	 Landers,	 D.	 (1987).	 A	meta-analytic	review	of	aerobic	fitness	and	reactivity	 to	 psychosocial	 stressors.	
Medicine	 and	 Science	 in	 Sports	 and	
Exercise,	19(5).	Critchley,	 H.	 D.,	 Wiens,	 S.,	 Rotshtein,	 P.,	Ohman,	 A.,	 &	 Dolan,	 R.	 J.	 (2004).	Neural	 systems	 supporting	interoceptive	 awareness.	 Nature	
Neuroscience,	 7(2),	 189–195.	https://doi.org/10.1038/nn1176	de	Carufel,	F.,	&	Trudel,	G.	(2006).	Effects	of	a	 new	 functional-sexological	treatment	for	premature	ejaculation.	
Journal	of	Sex	&	Marital	Therapy,	32,	97–114.	https://doi.org/10.1080/00926230500442292	Dehaene,	 S.,	 &	 Naccache,	 L.	 (2001).	Towards	a	cognitive	neuroscience	of	consciousness:	Basic	evidence	and	a	workspace	 framework.	 Cognition,	
79(1–2),	 1–37.	https://doi.org/10.1016/S0010-0277(00)00123-2	
		 73	
Derogatis,	 L.	 R.,	 &	Melisaratos,	 N.	 (1983).	The	 Brief	 Symptom	 Inventory:	 An	introductory	 report.	 Psychological	
Medicine,	13,	595–605.	Derogatis,	 L.	 R.,	 Rosen,	 R.,	 Leiblum,	 S.,	Burnett,	A.,	&	Heiman,	J.	(2002).	The	Female	Sexual	Distress	Scale	(FSDS):	Initial	 validation	 of	 a	 standardized	scale	 for	 assessment	 of	 sexually	related	personal	 distress	 in	women.	
Journal	of	Sex	&	Marital	Therapy,	28,	317–330.	https://doi.org/10.1080/00926230290001448	Dhejne,	 C.,	 Jern,	 P.,	 &	 Arver,	 S.	 (2017).	Orgasm-	och	utlösningsstörningar.	In	S.	 Arver,	 J.-E.	 Damber,	 &	 A.	Giwercman	 (Eds.),	 Andrologi	 (pp.	167–178).	 Lund,	 Sweden:	Studentlitteratur.	Dimitrov,	 D.	 M.,	 &	 Rumrill,	 P.	 D.	 (2003).	Pretest-posttest	 designs	 and	measurement	 of	 change.	 Work,	 20,	159–165.	Domschke,	K.,	Stevens,	S.,	Pfleiderer,	B.,	&	Gerlach,	 A.	 L.	 (2010).	 Interoceptive	sensitivity	 in	 anxiety	 and	 anxiety	disorders:	 An	 overview	 and	integration	 of	 neurobiological	findings.	Clinical	 Psychology	 Review,	
30(1),	 1–11.	https://doi.org/10.1016/j.cpr.2009.08.008	Dunn,	K.,	Croft,	P.	R.,	&	Hackett,	G.	I.	(1999).	Association	of	 sexual	problems	with	social,	 psychological,	 and	 physical	problems	in	men	and	women:	A	cross	sectional	population	 survey.	 Journal	
of	 Epidemiology	 and	 Community	
Health,	53,	144–148.	
Eisenmann,	J.	C.,	Milburn,	N.,	Jacobsen,	L.,	&	Moore,	 S.	 J.	 (2002).	 Reliability	 and	convergent	 validity	 of	 the	 Godin	Leisure-Time	Exercise	Questionnaire	in	 rural	 5th-grade	 school-children.	
Journal	of	Human	Movement	 Studies,	
43(2),	135–149.	Ertekin,	C.,	Colakoglu,	Z.,	&	Altay,	B.	(1995).	Hand	 and	 Genital	 Sympathetic	 Skin	Potentials	 in	 Flaccid	 and	 Erectile	Penile	 States	 in	Normal	Potent	Men	and	 Patients	 With	 Premature	Ejaculation.	 The	 Journal	 of	 Urology,	
153(1),	 76–79.	https://doi.org/10.1097/00005392-199501000-00027	Fanciullacci,	 F.,	 Colpi,	 G.	M.,	 Beretta,	 G.,	 &	Zanollo,	 A.	 (1988).	 Cortical	 Evoked	Potentials	 in	 Subjects	 with	 True	Premature	 Ejaculation	 Im	 Kortex	hervorgerufene	 Potentiale	 bei	Patienten	 mit	 echter	 vorzeitiger	Ejakulation,	20(4),	326–330.	Francomano,	D.,	Donini,	 L.	M.,	 Lenzi,	A.,	 &	Aversa,	A.	(2013).	Peripheral	arterial	tonometry	to	measure	the	effects	of	vardenafil	 on	 sympathetic	 tone	 in	men	 with	 lifelong	 premature	ejaculation.	 International	 Journal	 of	
Endocrinology,	 2013,	 1–9.	https://doi.org/10.1155/2013/394934	Freedland,	K.	E.,	Mohr,	 D.	C.,	Davidson,	K.	W.,	 &	 Schwartz,	 J.	 E.	 (2011).	 Usual	and	 unusual	 care:	 Existing	 practice	control	 groups	 in	 randomized	controlled	 trials	 of	 behavioral	interventions.	 Psychosomatic	
Medicine,	 73(4),	 323–335.	https://doi.org/10.1097/PSY.0b013
		 74	
e318218e1fb	Fridell,	 M.,	 Cesarec,	 Z.,	 Johansson,	 M.,	 &	Thorsen,	S.	M.	(2002).	SCL-90.	Svensk	
normering,	 standardisering	 och	
validering	av	symtomskalan.	SiS	följer	
upp	 och	 utvecklar	 4/02.	 Stockholm,	Sweden:	Statens	institutionsstyrelse.	Gao,	J.,	Zhang,	X.,	Su,	P.,	Liu,	J.,	Xia,	L.,	Yang,	J.,	…	Liang,	C.	(2013).	Prevalence	and	factors	associated	with	the	complaint	of	premature	ejaculation	and	the	four	premature	ejaculation	syndromes:	A	large	 observational	 study	 in	 China.	
Journal	 of	 Sexual	 Medicine,	 10(7),	1874–1881.	https://doi.org/10.1111/jsm.12180	Gao,	J.,	Zhang,	X.,	Su,	P.,	Peng,	Z.,	Liu,	J.,	Xia,	L.,	…	Liang,	C.	(2014).	The	impact	of	intravaginal	ejaculatory	latency	time	and	erectile	function	on	anxiety	and	depression	 in	 the	 four	 types	 of	premature	ejaculation:	A	large	cross-sectional	 study	 in	 a	 chinese	population.	 Journal	 of	 Sexual	
Medicine,	 11(2),	 521–528.	https://doi.org/10.1111/jsm.12383	George,	 D.,	 &	Mallery,	 P.	 (2003).	 SPSS	 for	
Windows	step	by	step:	A	simple	guide	
and	reference	(4th	ed.).	Boston:	Allyn	&	Bacon.	George,	 W.,	 &	 Stoner,	 S.	 A.	 (2000).	Understanding	 acute	 alcohol	 effects	on	sexual	behavior.	Annual	Review	of	
Sex	Research,	11,	92–123.	Gilbert,	 D.	 T.,	 King,	 G.,	 Pettigrew,	 S.,	 &	Wilson,	 T.	 D.	 (2016).	 Comment	 on	“Estimating	 the	 reproducibility	 of	psychological	 science.”	 Science,	
351(6277),	1037.	
Giuliano,	F.,	Patrick,	D.	L.,	Porst,	H.,	La	Pera,	G.,	 Kokoszka,	 A.,	 Merchant,	 S.,	 …	Polverejan,	 E.	 (2008).	 Premature	ejaculation:	 Results	 from	 a	 five-country	 european	 observational	study.	 European	 Urology,	 53(5),	1048–1057.	https://doi.org/10.1016/j.eururo.2007.10.015	Godin,	 G.	 (1997).	 Godin	 Leisure-Time	Exercise	 Questionnaire	 and	 Science	in	 Sports	 and	 Exercise	 .	 29	 June	Supplement :	 S36-S38	 .	 Godin	Leisure-Time	 Exercise	Questionnaire.	Medicine	 and	 Science	
in	Sports	and	Exercise,	14–15.	Godpodinoff,	 M.	 L.	 (1989).	 Premature	ejaculation:	 Clinical	 subgroups	 and	etiology.	 Journal	 of	 Sex	 and	 Marital	
Therapy,	 15(2),	 130–134.	https://doi.org/10.1080/00926238908403817	Goldmeier,	 D.,	 &	 Mears,	 A.	 (2010).	Meditation:	 A	 review	 of	 its	 use	 in	western	medicine	and,	 in	particular,	its	role	in	the	management	of	sexual	dysfunction.	 Current	 Psychiatry	
Reviews,	 6(1),	 11–14.	https://doi.org/10.2174/157340010790596508	Gorgel,	S.	N.,	Gorgel,	A.,	&	Sefik,	E.	(2014).	Sexual	function	in	male	patients	with	metabolic	 syndrome	 and	 effective	parameters	 on	 erectile	 dysfunction.	
International	 Brazilian	 Journal	 of	
Urology,	 40(1),	 56–61.	https://doi.org/10.1590/S1677-5538.IBJU.2014.01.08	Grenier,	 G.,	 &	 Byers,	 E.	 S.	 (1995).	 Rapid	ejaculation:	 A	 review	 of	 conceptual,	
		 75	
etiological,	 and	 treatment	 issues.	
Archives	 of	 Sexual	 Behavior,	 24(4),	447–472.	https://doi.org/10.1007/BF01541858	Gunst,	 A.,	 Ventus,	 D.,	 Arver,	 S.,	 Dhejne,	 C.,	Görts-Öberg,	K.,	Zamore-Söderström,	E.,	&	 Jern,	P.	 (2018).	A	 randomized,	waiting-list-controlled	 study	 shows	that	 brief,	 mindfulness-based	psychological	 interventions	 are	effective	 for	 treatment	 of	 women’s	low	sexual	desire.	The	Journal	of	Sex	
Research,	 [Epub	 ahead	 of	 print].	https://doi.org/10.1080/00224499.2018.1539463	Guo,	 L.,	 Liu,	 Y.,	Wang,	 X.,	 Yuan,	M.,	 Yu,	 Y.,	Zhang,	 X.,	 &	 Zhao,	 S.	 (2017).	Significance	 of	 penile	hypersensitivity	 in	 premature	ejaculation.	 Scientific	 Reports,	 7(1),	3–8.	https://doi.org/10.1038/s41598-017-09155-8	Hale,	V.	E.,	&	Strassberg,	D.	S.	 (1990).	The	Role	 of	 Anxiety	 on	 Sexual	 Arousal.	
Archives	 of	 Sexual	 Behavior,	 19(6),	569–581.	Hamaker,	E.	L.,	Kuiper,	R.	M.,	&	Grasman,	R.	P.	 P.	 P.	 (2015).	 A	 Critique	 of	 the	Cross-Lagged	 Panel	 Model.	
Psychological	 Methods,	 20(1),	 102–116.	https://doi.org/10.1037/a0038889	Han,	T.	S.,	Tajar,	A.,	O’Neill,	T.	W.,	Jiang,	M.,	Bartfai,	G.,	Boonen,	S.,	…	Korrovitz,	P.	(2011).	 Impaired	 quality	 of	 life	 and	sexual	 function	 in	 overweight	 and	obese	 men:	 The	 European	 male	ageing	 study.	 European	 Journal	 of	
Endocrinology,	 164(6),	 1003–1011.	https://doi.org/10.1530/EJE-10-1129	Handy,	 A.	 B.,	 &	 Meston,	 C.	 M.	 (2016).	Interoceptive	 Awareness	 Moderates	the	Relationship	Between	Perceived	and	Physiological	Genital	Arousal	 in	Women.	 The	 Journal	 of	 Sexual	
Medicine,	 13(12),	 1907–1914.	https://doi.org/10.1016/j.jsxm.2016.09.018	Handy,	 A.	 B.,	 &	 Meston,	 C.	 M.	 (2018).	Interoception	 and	 Awareness	 of	Physiological	 Sexual	 Arousal	 in	Women	 With	 Sexual	 Arousal	Concerns.	 Journal	of	Sex	and	Marital	
Therapy,	 44(4),	 398–409.	https://doi.org/10.1080/0092623X.2017.1405305	Hartmann,	U.,	Schedlowski,	M.,	&	Krüger,	T.	H.	C.	(2005).	Cognitive	and	partner-related	 factors	 in	 rapid	 ejaculation:	Differences	 between	 dysfunctional	and	functional	men.	World	Journal	of	
Urology,	 23,	 93–101.	https://doi.org/10.1007/s00345-004-0490-0	Hatzimouratidis,	 K.,	 Amar,	 E.,	 Eardley,	 I.,	Giuliano,	 F.,	 Hatzichristou,	 D.,	Montorsi,	 F.,	 …	 Wespes,	 E.	 (2010).	Guidelines	 on	 Male	 Sexual	Dysfunction:	 Erectile	 Dysfunction	and	Premature	Ejaculation.	European	
Urology,	 57(5),	 804–814.	https://doi.org/10.1016/j.eururo.2010.02.020	Herbenick,	D.,	Reece,	M.,	Sanders,	S.,	Dodge,	B.,	Ghassemi,	A.,	&	Fortenberry,	D.	J.	(2009).	 Prevalence	 and	characteristics	 of	 vibrator	 use	 by	
		 76	
women	in	the	United	States:	Results	from	 a	 nationally	 representative	study.	 Journal	 of	 Sexual	Medicine,	6,	1857–1866.	https://doi.org/10.1111/j.1743-6109.2009.01318.x	Hirschfeld,	 R.	 M.	 A.	 (2001).	 The	comorbidity	of	major	depression	and	axiety	 disorders:	 Recognition	 and	management	 in	 primary	 care:	
Primary	 Care	 Companion	 to	 the	
Journal	 of	 Clinical	 Psychoatry,	 3(6),	244–254.	Holi,	M.	M.,	Sammallahti,	P.	R.,	&	Aalberg,	V.	A.	(1998).	A	Finnish	validation	study	of	 the	 SCL-90.	 Acta	 Psychiatrica	
Scandinavica,	90(8),	42–46.	Hong,	L.	K.	(1984).	Survival	of	 the	fastest:	On	 the	 origin	 of	 premature	ejaculation.	 The	 Journal	 of	 Sex	
Research,	 20(2),	 109–122.	https://doi.org/10.1080/00224498409551212	Hull,	 E.	 M.,	 Muschamp,	 J.	 W.,	 &	 Sato,	 S.	(2004).	 Dopamine	 and	 serotonin:	Influences	on	male	 sexual	 behavior.	
Physiology	and	Behavior,	83(2),	291–307.	https://doi.org/10.1016/j.physbeh.2004.08.018	Inman,	B.	A.,	St.	Sauver,	J.	L.,	Jacobson,	D.	J.,	McGree,	M.	E.,	Nehra,	A.,	Lieber,	M.	M.,	…	 Jacobsen,	 S.	 J.	 (2009).	 A	Population-Based,	 Longitudinal	Study	 of	 Erectile	 Dysfunction	 and	Future	 Coronary	 Artery	 Disease.	
Mayo	Clinic	Proceedings,	84(2),	108–113.	https://doi.org/10.4065/84.2.108	
Jannini,	E.,	Lombardo,	F.,	&	Lenzi,	A.	(2005).	Correlation	between	ejaculatory	and	erectile	 dysfunction.	 International	
Journal	of	Andrology,	28	Suppl	2,	40–45.	 https://doi.org/10.1111/j.1365-2605.2005.00593.x	Jeh,	S.,	Yoon,	S.,	Do,	J.,	Seo,	D.	H.,	Lee,	S.	W.,	Choi,	 S.	 M.,	 …	 Hyun,	 J.	 S.	 (2018).	Metabolic	 syndrome	 is	 an	independent	risk	factor	for	acquired	premature	 ejaculation.	 The	 World	
Journal	of	Men’s	Health,	17(2),	e1573.	https://doi.org/10.1016/S1569-9056(18)31935-3	Jern,	 P.	 (2009).	 Premature	 and	 delayed	
ejaculation:	prevalence,	 heredity	and	
diagnostic	considerations.	PhD	thesis,	Åbo	Akademi	University.	Jern,	P.	(2014).	Evaluation	of	a	behavioral	treatment	 intervention	 for	premature	 ejaculation	 using	 a	handheld	stimulating	device.	Journal	
of	 Sex	 &	 Marital	 Therapy,	 40,	 358–366.	https://doi.org/10.1080/0092623X.2013.857376	Jern,	P.,	Johansson,	A.,	Piha,	J.,	Westberg,	L.,	&	Santtila,	P.	(2014).	Antidepressant	treatment	 of	 premature	 ejaculation:	Discontinuation	 rates	 and	prevalence	 of	 side	 effects	 for	dapoxetine	 and	 paroxetine	 in	 a	naturalistic	 setting.	 International	
Journal	of	Impotence	Research,	27(2),	75–80.	https://doi.org/10.1038/ijir.2014.37	Jern,	 P.,	 Piha,	 J.,	 &	 Santtila,	 P.	 (2013).	Validation	of	 three	early	 ejaculation	diagnostic	 tools:	 A	 composite	
		 77	
measure	 is	 accurate	 and	 more	adequate	 for	 diagnosis	 by	 updated	diagnostic	criteria.	PLoS	ONE,	8(10),	1–9.	https://doi.org/10.1371/journal.pone.0077676	Jern,	 P.,	 Santtila,	 P.,	 Johansson,	 A.,	 &	Sandnabba,	N.	K.	(2010).	Genetic	and	environmental	 effects	 on	 the	continuity	 of	 ejaculatory	dysfunction.	 BJU	 International,	
105(12),	 1698–1704.	https://doi.org/10.1111/j.1464-410X.2009.09040.x	Jern,	P.,	Santtila,	P.,	Johansson,	A.,	Varjonen,	M.,	 Witting,	 K.,	 Ålgars,	 M.,	 …	Sandnabba,	 K.	 (2008).	 Indicators	 of	premature	 ejaculation	 and	 their	associations	with	sexual	distress	in	a	population-based	 sample	 of	 young	twins	 and	 their	 siblings.	 Journal	 of	
Sexual	 Medicine,	 5,	 2191–2201.	https://doi.org/10.1111/j.1743-6109.2008.00863.x	Jern,	P.,	Santtila,	P.,	Johansson,	A.,	Varjonen,	M.,	Witting,	K.,	Von	Der	Pahlen,	B.,	&	Sandnabba,	 K.	 (2009).	 Subjectively	measured	 ejaculation	 latency	 time	and	 its	 association	 with	 different	sexual	activities	while	controlling	for	age	 and	 relationship	 length.	 Journal	
of	Sexual	Medicine,	6(9),	2568–2578.	https://doi.org/10.1111/j.1743-6109.2009.01360.x	Jern,	P.,	Santtila,	P.,	Johansson,	A.,	Varjonen,	M.,	Witting,	K.,	von	der	Pahlen,	B.,	&	Sandnabba,	 N.	 K.	 (2009).	 Evidence	for	 a	 genetic	 etiology	 to	ejaculatory	dysfunction.	 International	 Journal	 of	
Impotence	 Research,	 21,	 62–67.	
https://doi.org/10.1038/ijir.2008.61	Jern,	P.,	Santtila,	P.,	Witting,	K.,	Alanko,	K.,	Harlaar,	 N.,	 Johansson,	 A.,	 …	Sandnabba,	 K.	 (2007).	 Premature	and	delayed	ejaculation:	Genetic	and	environmental	 effects	 in	 a	population-based	 sample	 of	 finnish	twins.	 Journal	 of	 Sexual	 Medicine,	
4(6),	 1739–1749.	https://doi.org/10.1111/j.1743-6109.2007.00599.x	Jern,	P.,	&	Ventus,	D.	(2017).	Serotonergic	polymorphisms	 in	 the	 control	 of	ejaculation.	 Molecular	 and	 Cellular	
Endocrinology.	https://doi.org/10.1016/j.mce.2017.10.017	Johansson,	A.,	 Jern,	P.,	Santtila,	P.,	 von	der	Pahlen,	B.,	Eriksson,	E.,	Westberg,	L.,	…	 Sandnabba,	 N.	 K.	 (2013).	 The	Genetics	of	Sexuality	and	Aggression	(GSA)	twin	samples	in	Finland.	Twin	
Research	and	Human	Genetics,	16(1),	150–156.	https://doi.org/10.1017/thg.2012.108	Kaplan,	 H.	 S.	 (1975).	 New	 Sex	 Therapy:	
Active	 Treatment	 Of	 Sexual	
Dysfunctions.	London,	UK:	Routledge.	Kaplan,	 H.	 S.,	 Kohl,	 R.	 N.,	 Pomeroy,	W.	 B.,	Offit,	A.	K.,	&	Hogan,	B.	(1974).	Group	treatment	 of	 premature	 ejaculation.	
Archives	 of	 Sexual	 Behavior,	 3(5),	443–452.	 Retrieved	 from	http://www.ncbi.nlm.nih.gov/pubmed/4413604	Kaufman,	J.	M.,	Rosen,	R.	C.,	Mudumbi,	R.	V.,	Tesfaye,	F.,	Hashmonay,	R.,	 &	Rivas,	
		 78	
D.	 (2009).	 Treatment	 benefit	 of	dapoxetine	 for	 premature	ejaculation:	Results	 from	a	placebo-controlled	 phase	 III	 trial.	 BJU	
International,	 103(5),	 651–658.	https://doi.org/10.1111/j.1464-410X.2008.08165.x	Kempeneers,	P.,	Andrianne,	R.,	Cuddy,	M.,	&	Blairy,	 S.	 (2018).	 Sexual	 Cognitions,	Trait	 Anxiety,	 Sexual	 Anxiety,	 and	Distress	 in	 Men	 With	 Different	Subtypes	 of	 Premature	 Ejaculation	and	in	Their	Partners.	Journal	of	Sex	
and	Marital	Therapy,	44(4),	319–332.	https://doi.org/10.1080/0092623X.2017.1405299	Kilinc,	 M.	 F.,	 Aydogmus,	 Y.,	 Yildiz,	 Y.,	 &	Doluoglu,	 O.	 G.	 (2018).	 Impact	 of	physical	 activity	 on	 patient	 self-reported	 outcomes	 of	 lifelong	premature	 ejaculation	 patients:	Results	of	a	prospective,	randomised,	sham-controlled	 trial.	 Andrologia,	
50(1),	 1–7.	https://doi.org/10.1111/and.12799	Kumsar,	N.	A.,	Kumsar,	&	Dilbaz,	N.	(2016).	Sexual	dysfunction	in	men	diagnosed	as	 substance	 use	 disorder.	
Andrologia,	 48(10),	 1229–1235.	https://doi.org/10.1111/and.12566	La	 Pera,	 G.,	 &	 Nicastro,	 A.	 (1996).	 A	 new	treatment	for	premature	ejaculation:	The	rehabilitation	of	the	pelvic	floor.	
Journal	 of	 Sex	 &	 Marital	 Therapy,	
22(1),	22–26.	Lang,	 A.	 J.,	 Norman,	 S.	 B.,	 Means-Christensen,	A.,	&	Stein,	M.	B.	(2009).	Abbreviated	 brief	 symptom	inventory	 for	use	as	 an	anxiety	and	depression	 screening	 instrument	 in	
primary	care.	Depression	and	Anxiety,	
26(6),	 537–543.	https://doi.org/10.1002/da.20471	Liu,	T.,	Jia,	C.,	Peng,	Y.-F.,	Zhong,	W.,	&	Fang,	X.	 (2019).	 Correlation	 between	premature	 ejaculation	 and	psychological	 disorders	 in	 270	chinese	 outpatients.	 Psychiatry	
Research,	 272,	 69–72.	https://doi.org/S0165178118306899	Lundh,	A.,	Lexchin,	J.,	Mintzes,	B.,	Schroll,	J.,	&	 Bero,	 L.	 (2017).	 Industry	sponsorship	 and	 research	 outcome.	
Conchrane	 Database	 of	 Systematic	
Reviews,	 (2),	 1–143.	https://doi.org/10.1002/14651858.MR000033.pub3	Macleod,	 M.	 R.,	 Michie,	 S.,	 Roberts,	 I.,	Dirnagl,	U.,	 Chalmers,	 I.,	 Ioannidis,	 J.	P.	 A.,	 …	 Glasziou,	 P.	 (2014).	Biomedical	 research:	 Increasing	value,	 reducing	 waste.	 The	 Lancet,	
383(9912),	 101–104.	https://doi.org/10.1016/S0140-6736(13)62329-6	Majzoub,	A.,	Arafa,	M.,	Al-Said,	S.,	Dabbous,	Z.,	 Aboulsoud,	 S.,	 Khalafalla,	 K.,	 &	Elbardisi,	 H.	 (2016).	 Premature	ejaculation	 in	 type	 II	 diabetes	mellitus	 patients:	 association	 with	glycemic	 control.	 Translational	
Andrology	 and	 Urology,	 5(2),	 248–254.	https://doi.org/10.21037/tau.2016.03.11	Malatesta,	V.	J.,	Pollack,	R.	H.,	Wilbanks,	W.	A.,	 &	 Adams,	 H.	 E.	 (1979).	 Alcohol	Effects	 on	 the	 Orgasmic-Ejaculatory	Response	in	Human	Males.	Journal	of	
		 79	
Sex	 Research,	 15(2),	 101–107.	https://doi.org/10.1080/00224497909551027	Malavige,	L.	S.,	Wijesekara,	P.,	Ranasinghe,	P.,	 &	 Levy,	 J.	 C.	 (2015).	 The	association	between	physical	activity	and	 sexual	 dysfunction	 in	 patients	with	 diabetes	 mellitus	 of	 European	and	 South	 Asian	 origin:	 The	Oxford	Sexual	 Dysfunction	 Study.	European	
Journal	of	Medical	Research,	20(1),	1–7.	 https://doi.org/10.1186/s40001-015-0186-5	Malchaire,	J.,	Rodriguez	Diaz,	L.	S.,	Piette,	A.,	Gonçalves	Amaral,	F.,	&	de	Schaetzen,	D.	 (1998).	 Neurological	 and	functional	 effects	 of	 short-term	exposure	 to	 hand-arm	 vibration.	
International	 Archives	 of	
Occupational	 and	 Environmental	
Health,	 71,	 270–276.	https://doi.org/10.1007/s004200050280	Marmot,	M.,	&	Brunner,	E.	(1991).	Alcohol	and	 cardiovascular	 disease:	 the	status	 of	 the	 U	 shaped	 curve.	 BMJ	
(Clinical	 Research	 Ed.),	 303(6802),	565–568.	https://doi.org/10.1136/bmj.303.6802.565	Masters,	W.,	&	Johnson,	V.	(1970).	Human	
Sexual	 Inadequacy.	 Boston:	 Little,	Brown.	McCabe,	 M.	 P.	 (2001).	 Evaluation	 of	 a	cognitive	behavior	therapy	program	for	 people	 with	 sexual	 dysfunction.	
Journal	 of	 Sex	 and	 Marital	 Therapy,	
27(3),	 259–271.	https://doi.org/10.1080/009262301750257119	
McCabe,	M.	P.,	&	Cobain,	M.	 J.	 (1998).	The	impact	of	individual	and	relationship	factors	on	sexual	dysfunction	among	males	 and	 females.	 Sexual	 and	
Marital	 Therapy,	 13(2),	 131–143.	https://doi.org/10.1080/02674659808406554	McMahon,	 C.	 G.	 (2015).	 Current	 and	emerging	 treatments	 for	 premature	ejaculation.	Sexual	Medicine	Reviews,	
3(3),	 183–202.	https://doi.org/10.1002/smrj.49	McMahon,	 C.	 G.,	 Abdo,	 C.,	 Incrocci,	 L.,	Perelman,	 M.,	 Rowland,	 D.,	Waldinger,	 M.,	 &	 Xin,	 Z.	 C.	 (2004).	Disorders	of	orgasm	and	ejaculation	in	 men.	 The	 Journal	 of	 Sexual	
Medicine,	 1(1),	 58–65.	https://doi.org/10.1111/j.1743-6109.2004.10109.x	McMahon,	C.	G.,	Althof,	S.	E.,	Kaufman,	J.	M.,	Buvat,	J.,	Levine,	S.	B.,	Aquilina,	J.	W.,	…	 Porst,	 H.	 (2011).	 Efficacy	 and	safety	 of	 Dapoxetine	 for	 the	treatment	 of	 premature	 ejaculation:	Integrated	 analysis	 of	 results	 from	five	phase	3	 trials.	 Journal	 of	 Sexual	
Medicine,	 8(2),	 524–539.	https://doi.org/10.1111/j.1743-6109.2010.02097.x	McMahon,	C.	G.,	Jannini,	E.	A.,	Serefoglu,	E.	C.,	&	Hellstrom,	W.	 J.	G.	(2016).	The	pathophysiology	 of	 acquired	premature	ejaculation.	Translational	
Andrology	 and	 Urology,	 5(4),	 434–449.	https://doi.org/10.21037/tau.2016.07.06	Mehling,	W.	E.,	 Price,	 C.,	Daubenmier,	 J.	 J.,	Acree,	M.,	Bartmess,	E.,	&	Stewart,	A.	
		 80	
(2012).	 The	 Multidimensional	Assessment	 of	 Interoceptive	Awareness	(MAIA).	PLoS	ONE,	7(11).	https://doi.org/10.1371/journal.pone.0048230	Melnik,	T.,	Althof,	S.,	Atallah,	Á.	N.,	Puga,	M.	E.	D.	S.,	Glina,	S.,	&	Riera,	R.	(2011).	Psychosocial	 interventions	 for	premature	 ejaculation.	 Cochrane	
Database	of	 Systematic	 Reviews,	 (8).	https://doi.org/10.1002/14651858.CD008195.pub2	Mondaini,	N.,	Fusco,	F.,	Cai,	T.,	Benemei,	S.,	Mirone,	 V.,	 &	 Bartoletti,	 R.	 (2013).	Dapoxetine	 treatment	 in	 patients	with	 lifelong	 premature	ejaculation:	The	reasons	of	a	“Waterloo.”	Urology,	
82(3),	 620–624.	https://doi.org/10.1016/j.urology.2013.05.018	Moon,	 D.	 G.	 (2016).	 Is	 there	 a	 place	 for	surgical	 treatment	 of	 premature	ejaculation?	Translational	Andrology	
and	 Urology,	 5(4),	 502–507.	https://doi.org/10.21037/tau.2016.05.06	Mourikis,	 I.,	 Antoniou,	 M.,	 Matsouka,	 E.,	Vousoura,	E.,	Tzavara,	 C.,	 Ekizoglou,	C.,	…	Zervas,	I.	M.	(2015).	Anxiety	and	depression	 among	 Greek	 men	 with	primary	 erectile	 dysfunction	 and	premature	 ejaculation.	 Annals	 of	
General	 Psychiatry,	 14(1),	 1–8.	https://doi.org/10.1186/s12991-015-0074-y	Muris,	 P.	 (2002).	 Relationships	 between	self-efficacy	 and	 symptoms	 of	anxiety	disorders	and	depression	in	a	normal	 adolescent	 sample.	
Personality	 and	 Individual	
Differences,	32,	337–348.	Muthen,	B.,	&	Satorra,	A.	(1995).	Complex	Sample	 Data	 in	 Structural	 Equation	Modeling.	 Sociological	 Methodology,	
25,	 267–316.	https://doi.org/10.2307/271070	Myers,	C.,	&	Smith,	M.	(2019).	Pelvic	 floor	muscle	 training	 improves	 erectile	dysfunction	 and	 premature	ejaculation:	 a	 systematic	 review.	
Physiotherapy,	 in	 press.	https://doi.org/10.1016/j.physio.2019.01.002	Open	 Science	 Collaboration.	 (2015).	Estimating	 the	 reproducibility	 of	psychological	 science.	 Science,	
349(6251),	 aac4716.	https://doi.org/10.1126/science.aac4716	Oxford	Center	for	Evidence	Based	Medicine	Working	 Group.	 (2009).	 No	 Title.	Retrieved	 from	https://www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/	Park,	H.	J.,	Park,	N.	C.,	Kim,	T.	N.,	Baek,	S.	R.,	Lee,	 K.	 M.,	 &	 Choe,	 S.	 (2017).	Discontinuation	 of	 dapoxetine	treatment	 in	 patients	 with	premature	 ejaculation:	 A	 2-year	prospective	 observational	 study.	
Sexual	 Medicine,	 5(2),	 e99–e105.	https://doi.org/10.1016/j.esxm.2017.02.003	Pastore,	 A.	 L.,	 Palleschi,	 G.,	 Fuschi,	 A.,	Maggioni,	 C.,	 Rago,	 R.,	 Zucchi,	 A.,	 …	Carbone,	 A.	 (2014).	 Pelvic	 floor	muscle	 rehabilitation	 for	 patients	
		 81	
with	 lifelong	 premature	ejaculation:	a	 novel	 therapeutic	 approach.	
Therapeutic	 Advances	 in	 Urology,	 6,	83–88.	https://doi.org/10.1177/1756287214523329	Pastore,	A.	L.,	Palleschi,	G.,	Leto,	A.,	Pacini,	L.,	Iori,	F.,	Leonardo,	C.,	&	Carbone,	A.	(2012).	 A	 prospective	 randomized	study	 to	 compare	 pelvic	 floor	rehabilitation	 and	 dapoxetine	 for	treatment	 of	 lifelong	 premature	ejaculation.	 International	 Journal	 of	
Andrology,	 35(1),	 528–533.	https://doi.org/10.1111/j.1365-2605.2011.01243.x	Patrick,	D.	L.,	Althof,	S.	E.,	Pryor,	J.	L.,	Rosen,	R.,	Rowland,	D.,	Ho,	K.	F.,	…	Jamieson,	C.	(2005).	Premature	ejaculation:	An	observational	study	of	men	and	their	partners.	 The	 Journal	 of	 Sexual	
Medicine,	 2(3),	 358–367.	https://doi.org/10.1111/j.1743-6109.2005.20353.x	Patrick,	D.	L.,	Giuliano,	F.,	Ho,	K.	F.,	Gagnon,	D.	 D.,	 McNulty,	 P.,	 &	 Rothman,	 M.	(2009).	 The	 Premature	 Ejaculation	Profile:	 Validation	 of	 self-reported	outcome	measures	 for	 research	and	practice.	 BJU	 International,	 103(3),	358–364.	https://doi.org/10.1111/j.1464-410X.2008.08041.x	Pavone,	 C.,	 Abbadessa,	 D.,	 Gambino,	 G.,	Scaduto,	 G.,	 &	 Vella,	 M.	 (2017).	Premature	 ejaculation :	Pharmacotherapy	 vs	 group	psychotherapy	 alone	 or	 in	combination.	 Archivo	 Italiano	 Di	
Urologia	 e	 Andrologia,	 89(2),	 114–
119.	Perelman,	 M.	 (2006).	 A	 new	 combination	treatment	for	premature	ejaculation:	A	 sex	 therapist’s	 perspective.	 The	
Journal	 of	 Sexual	Medicine,	3,	 1004–1012.	https://doi.org/10.1111/j.1743-6109.2006.00238.x	Perelman,	 M.	 A.	 (2017).	 Reexamining	 the	Definitions	of	PE	and	DE.	 Journal	 of	
Sex	 &	 Marital	 Therapy,	 43(7),	 633–644.	https://doi.org/10.1080/0092623X.2016.1230161	Perretti,	 A.,	 Catalano,	 A.,	 Mirone,	 V.,	Imbimbo,	C.,	Balbi,	P.,	Palmieri,	A.,	…	Santoro,	L.	(2003).	Neurophysiologic	evaluation	 of	 central-peripheral	sensory	 and	 motor	 pudendal	pathways	 in	 primary	 premature	ejaculation.	Urology,	61(3),	623–628.	https://doi.org/10.1016/S0090-4295(02)02284-7	Polderman,	T.	J.	C.,	Benyamin,	B.,	De	Leeuw,	C.	A.,	Sullivan,	P.	F.,	Van	Bochoven,	A.,	Visscher,	 P.	 M.,	 &	 Posthuma,	 D.	(2015).	 Meta-analysis	 of	 the	heritability	of	human	traits	based	on	fifty	 years	 of	 twin	 studies.	 Nature	
Genetics,	 47(7),	 702–709.	https://doi.org/10.1038/ng.3285	Porst,	 H.,	 McMahon,	 C.	 G.,	 Althof,	 S.	 E.,	Sharlip,	 I.,	Bull,	 S.,	Aquilina,	 J.	W.,	…	Rivas,	 D.	 A.	 (2010).	 Baseline	characteristics	 and	 treatment	outcomes	 for	men	with	 acquired	 or	lifelong	 premature	 ejaculation	 with	mild	 or	 no	 erectile	 dysfunction:	Integrated	 analyses	 of	 two	 phase	 3	dapoxetine	 trials.	 The	 Journal	 of	
		 82	
Sexual	 Medicine,	 7(6),	 2231–2242.	https://doi.org/10.1111/J.1743-6109.2010.01820.X	Porst,	H.,	Montorsi,	F.,	Rosen,	R.	C.,	Gaynor,	L.,	 Grupe,	 S.,	&	Alexander,	 J.	 (2007).	The	 Premature	 Ejaculation	Prevalence	 and	 Attitudes	 (PEPA)	survey:	 Prevalence,	 comorbidities,	and	 professional	 help-seeking.	
European	 Urology,	 51,	 816–824.	https://doi.org/10.1016/j.eururo.2006.07.004	Post,	 R.	 M.,	 Kotin,	 J.,	 Goodwin,	 F.	 K.,	 &	Gordon,	 E.	 K.	 (1973).	 Psychomotor	activity	 and	 cerebrospinal	 fluid	amine	 metabolites	 in	 affective	illness.	 The	 American	 Journal	 of	
Psychiatry,	 130(1),	 67–72.	https://doi.org/10.1176/ajp.130.1.67	Prinz,	 F.,	 Schlange,	 T.,	 &	 Asadullah,	 K.	(2011).	Believe	it	or	not:	How	much	can	 we	 rely	 on	 published	 data	 on	potential	 drug	 targets?	 Nature	
Reviews	Drug	Discovery,	10(9),	712–713.	https://doi.org/10.1038/nrd3439-c1	Pryor,	J.	L.,	Althof,	S.	E.,	Steidle,	C.,	Rosen,	R.	C.,	Hellstrom,	W.	J.	G.,	Shabsigh,	R.,	…	Kell,	 S.	 (2006).	 Efficacy	 and	tolerability	 of	 dapoxetine	 in	treatment	 of	 premature	 ejaculation:	an	integrated	analysis	of	two	double-blind,	 randomised	 controlled	 trials.	
The	Lancet,	368,	939–947.	Rebar,	A.	L.,	Stanton,	R.,	Geard,	D.,	Short,	C.,	Duncan,	 M.	 J.,	 &	 Vandelanotte,	 C.	(2015).	A	meta-meta-analysis	of	 the	effect	 of	 physical	 activity	 on	
depression	 and	 anxiety	 in	 non-clinical	 adult	 populations.	 Health	
Psychology	 Review,	 9(3),	 366–378.	https://doi.org/10.1080/17437199.2015.1022901	Riley,	 A.,	 &	 Riley,	 E.	 (2005).	 Premature	ejaculation:	 Presentation	 and	associations.	 An	 audit	 of	 patients	attending	 a	 sexual	 problems	 clinic.	
International	 Journal	 of	 Clinical	
Practice,	 59(12),	 1482–1487.	https://doi.org/10.1111/j.1368-5031.2005.00730.x	Rodríguez,	 J.	 E.,	 &	 López,	 A.	 (2016).	Male	masturbation	 device	 for	 the	treatment	 of	 premature	 ejaculation.	
Asian	Pacific	Journal	of	Reproduction,	
5(1),	 80–83.	https://doi.org/10.1016/j.apjr.2015.12.015	Ronksley,	 P.	 E.,	 Brien,	 S.	 E.,	 Turner,	 B.	 J.,	Mukamal,	K.	J.,	&	Ghali,	W.	A.	(2011).	Association	 of	 alcohol	 consumption	with	selected	cardiovascular	disease	outcomes:	 a	 systematic	 review	 and	meta-analysis.	BMJ	(Clinical	Research	
Ed.),	 342,	 d671.	https://doi.org/10.1136/bmj.d671	Rosen,	R.	C.,	&	Althof,	S.	(2008).	 Impact	of	premature	 ejaculation:	 The	psychological,	 quality	 of	 life,	 and	sexual	 relationship	 consequence.	
Journal	 of	 Sexual	Medicine,	5,	 1296–1307.	https://doi.org/10.1111/j.1743-6109.2008.00825.x	Rosen,	R.	C.,	 Cappelleri,	 J.	 C.,	 Smith,	M.	D.,	Lipsky,	 J.,	 &	 Peña,	 B.	 M.	 (1999).	Development	 and	 evaluation	 of	 an	abridged,	 5-item	 version	 of	 the	
		 83	
International	 Index	 of	 Erectile	Function	(IIEF-5)	as	a	diagnostic	tool	for	 erectile	 dysfunction.	
International	 Journal	 of	 Impotence	
Research,	 11(6),	 319–326.	https://doi.org/10.1038/sj.ijir.3900472	Rosen,	R.	C.,	Heiman,	J.	R.,	Long,	J.	S.,	Fisher,	W.	A.,	&	Sand,	M.	S.	(2016).	Men	with	Sexual	Problems	and	Their	Partners:	Findings	 from	 the	 International	Survey	 of	 Relationships.	Archives	 of	
Sexual	 Behavior,	 45(1),	 159–173.	https://doi.org/10.1007/s10508-015-0568-3	Rosenbaum,	 T.	 Y.	 (2013).	 An	 integrated	mindfulness-based	 approach	 to	 the	treatment	of	women	with	sexual	pain	and	 anxiety:	 Promoting	 autonomy	and	 mind/body	 connection.	 Sexual	
and	 Relationship	 Therapy,	 28(1–2),	20–28.	https://doi.org/10.1080/14681994.2013.764981	Rowland,	 D.	 (2005).	 Psychophysiology	 of	ejaculatory	function	and	dysfunction.	
World	 Journal	 of	Urology,	23,	82–88.	https://doi.org/10.1007/s00345-004-0488-7	Rowland,	D.	(2010).	Genital	and	heart	rate	response	to	erotic	stimulation	in	men	with	 and	 without	 premature	ejaculation.	 International	 Journal	 of	
Impotence	Research,	22(5),	318–324.	https://doi.org/10.1038/ijir.2010.22	Rowland,	 D.,	 Haensel,	 S.	M.,	 Blom,	 J.	 H.,	 &	Slob,	A.	K.	 (1993).	Penile	 sensitivity	in	 men	 with	 premature	 ejaculation	and	 erectile	 dysfunction.	 Journal	 of	
Sex	 &	 Marital	 Therapy,	 19(3),	 189–197.	https://doi.org/10.1080/00926239308404903	Rowland,	 D.,	 &	 Kolba,	 T.	 N.	 (2015).	Understanding	 the	 Effects	 of	Establishing	 Various	 Cutoff	 Criteria	in	 the	 Definition	 of	 Men	 with	Premature	 Ejaculation.	 Journal	 of	
Sexual	 Medicine,	 12(5),	 1175–1183.	https://doi.org/10.1111/jsm.12881	Rowland,	 D.,	 &	 Motofei,	 I.	 G.	 (2007).	 The	aetiology	 of	 premature	 ejaculation	and	 the	 mind-body	 problem:	Implications	 for	 practice.	
International	 Journal	 of	 Clinical	
Practice,	 61(January),	 77–82.	https://doi.org/10.1111/j.1742-1241.2006.01035.x	Rowland,	D.,	Patrick,	D.	L.,	Rothman,	M.,	&	Gagnon,	 D.	 D.	 (2007).	 The	psychological	 burden	 of	 premature	ejaculation.	 Journal	 of	 Urology,	
177(3),	 1065–1070.	https://doi.org/10.1016/j.juro.2006.10.025	Rowland,	 D.,	 Perelman,	 M.,	 Althof,	 S.,	Barada,	 J.,	McCullough,	A.,	Bull,	S.,	…	Ho,	 K.	 F.	 (2004).	 Self-reported	premature	ejaculation	and	aspects	of	sexual	 functioning	 and	 satisfaction.	
Journal	of	Sexual	Medicine,	1(2),	225–232.	https://doi.org/10.1111/j.1743-6109.2004.04033.x	Rowland,	D.,	Tai,	W.	L.,	&	Slob,	A.	K.	(2003).	An	 Exploration	 of	 Emotional	Response	 to	 Erotic	 Stimulation	 in	Men	 with	 Premature	 Ejaculation:	Effects	 of	 Treatment	 with	
		 84	
Clomipramine.	 Archives	 of	 Sexual	
Behavior,	 32(2),	 145–153.	https://doi.org/10.1023/A:1022452525629	Saenz	de	Tejada,	 I.,	&	Goldstein,	 I.	 (1988).	Diabetic	 penile	 neuropathy.	 The	
Urologic	 Clinics	 of	 North	 America,	
15(1),	 17–22.	 Retrieved	 from	http://www.ncbi.nlm.nih.gov/pubmed/2830692	Safarinejad,	 M.	 R.	 (2007).	 Safety	 and	Efficacy	 of	 Escitalopram	 in	 the	Treatment	of	Premature	Ejaculation.	
Journal	 of	 Clinical	
Psychopharmacology,	 27(5),	 444–450.	https://doi.org/10.1097/jcp.0b013e31814b98d4	Safarinejad,	M.	R.,	&	Hosseini,	S.	Y.	(2006).	Safety	 and	 efficacy	 of	 citalopram	 in	the	 treatment	 of	 premature	ejaculation:	A	double-blind	placebo-controlled,	 fixed	 dose,	 randomized	study.	 International	 Journal	 of	
Impotence	Research,	18(2),	164–169.	https://doi.org/10.1038/sj.ijir.3901384	Salama,	N.,	Eid,	A.,	Swedan,	A.,	&	Hatem,	A.	(2017).	 Increased	 prevalence	 of	premature	 ejaculation	 in	 men	 with	metabolic	syndrome.	The	Aging	Male,	
20(2),	 89–95.	https://doi.org/10.1080/13685538.2016.1277515	Salem,	S.,	Abdi,	S.,	Mehrsai,	A.,	Saboury,	B.,	Saraji,	 A.,	 Shokohideh,	 V.,	 &	Pourmand,	 G.	 (2009).	 Erectile	Dysfunction	 Severity	 as	 a	 Risk	Predictor	 for	 Coronary	 Artery	Disease.	 The	 Journal	 of	 Sexual	
Medicine,	 6(12),	 3425–3432.	https://doi.org/10.1111/j.1743-6109.2009.01515.x	Salonia,	A.,	Rocchini,	L.,	Sacca’,	A.,	Pellucchi,	F.,	 Ferrari,	 M.,	 Carro,	 U.	 Del,	 …	Montorsi,	 F.	 (2009).	 Acceptance	 of	and	 discontinuation	 rate	 from	paroxetine	 treatment	 in	 patients	with	 lifelong	 premature	 ejaculation.	
The	Journal	of	Sexual	Medicine,	6(10),	2868–2877.	https://doi.org/10.1111/j.1743-6109.2009.01404.x	Salonia,	A.,	Saccà,	A.,	Briganti,	A.,	Del	Carro,	U.,	Dehò,	F.,	Zanni,	G.,	…	Montorsi,	F.	(2009).	Quantitative	sensory	testing	of	 peripheral	 thresholds	 in	 patients	with	 lifelong	 premature	ejaculation:	A	 case-controlled	 study.	 Journal	 of	
Sexual	 Medicine,	 6(6),	 1755–1762.	https://doi.org/10.1111/j.1743-6109.2009.01276.x	Santtila,	 P.,	 Sandnabba,	 N.	 K.,	 &	 Jern,	 P.	(2009).	Prevalence	and	determinants	of	 male	 sexual	 dysfunctions	 during	first	 intercourse.	 Journal	 of	 Sex	 and	
Marital	 Therapy,	 35(2),	 86–105.	https://doi.org/10.1080/00926230802712293	Saunders,	 J.	B.,	Aasland,	O.	G.,	Babor,	T.	F.,	de	la	Fuente,	J.	R.,	&	Grant,	M.	(1993).	Development	 of	 the	 Alcohol	 Use	Disorders	 Identification	 Test	(AUDIT):	WHO	collaborative	project	on	 early	 detection	 of	 persons	 with	harmful	 alcohol	 consumption--II.	
Addiction,	88(6),	791–804.	Screponi,	E.,	Carosa,	E.,	Di	Stasi,	S.	M.,	Pepe,	M.,	Carruba,	G.,	&	Jannini,	E.	a.	(2001).	Prevalence	 of	 chronic	 prostatitis	 in	
		 85	
men	 with	 premature	 ejaculation.	
Urology,	 58(2),	 198–202.	https://doi.org/10.1016/S0090-4295(01)01151-7	Semans,	J.	(1956).	Premature	ejaculation:	A	new	 approach.	 Southern	 Medical	
Journal,	49(4),	353–357.	Serefoglu,	E.	C.,	Mcmahon,	C.	G.,	Waldinger,	M.	 D.,	 Althof,	 S.	 E.,	 Shindel,	 A.,	Adaikan,	G.,	…	Torres,	L.	O.	(2014).	An	evidence-based	 unified	 definition	 of	lifelong	 and	 acquired	 premature	ejaculation:	 Report	 of	 the	 second	international	 society	 for	 sexual	medicine	 Ad	Hoc	 committee	 for	 the	definition	 of	 premature	 ejaculation.	
Sexual	 Medicine,	 11(6),	 1423–1441.	https://doi.org/10.1111/jsm.12524	Serefoglu,	E.	C.,	Yaman,	O.,	Cayan,	S.,	Asci,	R.,	Orhan,	 I.,	Usta,	M.	F.,	…	Kadioglu,	A.	(2011).	Prevalence	of	the	Complaint	of	 Ejaculating	 Prematurely	 and	 the	Four	 Premature	 Ejaculation	Syndromes:	Results	from	the	Turkish	Society	 of	 Andrology	 Sexual	 Health	Survey.	 Journal	 of	 Sexual	 Medicine,	
8(2),	 540–548.	https://doi.org/10.1111/j.1743-6109.2010.02095.x	Shapiro,	B.	(1943).	Premature	Ejaculation:	A	 Review	 of	 1130	 Cases.	 Journal	 of	
Urology,	50,	374–379.	Silverstein,	R.	G.,	Brown,	A.-C.	H.,	Roth,	H.	D.,	&	 Britton,	 W.	 B.	 (2011).	 Effects	 of	mindfulness	 training	 on	 body	awareness	 to	 sexual	 stimuli:	Implications	 for	 female	 sexual	dysfunction.	Psychosomatic	Medicine,	
73(9),	 817–825.	https://doi.org/10.1097/PSY.0b013
e318234e628	Söderfeldt,	Y.,	Droppe,	A.,	&	Ohnhäuser,	T.	(2017).	 Distress,	 disease,	 desire:	Perspectives	on	the	medicalisation	of	premature	 ejaculation.	 Journal	 of	
Medical	 Ethics,	 43(12),	 865–866.	https://doi.org/10.1136/medethics-2015-103248	Spence,	J.,	McGannon,	K.,	&	Poon,	P.	(2005).	The	effect	of	exercise	on	global	self-esteem:	 A	 quantitative	 review.	
Journal	 of	 Sport	 and	 Exercise	
Psychology,	27,	311–334.	Spielberger,	C.,	Gorusch,	R.,	&	Lushene,	R.	(1970).	 Manual	 for	 the	 State-Trait	
Anxiety	 Inventory.	 Palo	 Alto,	 CA:	Consulting	Psychologist	Press.	Staudt,	M.	D.,	Truitt,	W.	A.,	Mckenna,	K.	E.,	de	Oliveira,	C.	V.	R.,	Lehman,	M.	N.,	&	Coolen,	L.	M.	(2012).	A	Pivotal	Role	of	Lumbar	 Spinothalamic	 Cells	 in	 the	Regulation	 of	 Ejaculation	 via	Intraspinal	 Connections.	 Journal	 of	
Sexual	 Medicine,	 9(9),	 2256–2265.	https://doi.org/10.1111/j.1743-6109.2011.02574.x	Symonds,	 T.,	 Perelman,	 M.	 A.,	 Althof,	 S.,	Giuliano,	 F.,	 Martin,	 M.,	 May,	 K.,	 …	Morris,	M.	(2007).	Development	and	Validation	of	a	Premature	Ejaculation	Diagnostic	 Tool.	 European	 Urology,	
52(2),	 565–573.	https://doi.org/10.1016/j.eururo.2007.01.028	Symonds,	T.,	Roblin,	D.,	Hart,	K.,	&	Althof,	S.	(2003).	 How	 does	 premature	ejaculation	 impact	 a	 man’s	 life?	
Journal	 of	 Sex	 &	 Marital	 Therapy,	
29(5),	 361–370.	
		 86	
https://doi.org/10.1080/00926230390224738	Teixeira,	P.	J.,	Carraça,	E.	V,	Marques,	M.	M.,	Rutter,	 H.,	 Oppert,	 J.-M.,	 De	Bourdeaudhuij,	 I.,	…	Brug,	 J.	 (2015).	Successful	 behavior	 change	 in	obesity	 interventions	 in	 adults:	 a	systematic	 review	 of	 self-regulation	mediators.	BMC	Medicine,	13(84),	1–16.	https://doi.org/10.1186/s12916-015-0323-6	Verze,	P.,	Arcaniolo,	D.,	Palmieri,	A.,	Cai,	T.,	La	Rocca,	R.,	Franco,	M.,	…	Mirone,	V.	(2018).	 Premature	 Ejaculation	Among	 Italian	Men:	 Prevalence	 and	Clinical	 Correlates	 From	 an	Observational,	 Non-Interventional,	Cross-Sectional,	 Epidemiological	Study	 (IPER).	 Sexual	 Medicine.	https://doi.org/10.1016/j.esxm.2018.04.005	Vicens-Costa,	 E.,	Malinauskas,	 T.,	Mott,	 R.,	Ekman,	D.,	Atanur,	S.	S.,	Adams,	D.	J.,	…	 Cuppen,	 E.	 (2013).	 Combined	sequence-based	and	genetic	mapping	analysis	of	complex	traits	in	outbred	rats.	 Nature	 Genetics,	 45(7),	 767–775.	https://doi.org/10.1038/ng.2644	Waldinger,	 M.	 D.	 (2007).	 Premature	ejaculation:	 different	pathophysiologies	 and	 etiologies	determine	 its	 treatment.	 Journal	 of	
Sex	 &	 Marital	 Therapy,	 34(1),	 1–13.	https://doi.org/10.1080/00926230701640355	Waldinger,	M.	D.,	Berendsen,	H.	H.	G.,	Blok,	B.	 F.	 M.,	 Olivier,	 B.,	 &	 Holstege,	 G.	(1998).	 Premature	 ejaculation	 and	
serotonergic	 antidepressants-induced	 delayed	 ejaculation:	 The	involvement	 of	 the	 serotonergic	system.	Behavioural	 Brain	 Research,	
92(2),	 111–118.	https://doi.org/10.1016/S0166-4328(97)00183-6	Waldinger,	 M.	 D.,	 Hengeveld,	 M.	 W.,	Zwinderman,	 A.	 H.,	 &	 Olivier,	 B.	(1998).	 An	 empirical	operationalization	 study	 of	 DSM-IV	diagnostic	 criteria	 for	 premature	ejaculation.	 International	 Journal	 of	
Psychiatry	 in	 Clinical	 Practice,	 2(4),	287–293.	https://doi.org/10.3109/13651509809115376	Waldinger,	M.	D.,	Mcintosh,	J.,	&	Schweitzer,	D.	H.	(2009).	A	five-nation	survey	to	assess	 the	 distribution	 of	 the	intravaginal	ejaculatory	latency	time	among	the	general	male	population.	
Journal	 of	 Sexual	Medicine,	6,	 2888–2895.	https://doi.org/10.1111/j.1743-6109.2009.01392.x	Waldinger,	 M.	 D.,	 Quinn,	 P.,	 Dilleen,	 M.,	Mundayat,	 R.,	 Schweitzer,	 D.	 H.,	 &	Boolell,	 M.	 (2005).	 A	 multinational	population	 survey	 of	 intravaginal	ejaculation	 latency	 time.	 Journal	 of	
Sexual	 Medicine,	 2,	 492–497.	https://doi.org/10.1111/j.1743-6109.2005.00070.x	Waldinger,	 M.	 D.,	 &	 Schweitzer,	 D.	 H.	(2019).	Differences	between	 ICD-11	MMS	 and	 DSM-5	 definition	 of	premature	 ejaculation:	 a	continuation	 of	 historical	inadequacies	and	a	source	of	serious	
		 87	
misinterpretation	by	some	European	Regulatory	 Agencies	 (PART	 2).	
International	 Journal	 of	 Impotence	
Research,	 (June	 2018).	https://doi.org/10.1038/s41443-018-0108-5	Waldinger,	 M.	 D.,	 Zwinderman,	 A.	 H.,	Schweitzer,	D.	H.,	&	Olivier,	B.	(2004).	Relevance	 of	 methodological	 design	for	 the	 interpretation	 of	 efficacy	 of	drug	 treatment	 of	 premature	ejaculation:	a	systematic	review	and	meta-analysis.	 International	 Journal	
of	 Impotence	 Research,	 16(4),	 369–381.	https://doi.org/10.1038/sj.ijir.3901172	Wegner,	D.	M.,	Shortt,	J.	W.,	Blake,	A.	W.,	&	Page,	M.	 S.	(1990).	The	Suppression	of	 Exciting	 Thoughts.	 Journal	 of	
Personality	 and	 Social	 Psychology,	
58(3),	 409–418.	https://doi.org/10.1037/0022-3514.58.3.409	Winters,	 J.,	 Christoff,	 K.,	 &	 Gorzalka,	 B.	 B.	(2009).	 Conscious	 Regulation	 of	Sexual	Arousal	in	Men.	Journal	of	Sex	
Research,	 46(4),	 330–343.	https://doi.org/10.1080/00224490902754103	World	 Health	 Organization.	 (2018).	
International	statistical	classification	
of	 diseases	 and	 related	 health	
problems.	 Retrieved	 from	https://icd.who.int/browse11/l-m/en	Wyllie,	M.	G.,	&	Hellstrom,	W.	 J.	G.	(2011).	The	 link	 between	 penile	hypersensitivity	 and	 premature	ejaculation.	 BJU	 International,	
107(3),	 452–457.	https://doi.org/10.1111/j.1464-410X.2010.09456.x	Xia,	Y.,	Li,	J.,	Shan,	G.,	Qian,	H.,	Wang,	T.,	Wu,	W.,	 …	 Liu,	 L.	 (2016).	 Relationship	between	 premature	 ejaculation	 and	depression:	 A	 PRISMA-compliant	systematic	review	and	meta-analysis.	
Medicine,	 95(35),	 e4620.	https://doi.org/10.1097/MD.0000000000004620	Xin,	Z.	C.,	Chung,	W.	S.,	Choi,	Y.	D.,	Seong,	D.	H.,	 Choi,	 Y.	 J.,	 &	 Choi,	 H.	 K.	 (1996).	Penile	 sensitivity	 in	 patients	 with	primary	 premature	 ejaculation.	 The	
Journal	 of	 Urology,	 156,	 979–981.	Retrieved	 from	http://www.ncbi.nlm.nih.gov/pubmed/9186355	Yildiz,	 Y.,	 Kilinc,	 M.	 F.,	 &	 Doluoglu,	 O.	 G.	(2018).	 Is	 There	 Any	 Association	Between	 Regular	 Physical	 Activity	and	 Ejaculation	 Time?	 Urology	
Journal,	 ([Epub	 ahead	 of	 print]).	https://doi.org/10.22037/uj.v0i0.4031	Zamar,	A.	(2012).	Premature	ejaculation:	A	new	 treatment	 using	 a	 stimulating	device	in	conjunction	with	the	start-stop	technique.	In	Proceedings	of	the	
world	 meeting	 on	 sexual	 medicine,	
Journal	 of	 Sexual	 Medicine	 (Vol.	9(suppl	4),	p.	217).	Zhang,	X.,	Gao,	J.,	Liu,	J.,	Xia,	L.,	Yang,	J.,	Hao,	Z.,	 …	 Liang,	 C.	 (2013).	 Distribution	and	 factors	 associated	 with	 four	premature	ejaculation	syndromes	in	outpatients	 complaining	 of	ejaculating	 prematurely.	 Journal	 of	
Sexual	 Medicine,	 10(6),	 1603–1611.	
		 88	
https://doi.org/10.1111/jsm.12123	Zorba,	O.	U.,	Cicek,	Y.,	Uzun,	H.,	 Çetinkaya,	M.,	 Önem,	 K.,	 &	 Rifaioǧlu,	 M.	 M.	(2012).	 Autonomic	 nervous	 system	dysfunction	 in	 lifelong	 premature	ejaculation:	 Analysis	 of	 heart	 rate	variability.	 Urology,	 80(6),	 1283–1286.	https://doi.org/10.1016/j.urology.2012.08.029			
Daniel Ventus
Diagnosis, Etiology, and Psychobehavioral 
Treatment of Premature EjaculationDaniel Ventus | Prem
ature Ejaculation | 2019
Daniel Ventus
Diagnosis, Etiology, 
and Psychobehavioral 
Treatment of 
Premature Ejaculation
Premature ejaculation is a common sexual 
complaint among males, and is often associated 
with decreased quality of life for the man and 
his partner. 
This dissertation presents new evidence show-
ing that symptoms are sometimes not as stable 
over time as previously assumed, and implica-
tions for diagnosis and treatment are discussed. 
Associations between anxiety, depression, 
lifestyle factors, and premature ejaculation are 
also analyzed. A treatment involving vibrator-
assisted start-stop exercises is evaluated.
ISBN 978-952-12-3862-8
